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This project applies structure-activity relationship (SAR), structure-based and 
database mining approaches to study ligand-protein interactions.  To support these 
studies, we have developed a relational database system called EDinburgh University 
Ligand Selection System (EDULISS 2.0) which stores the structure-data files of +5.5 
million commercially available small molecules (+4.0 million are recognised as 
unique) and over 1,500 various calculated molecular properties (descriptors) for each 
compound.  A user-friendly web-based interface for EDULISS 2.0 has been 
established and is available at http://eduliss.bch.ed.ac.uk/.   
We have utilised PubChem bioassay data from an NMR based screen assay for a 
human FKBP12 protein (PubChem AID: 608).  A prediction model using a Logistic 
Regression approach was constructed to relate the assay result with a series of 
molecular descriptors.  The model reveals 38 descriptors which are found to be good 
predictors. These are mainly 3D-based descriptors, however, the presence of some 
predictive functional groups is also found to give a positive contribution to the 
binding interaction.  The application of a neural network technique called Self 
Organising Maps (SOMs) succeeded in visualising the similarity of the PubChem 
compounds based on the 38 descriptors and clustering the 36 % of active compounds 
(16 out of 44) in a cluster and discriminating them from 95 % of inactive compounds.   
We have developed a molecular descriptor called the Atomic Characteristic Distance 
(ACD) to profile the distribution of specified atom types in a compound.  ACD has 
been implemented as a pharmacophore searching tool within EDULISS 2.0.  A 
 
  II
structure-based screen succeeded in finding inhibitors for pyruvate kinase and the 
ligand-protein complexes have been successfully crystallised. 
This study also discusses the interaction of metal-binding sites in metalloproteins.  
We developed a database system and web-based interface to store and apply 
geometrical information of these metal sites.  The programme is called MEtal Sites 
in Proteins at Edinburgh UniverSity (MESPEUS; 
http://eduliss.bch.ed.ac.uk/MESPEUS/).  MESPEUS is an exceptionally versatile 
tool for the collation and abstraction of data on a wide range of structural questions.  
As an example we carried out a survey using this database indicating that the most 
common protein types which contain Mg-OATP-phosphate site are transferases and the 
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1. Introduction 
Various biological processes involve ligand-protein interactions, and these 
interactions play key roles in mediating enzyme catalysis, signal transduction or 
other protein functions (Schreyer and Blundell 2009).  Generally, ligands are defined 
as all non-protein and non-water molecules, such as nucleic acids, metals, small 
organic or inorganic ions as well as peptides of up to 20 residues (Hendlich, Bergner 
et al. 2003), which bind to a target protein.  In drug discovery projects, the general 
intent is to develop a new drug based on the mode of ligand-protein interactions as 
the new compound (or drug candidate) should specifically bind to the target protein 
resulting in the disruption of the native ligand-protein interactions and inhibition of 
the protein’s activity.  For example, cyclophilins are known essential proteins for the 
activity of Human Immunodeficiency Virus, HIV (Thali, Bukovsky et al. 1994; 
Gamble, Vajdos et al. 1996; Luban 1996) and malaria parasites (Bell, Wernli et al. 
1994; Silverman 2004), hence the inhibition of these proteins by targeting their 
ligand binding sites can be a useful strategy for anti-HIV therapy (Billich, 
Hammerschmid et al. 1995; Bose, Mathur et al. 2003) or anti-malarial (Nickell, 
Scheibel et al. 1982; Berriman and Fairlamb 1998) drug development. 
The starting point of drug discovery is typically from an investigation of ligand 
binding sites found in a target protein and various selections of structural motifs are 
then carried out iteratively.  The motifs are structurally or chemically similar to 
known active compounds and are predicted to interact with the binding sites.  The 
process commonly ends with small molecules called hits or leads which are capable 
of being synthesised and chemically modified and can be used for further 
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experimental work or biological testing (Bajorath, Klein et al. 1999).  Figure 1.1 
illustrates the outline of a practical and cost-effective strategy in modern drug 
discovery  (Agrafiotis, Lobanov et al. 2002).  It shows that after the genetic 
engineering required to clone and express the target protein, the process enters an 
iterative stage to refine the selection of candidate compounds.  Those approaches and 
resources mentioned in Figure 1.1 are divided into three main components in order 
and are described as: 
HTS (high-throughput screening): The first screening shown in Figure 1.1 is the 
application of HTS (high-throughput screening) to test the drug-like compounds 
against the preselected target.  The tested compounds are derived from a probe 
library.  HTS is a quantitative and universal ligand-protein binding assay.  As a drug 
discovery technique it started at the end of 1980s, up to the late 1990s and has been 
widely used throughout the pharmaceutical industry (Roberts 2001; Macarron 2006) 
due to its efficient capability in screening compounds in short order, say five weeks 
for a million compounds (Landro, Taylor et al. 2000). 
Unlike HTS which is experimental, the other theoretical method for rapidly 
screening compounds is the application of virtual high-throughput screening (VHTS) 
which has emerged and is growing greatly with the increased computational power 
available in recent decades (Bajorath 2002; Lee, Choi et al. 2008).  It is considered as 
a complementary and alternative technology to HTS (Alvarez 2004).  Several well-
known docking programmes are available to perform virtual screening, which 
primarily predict the conformation and orientation of tested liagnds within a 
preselected binding site (Anderson 2003; Kitchen, Decornez et al. 2004).  These 
Chapter 1: Introduction 
  3
programmes generally possess the features of time- and cost-saving in drug 
discovery projects compared with HTS as they effectively eliminate undesired 
compounds prior to experimental testing. 
SAR (structure-activity relationship): The development of SARs (structure-
activity relationships) is used in the analysis of binding results given by HTS and 
helps formulate a set of correlated molecular properties of tested compounds based 
on the reported quantitative structure-activity data.  SAR was initially proposed in 
the mid-1960s for the study of the correlation between biological activity and 
chemical structure as well as for the prediction of molecular partition coefficients 
between octanol and water (Fujita, Iwasa et al. 1964; Hansch and Fujita 1964).  The 
SAR analysis in this step reveals how molecular descriptors of test compounds 
influence the binding affinity to the target protein, i.e. the interaction mechanisms 
between molecular properties and binding activity (Frye 1999; Gao, Williams et al. 
1999).  With the SAR analysis suggesting the preferential molecular properties to be 
included in new compound synthesis, researchers can select the preferred compounds 
from a computer database which would ideally store the analogues of the drug-like 
compounds studied in the earlier step.  The selected compounds are then synthesised 
for subsequent testing to refine the screening criteria or may be used directly in 
biological testing.  Various statistical modelling, clustering or neural network 
techniques have been applied to aid the SAR analysis (Shi, Fan et al. 1998; 
Schneider 2000; Yoshida and Topliss 2000). 
Other than the SAR analysis integrated with HTS, some molecular properties are 
seen to be widely used for compound selection as they have been shown to correlate 
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with bioavailability.  For example, the number of rotatable bonds in a compound is a 
commonly used filter.  Previous studies indicate that when the number of rotatable 
bonds is greater than 10, the rat oral bioavailability tends to be decreased (Veber, 
Johnson et al. 2002) as well as reducing the ligand affinity to the targeted site on 
average (Lipinski 2004).  The molecular polar surface area, commonly called the 
PSA, is seen to influence the compound’s activity in the central nervous system 
(CNS) as a value of PSA less than 60-70 Å2 increases the ability of drugs to diffuse 
through the blood-brain barrier (Kelder, Grootenhuis et al. 1999).  A simpler 
approach to predict the drug transport across the blood-brain barrier based on the 
molecular properties is that if the sum of the nitrogen and oxygen atom counts in a 
compound is ≤  5, it possesses a higher probability to pass through the blood-brain 
barrier (Norinder and Haeberlein 2002).  These molecular properties and of course 
the molecular descriptors involved in various rule-based screenings (detailed in 
Chapter 2) have been commonly considered in the early stage of screening. 
Databases (or libraries): Although the application of HTS in drug discovery has 
shown an impressive progression, the number of successfully marketed drugs 
obtained through the screening process is very low.  The ratio of increased risk of 
failure estimated from the initial screening to the end is shown in Figure 1.2 (Oprea 
2000; Hann and Oprea 2004).  Approximately only one compound can reach the 
launched status successfully in one million tested compounds (or more) via HTS.  
Additionally, it on average takes 14 years to bring a compound from identified hits to 
an approved drug (Myers and Baker 2001). 
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In order to make overall discovery project more effective, researchers are working 
not only to optimise the performance of HTS, but also to enhance the functions of the 
other components shown in Figure 1.1.  For example, the databases (or libraries), 
whether for the storage of gene information, macro- or small-molecule structure, 
chemical reaction or experimental activity, have been readily established and are 
now being rapidly enlarged (Malik, Singh et al. 2006; Bharatam, Khanna et al. 2008).  
Some formats to represent, store or share the above information in computer usable 
formats are then adopted, such as Crystallographic Information File (CIF) and 
Protein Data Bank (PDB) file for crystal structures (Brown and McMahon 2002; 
Berman, Henrick et al. 2007), FASTA for nucleotide sequences or peptide sequences 
(Pearson and Lipman 1988) as well as Simplified Molecular Input Line Entry System 
(SMILES), IUPAC International Chemical Identifier (InChI) strings and MDL 
Structure-Data file (SDfile) for chemical structures (Weininger 1988; Dalby, Nourse 
et al. 1992).  These computer usable formats can also assist researchers to facilitate 
similarity searches by allowing them to rapidly identifing similar entries already 
available in databases. 
In overall drug discovery, the databases (or libraries) are seen to be involved 
throughout the process.  Therefore, the implementation, manipulation or utilisation of 
a bioinformatics or chemical database is becoming a crucial aspect in drug discovery.  
Figure 1.3 gives details of a census that show the number of papers in PubMed 
containing the keywords “drug discovery” and “database”.  It shows that the trend 
for research using or regarding databases in drug discovery has obviously increased 
in this decade.  As this thesis focuses on the database studies of ligand-protein 
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interaction, the following sections give a survey of some worldwide databases 
available for drug / ligand discovery as well as for understanding the interaction of 
metal atoms in proteins. 
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Figure 1.1. Outline of a practical strategy in modern drug discovery.  (a) and (b) 
are to obtain the target protein.  (c) is a probe library composed of drug-like 
compounds.  (d) is to find active hits via quantitative HTS (high-throughput 
screening).  (e) is to apply SAR (structure-activity relationship) approach based 
on the binding assay to formulate a set of correlated molecular properties for 
further compound selection.  (f) is to select compounds from a computer 
database according to the result of previous steps.  (g) is to synthesis the 
candidates for the further screening refinement or to be tested directly in some 













(Agrafiotis, Lobanov et al. 2002) 
Figure 1.2. Cascade of a typical drug discovery.  HTS hits: the compounds show 
activity during HTS.  HTS actives: the hits are retested to confirm the binding 
activity and structure.  Lead series: the amenable structures for further 
chemical synthesis.  Drug candidates: compounds meet the druggable criteria, 
including the consideration in toxicity, pharmacokinetic properties and the 
activity in animal models. 
HTS 1 million 
HTS hits 2000 
HTS actives 1200 
Lead series 50-200 
Drug candidates 10 
Drug 1 
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Figure 1.3. Number of papers found in PubMed from 1984 to present containing 












1.1 Small-molecule databases 
As shown in Figure 1.1, modern drug discovery iteratively screens small molecules 
for their ability to bind to a preselected target and/or for their amenability to 
chemical synthesis.  These small molecules are often presented in various formats 
and stored in publicly accessible databases, sometimes together with their bioassay 
or chemical reaction data, making the database a powerful tool in data retrieval and 
management (Schreiber 2000).  The fundamental information stored in small-
molecule databases normally includes the sketch of atoms and bonds or line 
notations, such as the string formats SMILES, InChI or fingerprint (Butina 1999), to 
represent a compound and sometimes includes the 2D or 3D coordinates of all atoms 
in the structure that allows researchers to see the identity of compounds by using 
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molecular viewers  (Miller 2002) or to be used in structure-based virtual screening 
(Lyne 2002; Anderson 2003; Ghosh, Nie et al. 2006).  On the other hand, as the lack 
of publicly available datasets of molecules would greatly hamper the development of 
chemoinformatics (Marris 2005), and so modern chemical databases should also 
concern their utility allowing users to retrieve the desired compounds.  Table 1.1 
summarises five publicly available small-molecule databases.  They possess distinct 
features in mining facilities, documentation or data source and are useful for drug or 
ligand discovery, and are introduced in the following sub-sections. 









ChemBank +1.2 M 
(unique) 
Bio-assay Yes 37 items 
PubChem +19 M 
(unique) 
Bio-assay Yes 12 items
a
 
BindingDB +28,000 Bio-assay Yes Molecular weight
DrugBank 4,886 Drugs
c










: The function needs to integrate with structure-based search. 
b
: The function is able to integrate with molecular activity filter. 
c
: FDA-approved and Experimental drugs. 
d
: The compounds of U.S. Patents and Applications. 
 
1.1.1 ChemBank (http://chembank.broad.harvard.edu/) 
This is a small-molecule database with the data of about 2,500 high-throughput 
biological assays results (Seiler, George et al. 2008).  There are more than 1.7 
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million compounds deposited in this database and 1.2 million of them are unique.  
This database also stores over 300 calculated molecular descriptors for each 
compound.  Users can find the information for small molecules, assays or targets 
currently resident in ChemBank via its web-based interface.  The interface provides 
not only the conventional tools allowing users to retrieve compounds, such as using 
substructure, similarity or descriptor search, but also offers the ability for users to 
search by bioassays, known function (e.g. biological process or therapeutic use) and 
the name of molecules or chemists (or vendors) who synthesised the compounds. 
ChemBank shows an impressive performance in responding to a query and displays 
the result on the web pages very quickly even when the query was formulated to 
select all compounds extant in the database, e.g. searching for molecular weight 
greater than 0.  The result page gives the hit compound’s primary name, chemical 
structure, biological annotations, calculated molecular descriptor values and the 
substances ID, if available, referred to PubChem (http://pubchem.ncbi.nlm.nih.gov/) 
as well as the information of relevant HTS screening instances.  The statistical data 
of bioassay outcomes can be presented in a histogram format to perform SAR 
analyses.  It also provides hyperlinks to search Google for specified molecule which 
gives more information concerning the compound.   
1.1.2 PubChem (http://pubchem.ncbi.nlm.nih.gov/) 
This is a very well-known resource for efficiently identifying the biological activity 
information of small molecules (Fontaine, Bolton et al. 2007; Han, Wang et al. 2008; 
Sayers, Barrett et al. 2008), belonging to the National Center for Biotechnology 
Information (NCBI) at the National Institutes of Health (NIH; http://www.nih.gov/).  
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It stores more than 19 million non-redundant compounds provided by about 70 
various organisations and 28 million bioassay test outcomes in 1,000 bioassays.  As 
it represents a vast deposit, it has been widely adopted in relevant research projects 
such that the number of papers found in PubMed from 2005 containing the keyword 
“PubChem” is over 60.  The web interface of the PubChem database provides a set 
of very complete query tools for users and has integrated its three sub-databases, i.e. 
PubChem Substance, PubChem Compound, and PubChem BioAssay respectively.  
The integration allows users to have a comprehensive overview and the query result 
pages also give associations between biological testing results for identical 
compounds.  The PubChem Substance database stores the descriptions of chemical 
samples provided by depositors.  PubChem Compound contains the unique 
compound structure content of PubChem Substance.  PubChem BioAssay deposits 
the biological activity testing results from various sources.  The web interface 
provides a set of built-in analysis facilities, including the functions “BioActivity 
Summary”, “Structure-Activity Analysis”, and “Structure Clustering” which can be 
found in the query result pages to perform a basic SAR analysis. 
As well as the molecular structure files, the bioassay results and their descriptions are 
downloadable from the web interface and the experimental protocols of the bioassays 
are described on the page.  All PubChem data is available on the PubChem FTP 
server and users can connect to the site freely to download the entire deposit.   
1.1.3 BindingDB (http://www.bindingdb.org/) 
This database holds over 28,000 compounds which have had their binding affinities 
in ligand-protein complexes experimentally determined (Liu, Lin et al. 2007).  At 
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present, over 56,000 measurements of enzyme inhibition constant or isothermal 
titration calorimetry (ITC) experiments have been carried out against 591 preselected 
targets which are mainly drug-targets or candidate drug-targets whose structural data 
have been deposited in the PDB. 
To retrieve the information from this database, users can set query criteria based on 
the basic features of the small compounds or the targets, such as a structure-based or 
similarity search, molecular weight, target sequence or their names.  Alternatively, a 
set of activity filters, such as asking the binding affinity in a specified range of IC50 
(nM) or ΔG° (kcal/mol), are available via its web-based interface.  For example, the 
query result page shows 1,630 observations when the given question was the 
measured IC50 (nM) between 2 and 5 in all of the available assays.  The information 
of various affinity measurements is then presented together with the hyperlinks 
connected to other databases for easy navigation, such as PDB, NCBI’s MMDB 
(Molecular Modeling DataBase), PubChem or PubMed, in which the details of the 
tested lignad or target can be found.   
The BindingDB website also provides a capability to perform non-structure-based 
virtual screening.  For example, users can upload their interesting compounds to the 
website, a built-in piece of software will then calculate the Tanimoto similarity 
between each uploaded compound and each active compound found in BindingDB 
database based on JChem chemical fingerprints (Csizmadia 2000), and rank the 
uploaded compounds according to the calculated maximal similarity to any active 
compound.  The drawback of this service is that users cannot know the maximal 
similarity to which active compound from the information shown on the page. 
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1.1.4 DrugBank (http://www.drugbank.ca/) 
This database stores the information of known drugs and their target proteins 
(Wishart, Knox et al. 2006; Wishart, Knox et al. 2007).  At present, it holds 4,886 
drug chemical structures with over 2,500 non-redundant sequences of targets, 
including proteins or DNA.  The drug collection contains more than 1,350 small 
molecule drugs approved by FDA (U.S. Food and Drug Administration; 
http://www.fda.gov/), 3,000 experimental drugs, some biotech drugs (a protein or 
peptide produced using living organisms such as yeast or bacteria) and nutraceuticals 
(nutritional supplements). 
The general molecular properties of the compounds deposited in DrugBank are listed 
in Table 1.2.  In this database, about 79 % of the compounds fit the Lipinski’s rule of 
five (Lipinski, Lombardo et al. 1997) and overall compounds are rather diverse 
indicated by the wide standard deviations observed in each molecular property.  For 
instance, two approved drugs that possess extreme values in some molecular 
properties are inulin (a hypoglycemic agent) and selenium sulfide (antifungals for 
topical use) and their chemical structures are shown in Figure 1.4 (a) and (b), 
respectively. 
The web-based interface of DrugBank provides a set of built-in tools for searching 
drugs, viewing and sorting the query results as well as for downloading small 
molecular structure data, target sequence (protein or gene sequence in FASTA 
format) and extracting text or images.  A unique feature of DrugBank is that it 
organises a very detailed report, called DrugCard, for each drug entry.  A DrugCard 
contains more than 100 data fields listing the information of chemical, 
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pharmacological, pharmacogenomic and molecular biological data.  The DrugCard 
also gives extensive hyperlinks to some useful bioinformatics, biomedical or 
pharmaceutical databases to show the expanded information of the specified drug.  
These expanded resources include KEGG, a database for understanding functions 
and utilities of the biological system (Kanehisa, Goto et al. 2006); ChEBI, a database 
for showing the chemical entities in ontology (Degtyarenko, Matos et al. 2007); 
RxList, a internet drug index (Hatfield, May et al. 1999); PharmGKB, a clinically 
oriented drug database for knowing the impact of human genetic variations on drug 
response (Hodge, Altman et al. 2007); PDB, PubChem, PubMed and so on. 
Table 1.2. General molecular properties of the compounds deposited in 
DrugBank. 





46.08 392.15 346.72 




 52.38 47.79 




 54.17 48.96 
Number of rings 38
*
 0 2.78 1.93 
Number of HAcc 191
*
 0 6.90 9.13 
Number of HDon 116
*
 0 3.11 5.96 





 1.54 3.15 
*: The compound that possesses maximum values in these observations is Inulin 
(CAS: 9005-80-5) and its structure is shown as Figure 1.4 (a) in 2D. 
+
: The compound that possesses minimum values in the number of atoms and bonds 
is Selenium Sulfide (CAS: 7446-34-6) and its structure is shown as Figure 1.4 (b) in 
2D. 
#
: Calculated octanol / water partition coefficient (Moriguchi, Hirono et al. 1992). 
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Figure 1.4. Structures of Inulin (a) and Selenium Sulfide (b) in 2D which both 
are approved drugs and possess extreme values in some molecular properties 








1.1.5 IBM Chemical Search Engine (https://chemsearch.almaden.ibm.com/) 
This is a chemical patent query system with a web-based interface (alpha site) 
allowing users to explore chemical structures from the corpus of U.S. Patents (1976 
to 2005) and Patent Applications (2003 to 2005).  The database contains more than 
4.1 million unique compounds (Rhodes, Boyer et al. 2006).  Considering the need of 
drug discovery, this system has identified the chemical terms for each patent entry 
and converted them into structures, so that it provides a patent mining facility using 
molecular similarity search instead of the traditional text mining, e.g. search by the 
name of molecules or the patent ID.  Other than SMILES string, the similarity search 
engine is mainly based on IUPAC International Chemical Identifier (InChI) standard 
for the calculation of similarity. 
The molecule name and patent information of hit compounds are present on the 
query result page.  The interface also provides a molecular network function to 
graphically exhibit the association between the similar compounds and their patents.  
For example, users can select 10 hit compounds and then the network of their patents 
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and applicants can be displayed on a single figure.  The drawback of this system is 
that it is still under development.  The molecular search function is out of order 
constantly and it can only be performed by drawing a query compound or inputting a 
SMILES / InChi string but further adding more restricted criteria for query, such as 
molecular property filters. 
1.2 Metalloprotein databases 
Another area of ligand-protein interactions considered in this thesis is the metal-
binding sites in metalloproteins.  Metal atoms play a broad variety of roles in biology, 
such as being the enzyme cofactors or involved in catalytic active site construction 
and protein structure maintenance (Cox and McLendon 2000; Wittung-Stafshede 
2002).  The following describes some resources which provide information on metal-
binding sites to aid the understanding of metalloproteins. 
1.2.1 MDB (http://metallo.scripps.edu/) 
MDB, the Metalloprotein Database and Browser, is a web-accessible database for 
metalloprotein research (Castagnetto, Hennessy et al. 2002).  It collects and extracts 
the geometry information of more than 32,000 metal-binding sites from 8,069 
structures existing at PDB.  From the viewpoint of a metal-binding site, the ligands 
conventionally mean the residues, molecules or charged ions that interact with the 
metal  atom (Yamashita, Wesson et al. 1990).  MDB allows users to search the 
metal-binding sites for 37 different metal atoms which are found to be bound with 
proteins via the first-shell ligands (i.e. ligands bind these metals) or the second-shell 
ligands, (i.e. residues contact the metal-binding ligands). 
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The ligand types found in MDB include amino acids, nucleic acids, metal, water, 
anion and hetero atoms.  The longest metal-ligand (first-shell) distance found in 
MDB is 3.5 Å.  Other than specifying metal atoms, users can also select some 
crystallographic filters to restrict the query, such as the number of donors, structure 
resolution (Å), R-value, metal-ligand distances etc.  The interface provides an 
interactive 3D viewer and on-line histogram plotting tool to display the geometry of 
hit metal sites and the statistical distribution of the metal-ligand distances, 
respectively.  The database can be accessed using an SQL (Structured Query 
Language) statement directly via a given page for a more flexible query but the users 
would need to be familiar with the SQL language. 
This resource is a useful tool for studying metal site geometries and properties.  This 
data is crucial for the construction of new metal binding sites into a known protein 
scaffold or for the refinement of exiting metal sites.  However, new material does not 
appear to have been added to this database since 2004 and the query results are not 
downloadable for further analysis.  
1.2.2 JenaLib (http://www.imb-jena.de/IMAGE.html) 
JenaLib, Jena Library of Biological Macromolecules, is an image library of 
biopolymer structures deposited in PDB and NDB (Nucleic Acid Database; 
http://ndbserver.rutgers.edu/) (Berman, Olson et al. 1992) with emphasis on 
visualisation and analysis (Reichert and Suhnel 2002).  Two sub-databases in the 
JenaLib system, called Hetero Components Database and Site Database, provide the 
fundamental descriptions of biopolymer structures containing hetero molecules or 
atoms.  All residues are taken into account to be the components of a site, which 
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have at least one atom located within a distance of 4.2 Å from a specific hetero atom 
or molecule. 
As metal atoms are defined as hetero atoms according to the format of a PDB file, 
users can find the information of metallopteins from its two sub-databases.  From the 
web-based interface of Hetero Components Database, users can simply choose a 
metal atom via the provided interactive periodic table of elements and the page will 
return the hit structures which contain the selected metal.  The pre-generated static 
images of the hit structures are available for structural observation which emphasise 
the location of selected metals occurring in the structure.  Alternatively, users can 
choose the dynamical molecule viewer (Jmol) provided to explore and manipulate 
the structures in 3D. 
The design of JenaLib is not exactly useful for metal site investigations, as it only 
lists some fundamental descriptions of the biopolymer structure, such as the title in 
PDB file, protein class, structure resolution or relevant references, and provides their 
images.  It does not detail the geometry of metal sites.  The number of available 
options for a query is also limited.  Users can merely specify the hetero ID or name 
presented in the PDB file, the metal name or search for the occurrence of any 
components in the environment of hetero components.  Only one single option can 
be selected in a query. 
1.2.3 PROMIS (http://metallo.scripps.edu/PROMISE/) 
PROMIS, Prosthetic Groups and Metal Ions in Protein Active Sites (version 2.0), is a 
database focused on the relationships between protein and metal ions and prosthetic 
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groups (Degtyarenko, North et al. 1998) found in protein’s active sites.  Prosthetic 
groups are defined as the non-amino acid portion conjugated to a protein, such as 
cofactors (Nagel, Dellweg et al. 1992). 
For the study of metal sites in proteins, the web-based interface of this database lists 
the information of known chlorophyll-containing proteins (i.e. proteins in 
photosynthetic organisms that contain magnesium), copper proteins, haem proteins, 
iron-sulphur proteins etc.  These proteins have been classified by their functions, 
classes or the centre types of the metal in the coordination (e.g. mononuclear and 
binuclear centre).  In order to illustrate the amino acid-metal coordination, the figures 
of various coordination groups are pre-generated by the MOLSCRIPT programme 
(Kraulis 1991).  The pages also list the associated bibliography for each mentioned 
protein, more than 2,000 references in total. 
One drawback of this resource is that it has not been updated for a long time.  It was 
last modified 1 March 1999.  Besides, its web-based interface is static without the 
functions for dynamic query or structural display. 
1.3 Project aims 
This project aims to collect the chemical structures of the vast number of 
commercially purchasable small molecules and to construct an accessible database 
with a web-based interface to maintain and utilise the data efficiently.  The 
generation and application of the molecular properties, i.e. the descriptors, for each 
deposited compound have been included in this project.  The approach of developing 
a Structure-Activity Relationship (SAR) is then used in the ligand-protein binding 
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study using the created molecular descriptors and the known bio-assay outcomes, in 
order to discover the correlation between compound activity and molecular 
descriptors.  A structure-based mining of pharmacophore searching approach is also 
designed and implemented using the deposited chemical structures as material for 
ligand discovery.  Additionally, this project involves a study dealing with the 
interaction of different metals with proteins.  Similarly, a database system has been 
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2. Development of small-molecule database, EDULISS 2.0 
2.1 Introduction 
EDinburgh University Ligand Selection System (EDULISS) is a relational database 
system which holds the physicochemical properties of compounds.  The initial 
version was created by Dr. Andrew Hinton of the Institute of Structural and 
Molecular Biology around 2002 to 2005.  Version 1.0 of the database contained 16 
prominent supplier chemical catalogues, +1.5 million compounds and over 1,500 
different descriptor items per compound. 
Since the suppliers are constantly synthesising novel compounds and building-blocks, 
the number of commercially purchasable compounds has considerably increased.  
Practise in this area varies, however many suppliers update their catalogues regularly, 
adding new compounds, removing unavailable compounds or altering the compound 
structure and its structure-data file (SDfile).  Table 2.1 shows the growth and decline 
between the various versions of several catalogues which display the largest variation 
between editions.  Furthermore, in some cases the SDfiles might be altered by 
vendors, such as the location of hydrogen or mineral atoms and modification to the 
bonding information (Figure 2.1).  For the reasons mentioned above, it is necessary 
to update EDULISS.  Unfortunately, the original EDULISS (version 1.0) only stored 
the supplier’s catalogue location details on the file system (that is the paths of files) 
with their index of string position of every compound entry in database rather than 
the whole SDfiles.  This considerably increases the difficulty in updating the SDfiles 
and EDULISS as the start-offset string position of every compound entry will be 
changed even when a single entry in the SDfile has been altered.  Hence, a newly 
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designed and updateable EDULISS database is required.  Additionally, in order to 
provide the drug discovery community use of the resource in Edinburgh and 
eventually throughout the world, a web-based interface for EDULISS is also needed.  
The following sections present the procedure of creation and manipulation of 
EDULISS 2.0 with some demonstrations. 










Asinex 96,073  130,012  55,068  21,477  
IBS 140,602  360,211  252,631  33,021  
ChemBridge 180,651  433,682  281,311  28,280  
Iflab 100,583  147,682  80,368  33,269  
Specs 232,028  196,586  1,901  37,343  
Maybridge 59,676  58,855  252  1,075  
Asinex: http://www.asinex.com/; IBS: http://www.ibscreen.com/; ChemBridge: 
http://chembridge.com/chembridge/; Iflab: http://www.lifechemicals.com/; Specs: 
http://www.specs.net/; Maybridge: http://www.maybridge.com/default.aspx. 







Old version New version 
Added H 
Added Cl 
Altered the K 
Chapter 2: Development of small-molecule database, EDULISS 2.0 
  28
2.2 Materials and Methods 
2.2.1 Collection of compound structure-data files, SDfiles 
The collection of compound structure-data files for EDULISS 2.0 can be separated 
into two parts: 1. Collections of the new version catalogues from original (version 
1.0) suppliers and additional new suppliers and 2. Collections from Zinc-Database 
which provides 3-dimensional, pre-selected compounds in SDfile, SMILES, and 
Flexi-Dock formats (Irwin & Shoichet, 2005).  Compounds in the Zinc-Database 
must be less than 700 Da, have XLogP values of –4 to 6, and be able to be converted 
into 3D.  Users can use simple Lipinski filters or download discreet subsets of 
compounds for selecting compounds that are defined as lead-like, drug-like, 
fragment-like and lipophilic.  The total of available compounds within the Zinc-
Database was 5,463,754 at the time of collection for EDULISS 2.0 (Figure 2.2).  
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2.2.2 The treatment of SDfiles 
Regardless of the source of catalogues, the compounds used for EDULISS 2.0 were 
entirely collected as 2-dimensional (2D) SDfile formats.  Different suppliers have 
used differing programmes for the generation of 3-dimensional (3D) atomic 
coordinates.  Differing programmes use alternative parameters for the calculation of 
energy minima, bond lengths and bond angles for the 2D to 3D conversion.  
Therefore, an identical 2D compound could be built with widely diverse geometry by 
different programmes, e.g. differing geometrical conformation and distances between 
each atom.  For instance, the sums of interatomic distances (hydrogen included) in a 
benzene could be 181.774, 183.324 and 228.558 Å depending on if the 2D to 3D 
conversions were performed by CORINA (Sadowski and Gasteiger 1993), web-
based service provided by the company of Molecular Networks GmbH 
(http://www.molecular-networks.com), CONCORD (discussed later) or the 
Chemistry Development Kit (CDK), an open source Java library for bio- and 
chemoinformatics (Steinbeck, Han et al. 2003), respectively.  To provide consistent 
structure-based screening and molecular geometrical property calculation for each 
compound, the conversion must be treated using a single programme throughout.  A 
well-established 3D generation software is CONCORDTM (Hendrickson, Nicklaus et 
al. 1993) created by Pearlman.  The process of generating the 3D structure of 
compounds in SDfile format includes two steps in which an intermediate 3D–
SYBYL mol2 format is required.  CONCORD will not add implicit hydrogen atoms 
when both input and output files are in SDfile format.  The mol2 format contains 
implicit hydrogen that could be further transformed by CONCORD into the SDfile 
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format.  Since EDULISS 1.0 had processed the 2D to 3D conversion by CONCORD 
and performed with an acceptable conversion time (0.02 seconds per compound), 
EDULISS 2.0 consistently utilised it for 3D generation.  As EDULISS 2.0 aims to 
store as many compounds as possible for further various applications, the number of 
non-hydrogen atoms, rotatable bonds and atoms per ring had been set up as the 
allowed maximums of CONCORD that were 250, 400 and 24 respectively.  Figure 
2.3 presents the schema for the collection and conversion process of EDULISS 2.0. 
After the conversion process, all of the 3D catalogues were assigned an in-house ID 
number to represent the suppliers uniquely, named Supplier_ID.  Furthermore, the 
other in-house ID was given for each compound, known for obscure historical 
reasons, as the SPH_Number.  The number format is “SPH1-XXX-XXX”.  When the 
Supplier_ID is combined with a SPH_Number, it forms a unique identification code 
for each compound.  For example, if the Supplier_ID of the Sigma catalogue is 25 
and the SPH_Number of a compound in this catalogue is SPH1-000-001, then the 
unique identification code is “25SPH1-000-001”.  This code not only plays an 
important role in representing a compound but is also a unique key to represent an 
entry throughout the EDULISS 2.0 database tables.  On the other hand, catalogues 
always contain varied tags in the annotation block of SDfiles.  For instance, the tag 
of compound ID given by Sigma itself is “>  <CAT_NO>” compared with the tag “>  
<code>” in the MayBridge catalogue.  These irregular tags will interfere with the 
function of relevant EDULISS 2.0 scripts and cause problem during further data-
mining operations.  Three regular tags, therefore, have been added into annotation 
block for each compound in SDfiles, including the tags of SPH number, the name of 
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the supplier and the original compound ID (given by the supplier).  The name of the 
supplier is referred to the name of database table that stored the 2D and 3D SDfiles.  
The added tags provide helpful patterns for a programmer to perform regular 
expression searches.  Figure 2.4 is a typical 3D SDfile format after treatment. 
The final numbers of successfully converted compounds of each supplier are shown 
in Figure 2.5.  The number of the compounds offered by the suppliers is significantly 
different from the largest library, TimTec (http://www.timtec.net/), containing 
828,288 compounds to the smallest, ontochem (http://www.ontochem.de/), 
containing only 703.  
Figure 2.3. Schema of collection and 2D to 3D converstion process of compound 
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2.2.3 The extraction of molecular properties 
The molecules in EDULISS 2.0 were processed by three programmes, DRAGON, 
DEREK and XLOGP, and series of scripts to extract their physicochemical 
properties.  These processes are schematically shown in Figure 2.6 and detailed in 
the following sub-sections together with the description of the extracted properties. 
Figure 2.6. Schema of generation of physicochemical properties (i.e. molecular 












* Atomic Characteristic Distance, described in section 2.2.3.2. 
Chapter 2: Development of small-molecule database, EDULISS 2.0 
  34
2.2.3.1 Molecular descriptors 
A vast majority of descriptors stored in EDULISS 2.0 were originated from the 
DRAGON 5.4 software, developed by Milano Chemometrics and QSAR Research 
Group (http://www.talete.mi.it/), which is capable of computing over 1,600 different 
molecular descriptors per compound.  The entire descriptor list and their meanings 
can be found on its website.  According to their characteristics, the DRAGON 
descriptors can be generally separated into five different classes including i) simple 
counts, ii) topological descriptors, iii) geometrical descriptors, iv) physiochemical 
descriptors and v) biological descriptors. 
In class i), as the name suggests, a compound can be profiled as counts of specific 
features, such as counts of a series of atoms, bonds and rings, the number of 
functional groups and fragments, the sum of atomic properties, etc.  Some of the 
atom- and bond-based counts also consider the specific hybridisation states and the 
bond order as well as taking the number of members in a ring into account.  In 
DRAGON software these count-based descriptors are termed constitutional 
descriptors.  The fragment-based descriptors are based on a list that contains 120 
atom-centred fragments proposed by Vellarkad and colleagues (Viswanadhan, Ghose 
et al. 1989) and classified by the commonly occurring atomic states of carbon, 
hydrogen, oxygen, nitrogen, halogens, sulfur, phosphorus and selenium in organic 
molecules. 
Class ii) and iii) are essentially shape-based descriptors mostly derived from various 
matrix representations of a chemical structure, usually hydrogen depleted.  There are 
two fundamental matrices that are extended into other matrices and then used to 
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deduce most descriptors of these two classes.  These are the adjacency matrix and the 
distance matrix.  The samples in Figure 2.7 illustrate the two matrices and their 
extensions of 3-methyloctane.  The adjacency matrix, commonly symbolised as A 
and denoted as A=A(G) where G is the molecular graph, is an important concept 
used in molecular graph theory (Lukovits 2000).  It is an N×N symmetric array 
where N is the atom count, such that the element Aij of the matrix is equal to one if 
atom Ai and Aj are adjacent (bonded) and zero otherwise.  Two descriptor groups, 
namely atomic walk counts (Ruecker and Ruecker 1993) and connectivity-based 
descriptors are mainly based on this matrix.  The adjacency can also be formed by 
edges (bonds) instead of atoms, known as edge-adjacency matrix (Estrada 1995; 
Estrada 1996; Estrada and Ramirez 1996; Estrada, Guevara et al. 1998) and denoted 
as E and E=E(G).  This matrix is the basis for the calculation of a series of edge-
based descriptors. 
The conformation of a distance matrix, usually symbolised as D and denoted as 
D=D(G), is similar to an adjacency matrix but it summarises the distance 
information between all the atom pairs (Bonchev and Trinajstic 1977; Mihalic and 
Veljan 1992).  The elements in a distance matrix are the topological distance Dij 
which is the number of edges (bonds) in the shortest path between atoms.  This 
matrix can be used to deduce the classical topological index the Wiener index 
(Wiener 1947b; Wiener 1947c).  In the literature, the term Weiner index is used 
interchangeably with Wiener number, Wiener path or path number.  It is calculated 
as half the sum of all topological distances in a molecular graph, such that the 
smaller is this index, the greater is the compactness of the molecule.  This calculation 
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of this index also deduces the polarity number of a compound which is defined as the 
number of pairs of atoms which are separated by three bonds.  The value of Wiener 
index of 3-methyloctane is 110 for the path number and 7 for the polarity number.  
There is a modified form of Wiener index which is known as Wiener 3D index and 
its matrix is symbolised as G.  While the 2D distance matrix captures the 
constitutional features of the molecule, the 3D character is encoded in the geometric 
distance matrix.  The Wiener 3D index simply measures the geometrical distance of 
atom pairs instead of the path number in the calculation (Crippen 1991; Mihalic and 
Veljan 1992).  When the elements (Dij) of a distance matrix have been converted into 
their reciprocals (excluding zero elements), that is 1/Dij, the resulting matrix is 
known as Reciprocal matrix (Ivanciuc, Balaban et al. 1993; Plavsic, Nikolic et al. 
1993).  There is yet another distance matrix known as the Detour matrix which 
counts the distance between all of the atom pairs in the longest path (Trinajstic, 
Nikolic et al. 1997; Rucker and Rucker 1998).  Furthermore, the adjacency matrix 
and distance matrix can be combined for descriptor calculation.  For instance, 
eccentric connectivity index (Sharma, Goswami et al. 1997) and eigenvalue-based 
descriptors (Balaban, Ciubotariu et al. 1991) accumulate the features of both matrices 
and are termed adjacency-cum-distance matrix and adjacency-plus-distance 
respectively.  The matrices mentioned above can also be weighted by a set of 
variances, including atomic mass, van der Waals volumes, electronegativity and 
polarizability (Schultz, Schultz et al. 1990; Ivanciuc, Ivanciuc et al. 1998) for further 
computing.  The calculation of the WHIM (Weighted Holistic Invariant Molecular) 
descriptor group (Todeschini, Lasagni et al. 1994) utilises the other conformation of 
the matrix where the elements are placed by the molecular coordinates (x, y, z) 
Chapter 2: Development of small-molecule database, EDULISS 2.0 
  37
forming an N×3 matrix where N is the number of atoms.  The details of this group 
will be described in a later chapter (section 3.2).  Apart from the descriptors deduced 
from various matrices, some topological and geometrical descriptors are simply 
obtained from the measurement of the shortest path or geometrical distance between 
the specific atom pairs, including oxygen, nitrogen, sulfur, phosphorus and halogen. 
Class iv) descriptors represent information related to various physicochemical traits 
that can be empirically measured, such as hydrophilicity index (Todeschini, Vighi et 
al. 1997), lipophilicity, molar refractivity (Ghose and Crippen 1987), molecular polar 
surface (Ertl, Rohde et al. 2000) and so forth.  
The final descriptor class v) represents those descriptors that relate to the biological 
properties of a compound such as toxicity descriptors which include an important 
solubility index called Log P, a partition coefficient between octanol and water.  An 
algorithm to calculate Log P was introduced using a regression analysis of biological 
activities to establish a QSAR (Hansch and Fujita 1964).  The more hydrophobic a 
compound, the easier is its uptake into (e.g. human) fat.  There are three different 
calculated Log P values that have been stored in EDULISS 2.0, MLogP (Moriguchi, 
Hirono et al. 1992) and ALogP (Viswanadhan, Ghose et al. 1989) are provided by 
DRAGON software as well as XLogP developed by Dr. Renxiao Wang (Wang, Fu et 
al. 1997; Wang, Gao et al. 2000).  The XLogP method uses 80 atom-pair descriptors 
with associated Log P values to calculate an overall Log P value.  Another important 
source of toxicity information in EDULISS 2.0 was obtained from the DEREK 
toxicity prediction software which is an expert system developed by Lhasa Ltd 
(Barratt, Castell et al. 2000).  The predicted toxicity includes skin sensitisation, 
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carcinogenic, photoallergenic potential, and so on.  These predicted results are 
outputted as a diagnosis-like report.  
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2.2.3.2 A bit string to represent Atomic Characteristic Distance (ACD) 
Atoms can be classified in differing ways, the atoms of hydrogen bond donors 
(HDon) and acceptors (HAcc) cause association of molecules by forming hydrogen 
bonding.  Halogens (fluorine, chlorine, bromine and iodine), sulfur and phosphorus 
often exhibit highly reactive and commonly occur in the functional groups of organic 
molecules.  Furthermore, the atoms of nitrogen, oxygen, sulfur and phosphorus 
contribute molecular polar surface area and volume (Palm, Luthman et al. 1998; 
Winiwarter, Bonham et al. 1998) which is useful in understanding their structure and 
ability to bind ligands and other molecules.  Thus, these atoms have conventionally 
been queried for compound selection.  Profiling the distribution of these atoms in a 
compound can be useful for the study of intermolecular interactions.  Although 
DRAGON software can provide the information regarding the geometrical distances 
between these atom pairs, they are described and output as the summation of the 
distances in a compound.  For instance, DRAGON gives a single value, 147.318 Å, 
which represents all of the observed distances between the three phosphorus atoms 
and the five nitrogens in an ATP molecule.  As a result, it is difficult to understand 
the relative location of these atoms and this figure cannot answer a question such as 
“Does any compound contain phosphorus and nitrogen within 3.5 Å of each other?”  
In order to obtain more precisely and completely these geometrical properties, a 
proper strategy which should be able to describe and store this distance information 
of each atom pair is needed. 
Atomic Characteristic Distance (ACD) in this study is designed to answer the 
requirement described above.  It includes each distance measured from each HDon 
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and HAcc, halogen (fluorine, chlorine, bromine and iodine), sulfur and phosphorus to 
each HDon and HAcc, thus fifteen types of interatomic distance for each compound.  
The measurement of ACD and identification of HDon and HAcc were done by an in-
house java script using CDK java tool kit and it defines HDon and HAcc as below 
(quoted from CDK application document): 
HDon: 
1. Any -OH where the formal charge of the oxygen is non-negative (that is 
formal charge >= 0). 
2. Any -NH where the formal charge of the nitrogen is non-negative (that is 
formal charge >= 0). 
HAcc: 
1. Any oxygen where the formal charge of the oxygen is non-positive (that is 
formal charge <= 0) except an aromatic ether oxygen (that is an ether oxygen 
adjacent to at least one aromatic carbon) or an oxygen adjacent to a nitrogen. 
2. Any nitrogen where the formal charge of the nitrogen is non-positive (that is 
formal charge <= 0) except a nitrogen adjacent to an oxygen. 
Since the number of observed distances from the entire EDULISS 2.0 compound 
collection (+5.5 M) is very large, recording each measurement as an individual 
distance in the storage is not a good solution for high-speed screening.  Thus, ACD 
employed the bit-wise algorithm to build a bit string, a boolean array, for each 
compound to describe the information of distances in which a bit represents the 
presence (true, i.e. 1) or absence (false, i.e. 0) of a distance between specific atom 
pairs, thus there are fifteen bit strings for a compound to represent the fifteen types of 
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distance pairs.  The length of a bit string is 128 long.  The first bit represents a 
distance less than or equal to 2.50 Å (i.e. <=2.50 Å) and its next bit is 0.25 Å longer 
(i.e. > 2.50 and <= 2.75 Å) and so forth until the last bit representing 34.25 Å.  
Figure 2.8 illustrates the composition of three bit strings of the distances between 
HAcc and HDon pairs where the example virtual compound contains two oxygens 
(shown as red) and two nitrogens (shown as blue) forming four HAcc and two HDon, 
respectively.  The bit 1, 10, 11 and 20 of HAcc - HDon string are recorded as true 
(i.e. 1) according to the observed distances, and other bits are recorded as false (i.e. 
0).  The HAcc-HAcc string has the same composition.  There is only one observed 
distance between HDon and HDon (that is 2.40 Å), so that the overall string only 
contains a true value in its first bit.  Since the example compound has no halogens, 
sulfurs and phosphorus atoms, the other twelve strings are formed by false bits 
entirely. 
As a search process, a bit string is generated for a user-defined query distance and 
then compared to that of each compound.  If a specific true bit in the query is not also 
true in the compound’s bit, then the compound could not fit the query distance.  A 
user, of course, could perform a multi-distance query in a single search.  Apart from 
its ideal storing and manipulative facility, the bit strings also make a very fast 
screening for molecule searching since computers perform the necessary boolean 
operations very quickly. 
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2.2.4 Storage of the information of molecular structures and properties 
After the collection and conversion of SDfiles and the extraction of molecular 
properties have been done, the issue of properly storing these data must be addressed.   
The storage should take the data management and further application requirements 
into account.  As mentioned in section 2.1, EDULISS 1.0 saved the SDfiles as 
general file system files making updating the database as difficult operation.   Given 
the greater number of collected compounds in EDULISS 2.0, the total size of the 
SDfiles is over 20 gigabytes.  It takes over 9 minutes to go through the files for a 
simple operation such as counting the total number of compounds in Sigma 
catalogue by a perl script.  To address these problems and store the data in a way that 
facilitates efficient loading, incremental updating, varied querying and data 
subsetting, a relational database is the most reasonable choice.  It is fast, efficient, 
compatible with various scripts and, in the case of MySQL (http://www.mysql.com/), 
free.  This study employed MySQL version 4.1.10a and involved the design of a 
database schema to relationally organise data. 
The major schema of EDULISS 2.0 database design is shown in Figure 2.9.  The 
schema could be divided into two phases, the storage of molecular structures 
(SDfiles) and molecular properties (descriptor values), respectively.  The root of 
molecular structure tables is the “Supplier” table which contains the fundamental 
information of collected suppliers, including the name, website link, ID for 
EDULISS 2.0, the day of last update and the table name through which their SDfile 
could be found.  The “Molecule” table determines the entry ID and the unique 
identification code (described in section 2.2.2) for each compound, that is any 
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compound and its properties only possess a unique entry ID and identification code 
to represent itself throughout the database.  EDULISS 2.0 also stores the compound 
pictures in 2D and the postscript for each.  It aims to display molecule 2D pictures on 
web pages directly instead of taking time to invoke browser plugins, such as Java 
applets or server-side programmes for display of the individual structures.  The 
actual molecular structures, both 2D and 3D SDfiles, were deposited in 28 tables for 
each catalogue.  The names of these tables refer to the column, named 
TABLE_NAME, being listed in the “Supplier” table.  Each of these molecular 
structure tables contains a boolean column, named STATE, to describe the usability 
of a compound, where the value is equal to zero if a compound no longer exists in 
the new version of catalogue and one otherwise.  This design aims to keep the 
EDULISS 1.0 data and to ensure that the earlier studies could be continued with 
EDULISS 2.0.  In the same way, all of the property tables refer to a root table, named 
“descriptor_groups”.  This table lists each descriptor group ID and name, and is 
associated with the next table, named “descriptors” where the details, such as the 
name, referred group ID, and short description for each descriptor can be found.  
This table also contains a column, named QUERY_COUNTER, to record the query 
frequency of a descriptor.  At present, the highest frequency of queried descriptor is 
the set of descriptors dealing with Lipinski’s rule of five.  Since DRAGON software 
has logically separated the descriptors into twenty groups, EDULISS 2.0 database 
uses the same principle for the design of the molecular property tables, i.e. storing 
descriptor values in twenty tables. 
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Relational databases can perform queries very quickly given correct table design 
with the utilisation of indices for columns.  Indices guide MySQL to directly and 
quickly find rows with specific column values, rather than find the relevant rows 
from sequential searches of the table.  The EDULISS 2.0 database has deployed a 
number of indices in the relevant tables, especially for the columns where the 
descriptor values and the unique identification codes were deposited.  It therefore 
only took 0.35 second to count the total number of compounds in Sigma catalogue, 
in comparison to the 9 minutes search time given in the beginning of this section. 
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2.3 The profile of molecular properties in EDULISS 2.0 
The EDULISS 2.0 database stores over 5.5 million available compounds in total, 
containing the data from 28 different commercial and other smaller specialist 
compound catalogues.  2D and 3D coordinates for each molecule are stored with 
over 1600 constitutional, topological, geometrical, physicochemical and 
toxicological descriptors per compound.  The descriptors can be used interactively to 
select the subgroups of the database and to provide profiling information. 
In this database, over +3.9 million fit the Lipinski’s rule of five, that is molecular 
weight (MW) ≤ 500, calculated Log P ≤ 5 (MLogP ≤ 4.15), number of hydrogen 
bond acceptors (nHAcc) ≤ 10 and number of hydrogen bond donors (nHDon) ≤ 5.  A 
total of +3.4 million fit the Oprea lead-like criteria, that is MW ≤ 460, number of 
rotatable bonds (RBN) ≤ 10, MLogP between -4 and 4.2, nHAcc ≤ 9, nHDon ≤ 5 and 
number of rings (nCIC) ≤ 4 (Hann and Oprea 2004).  The more stringent Astex Rule 
of three is met by 254,018 compounds, that is MW ≤ 300, topological polar surface 
area (PSA) ≤ 60, RBN ≤ 3, MLogP ≤ 3 (Rees, Congreve et al. 2004).  The statistical 
profiles of some general descriptors are shown in Figure 2.10 and descriptor ranges 
are shown in Table 2.2.  There are +3.8 million (69 %) observed molecular weights 
(MW) placed in the range between 300 and 500 Da and the average, 373.53 Da, fits 
the MW limitation in lead-like criteria.  The database also contains +520,000 
compounds with MWs lower than 250 Da and potentially fitting the need of 
fragment-based screening.  A fragment is defined as a small molecule, 100-250 Da, 
with few functional groups (Rees, Congreve et al. 2004; Hartshorn, Murray et al. 
2005). 
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The distribution of three calculated Log P values is shown in Figure 2.10 (b). 
Algorithms for predicting aqueous solubility from structure generally rely on a 
directly proportional relationship between Log P and solubility (Jorgensen and Duffy 
2002; Delaney 2005).  In EDULISS 2.0, the most observed Log P value is 4 through 
three types of Log P and the average of MLogP is 3.26, and hence most compounds 
meet the solubility requirement essential for compound solubility during screening.  
There are +5.4 million (99 %) compounds that contain hydrogen bond acceptor ≤ 10 
(avg. is 5.38) and donor ≤ 5 (avg. is 1.27) respectively.  They fit the need of 
conventional rule-based screenings. 
The distributions of oxygen and nitrogen counts are shown in Figure 2.10 (d) and 
exhibit a similar tendency.  Both distributions mainly range between 0 and 7 with the 
near averages, and contain 2.88 oxygens and 2.61 nitrogens per observed compound.  
Figure 2.10 also shows the distribution of sulfur and phosphorus in (d) whereas 
Figure 2.10 (e) displays a set of halogen atoms (fluorine, chlorine, bromine and 
iodine).  These atoms have often been queried for compound selection.  The 
phosphorus containing compounds are very rare in the whole collection since only 
some 26 thousand have been observed.  In the whole database, over 2.2 million (41 
%) sulfur containing compounds have been observed and they mainly have one or 
two sulfurs.  The most frequently occurring halogen is the chlorine atom as +1.2 
million compounds can be found in the EDULISS 2.0 collection.  Apart from chorine, 
the database does not have many compounds that contain other halogen atoms.  
There is an interesting distribution occurring in fluorine atoms.  Although the 
fluorine containing compounds are rare, they mainly have one or three fluorine atoms.  
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Referring to the distribution shown in Figure 2.10 (f), almost all compounds 
deposited in EDULISS 2.0 are composed of one or more rings (98 %) and each 
compound contains about three rings on average.  The rings in a compound are 
mainly formed by 6-membered and then 5-membered rings.  
From the perspective of protein-ligand docking research, the relevant geometric 
conformation of small molecules is of particular interest.  Figure 2.11 profiles the 
distribution of Wiener 3D index (W3D) of the EDULISS 2.0 compounds, which 
represents the compactness of a compound, as well as the distances of the ACD atom 
pairs previously described in section 2.2.3.2.  To highlight the contrast, it also 
indicates the locations of glycine (W3D is 113.079 Å), the smallest amino acid, and 
adenosine triphosphate (ATP and its W3D is 7,264.493 Å) molecules around the 
distribution curve in Figure 2.11 (a).  As it exhibits a left-skewed tendency, it can be 
seen that there are +3.3 million compounds (62 %) with geometric compactness 
relatively more then ATP.  Figure 2.11 (b), (c) and (d) show the distances from HAcc, 
HDon, S and P to HAcc and HDon respectively.  The number of observed within 2.5 
Å are much greater than those in longer distances, but the distributions of halogens 
do not display the same tendency as those which are shown in Figure 2.11 (e) and (f).  
At this short distance, 2.5 Å, it can be assumed that the atoms of O, N, S and P were 
synthesised in the same functional group or occur adjacent to each other.  The overall 
distributions show that the distance between the atoms and HAcc and HDon are 
mainly within 10 Å and halogens can be longer at 15 Å, but it is rare for them to have 
distances greater than 17.5 Å.  
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Figure 2.10. Molecular property profiles in the EDULISS 2.0 database.  (a) MW.  
(b) three types of Log P.  (c) number of HAcc and HDon.  (d) number of N, O, P 
and S.  (e) number of halogen atoms.  (f) number of rings, 5-membered and 6-
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Figure 2.11. Geometric conformation profiles of compounds in the EDULISS 2.0 
database.  (a) Wiener 3D index.  (b) The distances between hydrogen bond 
donor (HDon) and acceptor (HAcc) atoms.  (c) to (f) The distances between S, P 
and halogens and HDon and HAcc atoms, respectively.  The vertical axes are 
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Table 2.2. Descriptor ranges for the +5.5 million compounds stored in the 
EDULISS 2.0 database. 
Descriptor Max Min Average 
Standard
deviation
Molecule weight 2,952.20 13.84 373.53 96.82 
Number of atoms 395 2 44.90 12.46 
Number of oxygen atoms 61 0 2.88 1.74 
Number of nitrogen atoms 49 0 2.61 1.51 
Number of HAcc 89 0 5.38 2.16 
Number of HDon 62 0 1.27 1.10 
Number of phosphorus atoms 9 0 0.01 0.09 
Number of sulfur atoms 21 0 0.51 0.69 
Number of fluorine atoms 51 0 0.26 0.85 
Number of chlorine atoms 23 0 0.31 0.66 
Number of bromine atoms 14 0 0.10 0.34 
Number of iodine atoms 6 0 0.01 0.11 
Number of bonds 399 1 47.03 13.24 
Number of aromatic bonds 96 0 13.34 5.99 
Number of rotatable bonds 107 0 5.30 2.77 
Number of rings 24 0 3.13 1.18 
Number of 5-membered rings 16 0 0.78 0.77 
Number of 6-membered rings 17 0 2.32 1.08 
MLogP 134.05 -34.80 3.26 3.30 




) 221.83 0.71 29.25 7.81 




) 1,416.43 -11.58 74.06 42.32 
Wiener 3D index 
c
(Å) 2,021,122 0.92 6969.63 6190.85 
a: VDW stands for van der Waals, scaled on carbon atom; b: Using N, O, S and P 
polar contributions; c: hydrogen included in the calculation.
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2.4 The facilities of EDULISS 2.0 
As described in section 2.2.4, EDULISS 2.0 has a set of relationally organised tables 
designed to hold the molecule’s SDfiles, their properties (descriptor values) and 
relevant data.  Researchers can access EDULISS 2.0 by logging into the database 
directly or by using scripts, such as Perl, Python, Java or C++.  The application 
libraries of these programming languages have provided the essential MySQL driver 
which acts as an interface between the database and programmers.  All information 
in EDULISS 2.0 can be retrieved by the above approaches.  However, a basic 
knowledge of SQL (Structured Query Language) is required.  It is a relational data 
language providing a consistent and English keyword-oriented set of facilities, 
including data definition, manipulation and control for query (Chamberlin, Astrahan 
et al. 1976).  In order to deal with the case where the users are unfamiliar with SQL, 
a user-friendly web-based interface of EDULISS 2.0 has been established to provide 
a series of straightforward facilities to satisfy the need of data-mining for drug 
discovery.  Details of the interface and facilities of EDULISS 2.0 will be described in 
following sections. 
2.4.1 The construction of the web-based interface 
The web-based interface of EDULISS 2.0 uses Java Servlet technology (see 
http://java.sun.com/products/servlet/) and JavaServer Pages (JSP, see 
http://java.sun.com/products/jsp/) to build the web pages.  The web site utilises 
Apache Tomcat (see http://tomcat.apache.org/index.html) as the web server and the 
runtime environment for Java technologies mentioned above.  To enable extensibility 
in functionality and for ease of maintenance, the web site was constructed using the 
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Model-View-Controller (MVC) software architecture.  MVC separates the data 
model, user phase, and control logic into three individual components so that 
modifications to one component can be made with minimal impact to the others.  
Figure 2.12 is the schema of this web site.  When a task is requested by a client, the 
servlet, (i.e. the controller), dispatches the request to an appropriate functional script, 
(i.e. the model), in order to carry out computing jobs.  Upon the completion of the 
task, the process will return to the servlet and then dispatched to the relevant web 
pages, i.e. the views, to display the query result on the client’s browser.  Although 
the MVC makes the web site look more complicated and its development more time-
consuming, it is easier to extend its functions whenever necessary.  The web site 
developer can plug a new script in the model phase for some specific function, such 
as a new similarity search approach, with minimal or no amendment to other 
components.  Furthermore, the MVC architecture provides a safer server 
environment because the controller phase separates the model phase from the client.  
The components of the model phase run on the server side and manage access to 
databases or files in the file system, and therefore often contain privileged 
information, such as the account, password and relevant folder paths, of the database 
and server.  This separation prevents the server information from being exposed. 
2.4.2 Retrieval of SDfiles and the molecular properties 
The EDULISS 2.0 web site is available at http://eduliss.bch.ed.ac.uk/.  Its homepage 
is shown in Figure 2.13.  The web site provides four different data-mining 
approaches to select preferred compounds and their properties, including descriptor- 
or rule-based mining, molecule similarity search, Atomic Characteristic Distance 
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(ACD) mining and mining by molecule ID.  Users can simply choose one of them in 
the home page and then perform the data-mining.  Before the web site performs the 
data-mining, users can specify the preferred catalogues.  Shown in Figure 2.14 (a) is 
a list for catalogue selection with supplier’s link, the number of deposited 
compounds and the date of latest update.  Although it is possible to select one or 
more catalogues for a query, the server will only extract a maximum of two million 
hits per batch a limit instituted to ensure stable service.  After the catalogue has been 
selected, the four mining approaches can be performed and these will be described in 
the following sections. 
2.4.2.1 Descriptor- or rule-based mining 
Since EDULISS 2.0 has more than 1,600 molecular descriptors for each compound, 
it allows users to determine a series of descriptor items for a query.  Figure 2.14 (b) 
lists the available options for descriptor items.  From the top, the first twenty groups 
are the DRAGON descriptors with 1,664 items in total.  When the link has been 
clicked, the page will display the entire descriptors belonging to the group, so that 
the users can choose various items and set the preferred values for the query.  Shown 
in Figure 2.14 (c) is an example to determine the number of carboxylic acids 
(nRCOOH) of a compound.  The page displays the general statistical profile of the 
item and allows the users to set a range for the values or specify the logical operator.  
Since it is not easy to find out the preferred descriptor from thousands of items, the 
web site has a function that helps users to search for the proper descriptor by its key 
word.  Apart from the options of DRAGON descriptors, the users can also perform a 
rule-based query, such as Lipinski rule of five, Astex rule of three or Oprea lead-like.  
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If Lipinski rule of five has been chosen, the page will bring up the relevant 
descriptors directly and the users can amend them if necessary.  The list shown in 
Figure 2.14 (b) also gives three convenient links to help the users set up the criteria 
quickly.  These links include “Top 10 selected Descriptors” that brings up the ten 
most frequently selected descriptors for query; the link “User Defined” that allows 
the users to set up their preferred items, and the link “Your Last Query Condition” 
that records the users’ last criteria for query.  Since the criteria have been determined, 
the page will display the selected items with their values and the SQL statement.  It 
provides a final opportunity to amend the criteria before submission.  As shown in 
Figure 2.14 (d) for demonstration, we select the catalogues of Sigma and MayBridge 
with Lipinski rule of five as the criteria, and then this query selects 223,687 
compounds in total.  On the page, the users can download the SDfiles of hit 
compounds with their descriptor values.  The descriptor information can be added to 
the annotation block of an SDfile or written in a tab-separated file individually.  The 
tab-separated file can be imported into some software directly, such as Microsoft 
Excel, and it is convenient for further treatment.  Alternatively, the users can choose 
to display the details for each compound in the form of 2D pictures or further display 
3D structures graphically by Jmol, an open-source Java viewer for chemical 
structures in 3D (see http://jmol.sourceforge.net/).  As shown in Figure 2.14 (e), the 
page also displays the number of identical compounds that can be found in the whole 
EDULISS 2.0 collection. 
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2.4.2.2 Molecular structure similarity search 
Apart from the descriptor-based mining, EDULISS 2.0 is able to perform molecular 
structure similarity searches.  The web site provides a molecule editor, JME 
Molecular Editor (see http://www.molinspiration.com/jme/), which is a Java applet 
for drawing directly the query structure as shown in Figure 2.15 (a).  After drawing 
the query structure and submitting it, the web site will convert the query into a 3D 
format by CONCORD software and generate its SMILES string as well as calculate 
some common molecular descriptors using the CDK tool kit, and these are shown in 
Figure 2.15 (b).  The SDfile and 3D structure of the query are also displayed.  At 
present, EDULISS 2.0 is capable of performing similarity searches in terms of 
topological and geometrical approaches.  The topological approach bases on the 
compound path number and polarity number, i.e. Wiener index (described in section 
2.2.3.1), to compare the index of the query compound with each target, i.e. the 
EDULISS 2.0 collection, and then measure the similarity between them using 
Euclidean distance, i.e. the shorter the distance, the more the query is similar to those 
of the target; thus the connectivity of bonds of hit compounds should be similar to 
those of query structure.  The users can limit the number of hit compounds, such as 
searching for the top 100 or more.  Figure 2.15 (c) displays the search result of which 
the compounds are the top four and topologically similar to query structure.  For 
comparison, the four compounds are placed on the right side in each frame and the 
query structure is placed on the left side iteratively.  Similarly, the query structure 
and hit compound can be displayed in a 3D picture and their SDfiles can be 
downloaded. 
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Apart from the topological approach, the web site also provides geometrical 
similarity searches based on a 3D similarity measurement developed by my 
colleague Steven Shave (paper in progress).  It evaluates the 3D similarity between 
two specified molecules by a method that generates some descriptors used to 
geometrically characterise the structure and then stores the descriptor values in a 
binary file for the similarity calculation (For details, see 
http://eduliss.bch.ed.ac.uk/eduliss/Eduliss_introduction.jsp?topic=UFSRAT).  The 
implementation of this similarity search was written in C++ and then plugged into 
EDULISS 2.0 web site.  Although the web site was built using a Java solution, the 
integration of the C++ implementation and the web site can be achieved smoothly as 
the web site was designed using the MVC architecture mentioned in section 2.4.1. 
2.4.2.3 Mining by Atomic Characteristic Distance (ACD)  
This facility aims to pull out compounds that contain the specific atoms introduced in 
some distances between the atoms and HAcc or HDon as described in section 2.2.3.2.  
On the page, the users can select a series of the atoms and determine the HAcc or 
HDon, and then specify the preferred distances between them to be the query criteria.  
Figure 2.16 shows the criteria that aim to pull out the compounds containing the four 
atomic characteristic distances between the specified atom pairs.  If the users click 
the “add” button, the page will bring up an additional entry to add one more criterion 
to a query whenever necessary.  Alternatively, the users can click the “−” button to 
remove the entry.  The query result will be displayed and can be downloaded as 
described in section 2.4.2.1.  
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2.4.2.4 Mining by molecule ID 
It is the simplest mining approach in EDULISS 2.0 for selecting a compound from 
the EDULISS 2.0 collection.  The users can simply specify a catalogue and then 
input the identification code of the compound using either the in-house SPH number 
or the code a supplier assigns.  For instance, if a user selects Sigma as the supplier 
and inputs the SPH number as SPH1-131-349, the web site will retrieve the referred 
compound and display relevant information on the page, as shown in Figure 2.17.  
The page not only displays the hit compound in 2D and 3D graphs, but also lists the 
identical compounds found in the whole database.  The result in the example shows 
two identical compounds that can be found in the catalogues of InterBioScreen and 
ChemBridge.  This function is practically useful for the purpose of compound 
purchase.  For example, if this compound is out of stock at Sigma or has a long lead 
time to delivery, a researcher can purchase the compound from the other two 
suppliers instead.  This also facilitates prices comparison of the compound. 
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Figure 2.14. Components of pages for descriptor-based mining.  (a) A list of 
available of suppliers.  (b) A list of available of descriptors.  (c) The setting of 
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Figure 2.15, Components of pages for molecular structure similarity search. (a) 
The molecule editor for drawing directly the query structure.  (b) Details of the 
query structure, including its SMILES string, general descriptors and 3D SDfile.  
Users can choose an approach to perform similarity search and determine the 
number of the hit compounds on this page.  (c) The similarity search result of 
topological approach.  The compound on the left of each frame is the query 
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Figure 2.17. Components of pages for the retrieval by a compound identification 
code.  This page lists the identical compounds that can be found in the entire 
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3. The recognition of unique compounds 
As EDULISS 2.0 holds millions of compounds, it is of great interest to be able to 
know the number of unique compounds throughout the collection.  The following 
sections describe procedures to identify unique compounds in EDULISS 2.0. 
3.1 The comparison of compounds using Maximum Common Subgraph (MCS) 
Conventionally, the recognition of the difference between compounds requires the 
pair-wise comparison of all the structures.  There is a very elegant and pure 2D graph 
theory algorithm to perform the comparison known as Maximum Common Subgraph, 
MCS (Barrow and Burstall 1976; Bayada, Simpson et al. 1992; Raymond, Gardiner 
et al. 2002).  To compare two compounds it constructs the product graphs for each of 
the two structures as G1 and G2 and then finds the clique which corresponds to the 
largest matching of the bonds and atoms between G1 and G2.  A measure of the 
similarity between the two compound based on MCS can be given by the Tanimoto 
coefficient: 
eq. 3.1 
where T is the index representing the similarity between the two structures, i.e. G1 
and G2; A and B are the numbers of non-hydrogen atoms in G1 and G2 respectively; 
C is the number of non-hydrogen atoms in the MCS which can be found in G1 and 
G2.  Figure 3.1 illustrates the mapping of two graphs (compounds) using MCS and 
the maximum common subgraphs are coloured by red.  The Tanimoto coefficient is 
0.2195.  If G1 and G2 are entirely matched together, i.e. the coefficient is 1.00, they 
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Figure 3.1. Mapping of two graphs (compounds) using MCS.  The red 







3.2 The survey of high discrimination descriptors 
Although the MCS is able to identify isomorphic compounds in terms of the structure 
graph, the drawback of the application of MCS in finding the unique compounds 
from a great dataset is that the number of pair-wise comparisons can be very large as 
the required number is N×(N−1) where N is the number of compounds.  To compare 
throughout the collection in EDULISS 2.0, the estimated number of the pair-wise 
comparison is over 3×1013, as the database holds +5.5 million compounds.  Figure 
3.2 illustrates the requirement of the essential run time of the pair-wise comparisons 
for the seven datasets containing 50, 100, 200, 400, 800, 1,600 and 3,200 compounds, 
respectively.  These comparisons were performed using an in-house programme 
CONCOMP written in C++ which implements the MCS theory.  The tasks ran on a 
workstation equipped with an Intel(R) Pentium(R) D 3.00GHz CPU.  As the result, 
the required run time grows dramatically raised in a geometric fashion from within 
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an hour to near a day when the dataset contains greater than 800 compounds.  The 
rate of growth is directly proportional to the present number of pair-wise 
comparisons.  Thus, it is impossible to go through the whole EDULISS 2.0 collection 
by this pure comparison. 
Figure 3.2. Required run time of pair-wise comparisons for a given number of 
compounds.  The lower X axis gives the number of compounds to be compared 









Inspecting the numbers of heavy atoms (i.e. C, O, N, P and S) in the examined 
compounds prior to performing the structure comparisons is a conventional method 
to improve the comparison speed.  Unfortunately, there are only 5,599 compounds in 
EDULISS containing the numbers of these heavy atoms uniquely and so billions of 
comparisons are still required.  If the compounds can be efficiently distinguished as 
unique, or characterised into clusters in which the compounds have identical specific 
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properties (i.e. descriptor values), the required comparisons can be considerably 
decreased because it is not necessary to run the inter-cluster comparisons.  For 
example, dividing ten compounds into three clusters as 3, 3 and 4, the number of 
comparisons can be decreased from 90, i.e. 10×9, to 24, i.e. (3×2)+(3×2)+(4×3), 
times.  The more the clusters, the less the comparisons are required.  To implement 
this strategy, a survey for finding highly discrimination descriptors has been carried 
out.  The survey uses the Sigma catalogue containing 199,267 compounds to be a 
training set and utilises each DRAGON descriptor, 1,664 items, to distinguish the 
compounds from the training set.  Shown in Figure 3.3 is the result of the top 20 high 
discrimination descriptors in which the bars represent the numbers of unique 
compounds being recognised by the descriptors and the curve is the accumulation of 
the unique compound amount.  It shows that the four descriptor groups, i.e. 
geometrical group (coloured by red), topological group (coloured by green), 
eigenvalue based indices (coloured by black) and WHIM (Weighted Holistic 
Invariant Molecular) descriptors (coloured by blue), exhibit the highest 
discriminating power among the 20 groups.  The top 20 descriptors are able to 
recognise over 171,000 (+85 %) unique compounds in total.  The most efficient item 
is W3D (Wiener 3D index, described in section 2.2.3.1) and is noted as point A on 
the curve, which is able to find over 147,000 (+73 %) unique compounds alone.  
From the shape of the curve, it is clear that points B and C exhibit a higher growth 
rate in finding unique compounds and they are Whete (topological group) and Vu 
(WHIM descriptors) respectively.  In total, there are over 167,000 (+84 %) 
compounds that can be distinguished as unique since they have different values of 
W3D, Whete and Vu.  These three descriptors can further characterise the rest of 
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compounds and group them into over 5,700 clusters allowing efficient use of MCS.  
Shown in Figure 3.4 is the distribution of the number of the rest of compounds in the 
clusters and the compounds in a cluster have the same values of the three descriptors.  
As each cluster has less than 4 compounds on average and only 20 clusters have over 
50 compounds, the required pair-wise comparisons using MCS are only 310,754 in 
total which is less than the requirement of 800 compounds shown in Figure 3.2.  The 
details of the Whete and Vu descriptors are described as following. 
Whete: this descriptor is a Wiener-type index and is deduced from a distance matrix 
whose elements, i.e. the path numbers, are weighted by a series of atomic and bond 
parameters with the relative electronegativity values using carbon as standard.  
Electronegativity describes an element's ability to attract electrons and the 
electronegativities of main group atoms for this descriptor’s calculation were 
estimated based on the Pauling’s scale (Sanderson 1983).  The fundamental of the 
Whete calculation is the same as the Wiener index but plus a weighting scheme for 
considering the presence of heteroatoms and multiple bonds.  Figure 3.5 lists the 
atomic and bond weighting parameters used by Ivanciuc and colleagues (Ivanciuc, 
Ivanciuc et al. 1998), and the weighted matrix of a sample compound.  In the figure, 
table (a) lists the atomic parameters based on relative electronegativity and listed in 
table (b) are the bond parameters of relative electronegativity where i and j are the 
identifiers of the atoms in a compound.  The bond parameters are varied depending 
on the bond orders.  During the construction of the distance matrix, the element Dij of 
the matrix should be weighted by the atomic parameters listed in table (a) if i equals j, 
and weighted by the bond parameters listed in table (b) otherwise.  Table (c) is the 
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weighted matrix of the sample compound whose structure is similar to 3-
methyloctane shown in section 2.2.3.1 but it contains a double bond (C1=C2) instead 
of a single bond (C1−C2) and a carbon has been replaced by a heteroatom, oxygen.  
Thus, the elements of the matrix regarding C1 and the oxygen are weighted by the 
referred parameters listed in (a) and (b).  As the original Wiener index only takes the 
path number into account for its calculation, the index values of the sample 
compound and 3-methyloctane both are 110 but the Whete values of these two 
compounds are 104.282 and 110 respectively.  They can be distinguished 
successfully because of the consideration for the presence of the multiple bond and 
heteroatom in the calculation of Whete. 
Vu: it is one of the descriptors in the WHIM group which was first proposed by 
Todeschini and colleagues (Todeschini, Lasagni et al. 1994).  The indices in this 
group contain the information of a molecular structure in terms of its size, shape, 
symmetry and atom distribution and have found application in fields such as those 
using Quantitative Structure-Activity Relationship (QSAR; (Todeschini, Vighi et al. 
1996)) or modelling physicochemical properties of organic compounds (Todeschini, 
Gramatica et al. 1995; Gramatica, Navas et al. 1998).  They can be divided into two 
subgroups according to their calculation, as directional and non-directional 
descriptors.  The procedure for the calculation of WHIM descriptors is schematically 
shown in Figure 3.6.  The utilisation of Principal Component Analysis (PCA) is the 
core of WHIM’s calculation.  PCA is a useful and common statistical technique for 
finding patterns in the data of high dimension.  The calculation of these descriptors is 
performed in the following six steps. 
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1. The starting point is the use of the molecular geometry, i.e. the coordinates (x, y, 
z), to construct an N×3 matrix where the N is the number of atoms and the three 
columns for x, y and z coordinates. 
2. The second step is the application of a weighting scheme to characterise some 
particular aspects of the molecule, such as atomic mass, van der Waals, 
electronegativity and polarizability.  A set of weighted matrices are defined and used 
in the later step.  Similar to the weighting scheme of Whete, the weighting 
parameters are a series of relative values using carbon as standard and Todeschini 
and Gramatica have particularly tabulated the parameters in their publication 
(Todeschini and Gramatica 1998). 
3. This step aims to centre the molecular coordinates.  It makes the coordinates 
independent of the origin, referring other matrices a unique reference point, i.e. 
invariance to translation. 
4. PCA is performed to diagonalise the weighted covariance matrix from the centred 
molecular matrix which is calculated by the decomposition process of eigenvalue and 
eigenvector.  The PCA can also lead to three principal component axes for the next 
step. 
5. There is a set of new atomic coordinates obtained by projecting the old axes on to 
the three principal component axes.  The new atomic coordinates construct a score 
matrix which is the same dimension as the original molecular matrix, i.e. invariance 
to rotation. 
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6. Finally, for each weighting scheme a number of descriptors are calculated from 
each component.  According to the decomposition results of eigenvalues and 
eigenvector along each component, the statistical parameters are able to represent the 
characteristics of the compound.  In the directional group, when the descriptors are 
directly defined by the eigenvalues λ1, λ2, λ3 and represent the variances of the 
atoms along each component, they are related to the molecular size.  If the 
descriptors are constituted by the eigenvalue proportions, they represent a global 
view of the molecular shape.  When the descriptors are calculated from an 
information content index on the symmetry along each component, they represent the 
symmetry of the compound.  Furthermore, the tendency of data points, i.e. the atom 
projections, around the origin and along the principal axes can represent the atom 
distribution.  The descriptors in the non-directional group are directly derived from 
the directional group.  Vu belongs to the non-directional group and obtained from an 
unweighted matrix.  This descriptor is deduced from the eigenvalues λ1, λ2 and λ3 in 
three different ways shown as below:  
T = λ1 + λ2 + λ3 
A = λ1λ2 + λ1λ3 + λ2λ3 
Vu = T + A +λ1λ2λ3 
The T and A are related to linear and quadratic contributions respectively and the Vu 
considers the T, A and the third-order term.  Thus a complete expression of the 
molecular size can be represented by this index. 
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Figure 3.3. Top 20 items of the result of high discrimination descriptor survey. 
The bars are the numbers of the unique compounds found by referred 

















Figure 3.4. Distribution of the number of compounds in each cluster in which 
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Figure 3.5. Example of the weighted distance matrix for the Whete’s calculation. 
(a) Atomic parameters based on relative electronegativity (denoted as X).  (b) 
Bond parameters based on relative electronegativity where i and j are the 
identifiers of the atoms in a compound.  (c) The weighted matrix of the sample 
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(Todeschini and Gramatica 1998) 
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3.3 Result 
Utilising these high discrimination descriptors, i.e. W3D, Whete and Vu, with the 
clustering approach in the whole EDULISS 2.0 collection, these three descriptors are 
able to find 3,117,625 unique compounds prior to performing MCS comparisons and 
characterise the rest into 845,193 clusters.  The number of required pair-wise 
comparisons using MCS is 6,495,096.  Thus the recognition of unique compounds in 
EDULISS 2.0 can be done very efficiently and the total number of unique 
compounds present is 4,011,697.  Additionally, in these +4 million unique 
compounds with distinct molecular formula and molecular weight are only 328,902 
(8.2 % out of +4 M) and 321,520 (8 % out of +4 M) respectively.  In the final 
analysis, although inspecting the atomic types or examining the molecular weights 
can recognise about 8 % of unique compounds prior to performing pair-wise 
comparison, we did not apply these two attributes in coordination with the molecular 
compactness, size and atomic parameters in the recognition of unique compounds. 
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4. The correlation between molecular descriptors 
This chapter presents an investigation of the correlation between molecular 
descriptors, using the descriptors that have been calculated by DRAGON software.  
As the number of descriptors is large (1,664 items), this study mainly focuses on the 
descriptors which have been implicated in and frequently discussed in the studies of 
QSAR, and uses a statistical approach to reveal the relationship between them.  The 
following sections describe the procedures and results of this investigation. 
4.1 Materials and methods 
The Pearson correlation coefficient (γ) has been applied in this study.  It is the most 
commonly utilised measure of correlation between a pair of interval- or ratio-scaling 
variables (Miller 1996).  As the DRAGON descriptors are mainly expressed by 
interval scaling or calculated using these scaling concepts, the coefficient is proper 




where the N is the number of subjects, i.e. the number of used compounds in the 
present study.  The γ(x, y) value varies between +1 and -1.  The size of the 
coefficient value indicates the degree of the relationship between two variables and 
its sign represents the direction of the relationship.  A positive value means the direct 
correlation between x and y, and a negative γ indicates the reverse pattern, and γ of 
zero is obtained when there is no linear relationship between x and y.  
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The calculation time for the entire database would be unacceptably long and 
therefore a test set was taken from the EDULISS collection by random selection of 
500,000 entries (i.e. compounds), each entry having the values of 1,664 DRAGON 
descriptos.  The statistical analysis was carried out using the SAS 9.1 statistical 
package (SAS 2004).  Table 4.1 is the profile of some general descriptors of the test 
set.  Comparing this table to the molecular property profiles of the EDULISS 
database shown in Figure 2.10 and Table 2.2, the general distribution of this test set 
is consistent with the whole EDULISS collection.  Thus, the test set is qualified to 
represent the molecular properties in the database for this study. 
Table 4.1. Descriptor ranges for the test set of 500,000 compounds*. 
Descriptor Max Min Average 
Standard 
deviation 
Molecule weight 2,834 41.06 371.45 94.80 
Number of atoms 395 4 44.58 12.11 
Number of bonds 399 3 46.72 12.88 
Number of rings 24 0 3.17 1.13 
Number of oxygen atoms 61 0 3.08 1.63 
Number of nitrogen atoms 31 0 2.71 1.38 
Number of HAcc 88 0 5.34 2.11 
Number of HDon 54 0 1.67 0.96 
MLogP 78.12 -19.25 3.68 2.72 
Wiener 3D index (Å) 1,293,163 9.81 6,781 6,591 
*: HAcc: hydrogen bond acceptors; HDon: hydrogen bond donors. 
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4.2 Results and discussions 
4.2.1 The correlations of overall descriptors 
Figure 4.1 shows a colour scale image of the correlation matrix for each descriptor 
pair where blue and red represent the direct (0<γ≤1) and reverse (0>γ≥-1) 
correlation, respectively.  Each pixel represents a correlation coefficient and the main 
diagonal the coefficients of the descriptors correlated to themselves, i.e. γ(x, x) = 1.  
Other pairs of coefficients are counted only once, diagonal elements are excluded (i.e. 
used γ(x, y) and excluded γ(y, x)).  Thus, a total of (16642)/2 = 1,384,448 values are 
considered.  Obviously, the dimension of the matrix is too high to detail the analysis 
of the relationship between each pair of descriptors.  However, the matrix is able to 
indicate that some descriptors are highly correlated to others. 
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Figure 4.2 shows a histogram of the distribution of correlation coefficients.  Bars are 
filled with the same colour scale as used in Figure 4.1.  The observations of diagonal 
elements and γ(x, x) are excluded, i.e. (16642-1664)/2 = 1,383,616 values are used.  
In the cases of direct correlation (i.e. blue side) the mean and median of coefficients 
are 0.19 and 0.07, and in reverse correlation (i.e. red side) the values are -0.15 and -
0.09 respectively.  The overall distribution shows that most descriptors have little 
correlation to others.  However, there are still over 20,000 pairs of descriptors that 
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the same descriptor classes.  As DRAGON software has logically separated the 
descriptors into twenty groups, the high correlation tendency, for example, can be 
easily seen by Figure 4.3 which shows the intercorrelations of two descriptor groups 
including Burden eigenvalues (64 items) and Randic molecular profiles (41 items).  
Burden eigenvalue descriptors are obtained from the positive and negative 
eigenvalues of a molecular adjacency matrix, weighting the diagonal elements by a 
series of atomic parameters (Burden 1989; Burden 1997).  Randic molecular profiles 
are derived from the geometry matrix of a compound, defined as the average row 
sum of its entries raised at the kth power and normalise the averages by the factorial k! 
in turn (Randic 1995).  The DRAGON software computes Randic molecular profiles 
for k = 1 to 20.  As a result, the descriptors belonging to the same group present high 
correlations between themselves, as their calculations are often based on the same or 
similar principle and weighted by certain parameters iteratively.  The group of 
Burden eigenvalues is an instance which uses atomic masses, van der Waals volumes, 
electronegativities and polarizabilities to weight elements of the adjacency matrix.  
Consequently, Figure 4.3 (a) shows a clear correlation gradation. 
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Figure 4.2. Histogram of correlation coefficients.  Bars are filled with the same 
colour scale as used in Figure 4.1.  The number of used observations is 1,383,616 
(i.e. 16642-1664)/2) as the diagonal elements and γ(x, x) are excluded.  The 
vertical axis represents the number of descriptor pairs.  The horizontal axis is 
















a. Burden eigenvalues (64) b. Randic molecular profiles (41)
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4.2.2 The correlations of some fundamental descriptors 
Figure 4.4 is a matrix excerpted from Figure 4.1 to show the correlations between 41 
fundamental descriptors and their introductions are printed in gray.  The descriptors 
include the groups of simple counts, some atomic properties (van der Waals volumes, 
electronegativities, polarizabilities), shape-based descriptors, physicochemical traits 
and biological properties (MLogP and ALogP).  The details and calculations of W, 
W3D, Wiener-type (i.e. Whetm, Whetv, Whete and Whetp) indices and WHIM (i.e. 
Vu, Vm, Vv, Ve, Vp and Vs) descriptors have been described in previous chapter.  
The Ss descriptor, Kier-Hall electrotopological states or E-states, was first proposed 
by Hall and colleagues (Hall, Mohney et al. 1991) and were developed from graph 
theory as an index of the molecular skeletal group and combines both the electronic 
character and the 2D feature of each skeletal atom in a molecule.  It has been tested 
and applied in the field of QSAR (Butina 2004). 
As expected, molecular weight is directly correlated to the number of non-H atoms (γ 
= 0.95) and bonds (γ = 0.84) as well as with the general atomic properties such as Sv 
(γ = 0.91), Se (γ = 0.85), Sp (γ = 0.90) and Ss (γ = 0.88).  The “size” of a molecule 
does not absolutely determine its molecular weight as the coefficient of γ(MW, Vu) 
is 0.37 but the “compactness” of a molecule displays relatively higher correlations to 
MW as γ(MW, W) = 0.69 and γ(MW, W3D) = 0.65.  Previous studies indicated that 
the number of rotatable bonds increases with molecular weight (Ajay, Walters et al. 
1998) whereas it shows a median correlation in this study as γ(MW, RBN) = 0.55.  
The number of hydrogens gives higher contributions to the sums of Sv, Se and Sp 
than the number of heavy atoms. 
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Comparing the values of γ(nCIC, nR06) and γ(nCIC, nR05), the correlation 
coefficient between the number of rings and 6-membered rings is two-fold greater 
than the coefficient of 5-membered ring pair as 0.74 vs. 0.35.  It is consistent with 
the molecular profile shown in Figure 2.10 (f), as in the EDULISS collection, the 
rings in a compound are mainly 6-membered and then 5-membered. 
In the case of inter-correlations, the descriptors of Wiener-type indices appear to be 
in a statistically significant relationship between each other though they have been 
weighted by various parameters respectively.  The descriptors of the WHIM group 
have a similar tendency.  On the other hand, as the descriptors of Wiener-type 
indices and WHIM group are deduced from 2D and 3D matrices respectively, the 
pair correlations between them are 0.62 on average.  It tends to agree with previous 
research which suggested that the geometrical descriptors as a class are not very 
different from the topological indices (Braun, Kerber et al. 2004). 
The five descriptors that include calculated values of octanol/water partition 
coefficients (i.e. MLogP and ALogP described in previous chapter), PSA, nHAcc 
and nHDon, have shown to be highly interesting for drug discovery and development 
as these parameters are easy to understand and are known to be related to the 
molecular transport properties, particularly intestinal absorption and blood-brain 
barrier penetration (Blake 2000; Clark and Pickett 2000).  The PSA mentioned here 
is a simple topology based method and is calculated from the summation of the 
surface contributions of 43 polar fragments noting the atom types and their bonding 
pattern, including max bond order, sum of bond order, number of neighbours, 
hydrogen count, formal charge, aromatic bonds, number of 3-membered rings, 
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numbers of single-bonds, double-bonds and triple-bonds (Ertl, Rohde et al. 2000).  
The descriptors regarding the molecular weight, “size” and “compactness” show 
poor correlations to these five descriptors.  The correlation coefficients are from 
γ(Vu, ALogP) = 0.09 to γ(MW, nHAcc) = 0.58.  The number of hydrogen bond 
donor (nHDon) and acceptor (nHAcc) do not simply depend on the number of 
oxygen and nitrogen as their definitions take the adjacency of atoms and atomic 
formal charge into account.  Similarly, the total positive charge (Qpos) exhibits a 
reverse correlation to nHAcc and direct to nHDon.  As the nHDon exhibits a lower 
correlation to the polar surface area than nHAcc (γ(PSA, nHDon) = 0.31 and γ(PSA, 
nHAcc) = 0.57) and the Qpos is also reversely correlated to PSA, it could be 
presumed that a fragment with positive charge gives lower contribution to form the 
PSA.  In the cases of MLogP and ALogP, they display the reverse correlation to PSA 
as the Log P coefficients use negative values to express the higher solubility of a 
compound. 
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4.2.3 The correlations between five selected descriptors and 151 molecular 
functional groups 
Table 4.2 summarises the statistical profile of absolute values of correlation 
coefficients between the five selected descriptors, including nHAcc, nHDon, PSA, 
MLogP and ALogP, and the counting of 151 chemical functional groups.  The 151 
items and their 2D pictures with introductions can be found on the DRAGON 
website (http://www.talete.mi.it/help/dragon_help/index.html?ListTopolDesc).  
There are only three items which show linear correlation with the five descriptors, 
including number of aromatic dithioesters (nArCSSR), number of thiophosphates 
(nPO4) and number of phosphanes (nPR3). 
Table 4.2. Statistical profile of absolute values of correlation coefficients 
between the five selected descriptors, including nHAcc, nHDon, PSA, MLogP 
and ALogP, and the counting of 151 chemical functional groups. 
correlated pairs* Max Min Average 
Standard
deviation
|γ(nHAcc, 151 functional groups)| 0.91 0 0.14 0.17 
|γ(nHDon, 151 functional groups)| 0.80 0 0.12 0.16 
|γ(PSA, 151 functional groups)| 0.96 0 0.12 0.17 
|γ(MLogP, 151 functional groups)| 0.78 0 0.07 0.12 
|γ(ALogP, 151 functional groups)| 0.75 0 0.06 0.12 
*: each entry in this column contains 151 observations, e.g. nHAcc against 151 
functional groups. 
nHAcc: number of hydrogen bond acceptors; nHDon: number of hydrogen bond 
donors; PSA: topological polar surface area using N, O, S and P polar contributions. 
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The higher correlations occur in the pairs of following:  
nHAcc vs. nArCSSR (γ = 0.91) 
nHAcc vs. nPO4 (γ = 0.83) 
nHDon vs. nPO4 (γ = 0.80) 
PSA vs. nArCSSR (γ = 0.96) 
PSA vs. nPO4 (γ = 0.85) 
MLogP vs. nPR3 (γ = 0.78) 
ALogP vs. nPR3 (γ = 0.75). 
The nArCSSR and nPO4 groups make higher contributions to hydrogen bonding and 
polar surface, and the nPR3 group tends to affect the calculated Log P values of 
compounds. 
It is generally thought that the variety of molecular toxicity mainly depends on the 
nature and location of functional groups (Turabekova and Rasulev 2005).  In 
particular, the calculated Log P value has been used as a principal descriptor of 
lipophilicty or hydrophobicity as well as related to the biological properties of a 
compound such as toxicity because the experimental measurement of Log P values is 
expensive, time consuming and labour intensive.  At present, the most common and 
accepted approach to calculate Log P values is the fragmental or additive method 
(Thompson, Hattotuwagama et al. 2006).  MLogP and ALogP are examples of this 
type as their Log P values are obtained by summing the contributions of each 
nArCSSR: 
Y = aromatic or 
aliphatic group 
linked through C 
nPO4: 
Y = O or S 
nPR3: 
Y = H, C, halogens 
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particular fragment (functional groups).  However, apart from the items mentioned 
above, none of other functional groups is statistically correlated to the calculated Log 
P values and the other four descriptors according to the results.  It could be presumed 
that the relationship between functional groups and these five descriptors does not 
only simply involve the count but also other factors, such as their location in a 
compound. 
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5. The application of Structure-Activity Relationship (SAR) in 
ligand-protein binding study 
This chapter presents a study on modelled prediction of ligand-protein binding by a 
statistical method which is based on Structure-Activity Relationship (SAR) 
modelling.  The construction of the model involves comparison of known 
experimental ligand-protein binding outcomes against a series of molecular 
descriptors.  The model aims to reveal those molecular descriptors which are 
correlated with ligand activity, and to predict the probability of ligand-protein 
binding. 
PubChem bioassay data, which is an NMR based screening assay for a human 
FKBP12 protein (PubChem AID: 608), has been used in this study.  The depositor 
source of this bioassay was provided by the Burnham Center for Chemical Genomics 
(BCCG; http://sdccg.burnham.org/metadot/index.pl) which was formerly the San 
Diego Center for Chemical Genomics.  
FKBP12 is critical for life and occurs in high concentrations in all cells.  Thus, it can 
be expected to control fundamental functions of cell biology.  An in vivo experiment 
shows that the mutant mice died during the embryonic stage when FKBP12 had been 
deleted (Shou, Aghdasi et al. 1998).  Furthermore, FKBP12 has been identified as a 
receptor to the immunosuppressant drug FK506 (Liu, Farmer et al. 1991; Aghdasi, 
Ye et al. 2001).  This protein catalyses the cis-trans transition of the peptide bond at 
proline residues, which is a rate-limiting step in protein folding (Kay 1996; Iida, 
Furutani et al. 1998). 
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In the PubChem bioassay, the human FKBP12 was expressed in an Escherichia coli 
strain.  There were 3,775 compounds assembled for the NMR based screening.  The 
compounds were selected from four different sources, including a set of building 
blocks or scaffold compounds from MayBridge (http://www.maybridge.com/), Life 
Chemicals (http://www.lifechemicals.com/), ChemBridge 
(http://www.chembridge.com/) and a collection of 602 natural products from NIH 
Molecular Libraries Screening Centers Network (MLSCN; 
http://mli.nih.gov/mli/mlscn/index.php).  Despite the presence of many natural 
products, the average overall molecular diversity of other sets is greater than 86 % 
measured by the UNITY module of SYBYL software (UNITY Tripos Inc.) (Stebbins, 
Zhang et al. 2007).  The compound activity is classified by the binding affinity 
(estimated dissociation constant, Kd) of the compound against the target.  Compound 
Kd values less than 500 μM are treated as active, otherwise they are classified as 
inactive.  The detail and protocol of this NMR based screening assay can be found on 
PubChem website (http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=608).  The 
final result of this screening was that only 44 compounds (structurally shown in 
Appendix 1) were identified as active and 3,731 as inactive. 
There are two statistical approaches applied in the present study for different 
purposes: Logistic Regression Model and Self Organising Maps (SOMs).  The 
PubChem data set is split into a training set and a test set and they are defined in 
Figure 5.1.  The compounds assembled for the PubChem bioassay are called the 
“available data set” (shown as red in Figure 5.1); the compounds randomly removed 
from the available data set for model validation are called the “test set” (shown as 
yellow); the remaining compounds for regression model building are called the 
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“training set” (shown as blue).  These terms will be used consistently in the 
subsequent sections.  The molecular properties (i.e. descriptor values) of the 
compounds involved in these analyses were calculated using the DRAGON 
programme.  The two statistical approaches are described in the following sections 
5.1 and 5.2.   
Figure 5.1. Terms of data sets for modelling exercises.  The compounds 
assembled for the PubChem bioassay are called the “available data set” (shown 
as red); the randomly removed compounds for model validation are called the 
“test set” (shown as yellow); the remaining compounds for regression model 








5.1 Logistic Regression Model 
Logistic regression characterises the relationship between a response variable and a 
series of predictor variables.  As the PubChem bioassay has examined and defined 
the compounds as active or inactive, i.e. a binary format, the Logistic Regression 
Method is adequate for modelling the probability of the compound’s bioactivity.  In 
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this binary response model, the response, Y, of the experimental outcome means one 
of two possible values which are denoted as 1 and 0 conventionally.  For example, Y 
= 1 if a compound is active, whereas Y = 0 if a compound is inactive.  Assuming Xˈ 
is a vector of independent variables, i.e. the molecular descriptors, then P = (Y = 1 | 
Xˈ) is the probability of response Y = 1 to be predicted.  Unlike general linear 
functions that would give a bad fit (Figure 5.2 (a)), the Logistic Regression Model 
provides an S-shape function so that the fit can be largely improved (Figure 5.2 (b)) 
when the Y axis represents a binary outcome, such as Yes/No or Active/Inactive, and 
the X axis represents an independent variable, such as molecule weight.  This 
regression model also ensures that whatever evaluation of the response one obtains, it 
always gives a value to represent the calculated probability between 0 and 1 that can 
be easily converted into a binary response using a proper threshold value such as 0.5. 
Figure 5.2. Schematic plots of general linear and logistic functions.  The Y axes 
represent a binary response, such as the activity of the compounds.  The X axes 
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where the letter P is the event probability.  The letters β0 to βn are the regression 
coefficients and χ1 to χn are the molecular descriptors.  During the model building 
process, the most predictive molecular descriptors are first identified from the quality 
of a single descriptor logistic model according to the p-values which were estimated 
for each of the descriptors.  The p-value indicates the significance level for the Wald 
Chi-Square Test which is used to examine whether the independent variable (i.e. the 
descriptor) significantly affects the dependent variable (i.e. compound activity) or 
not (Peng, Lee et al. 2002).   Then, the model omitted the descriptors whose p-value 
was greater than 0.05 from further analysis.  The remaining potentially predictive 
descriptors were used in the procedure of stepwise selection.  The selection strategy 
starts from the inclusion of the most significant predictive descriptor in a regression 
model and sequentially applies the next one to obtain the most appropriate 
combination of descriptors and the best model (instanced as Figure 5.5).  The 
selection aims to improve the prediction of the model and to reduce the number of 
predictors in a model. 
To check the predictive ability of the model we can apply it to data unused in the 
model building, using a separate hold-out test sample or leave-one-out cross-
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validation standard method to validate this technique (Hawkins, Basak et al. 2003).  
As the leave-one-out cross-validation is much more computationally intensive 
involving repeating the full modelling analysis a total of sample number plus one 
times, i.e. n+1, this study adopts the hold-out sample treatment (shown as Figure 5.1).  
The statistical analysis was carried out using the SAS 9.1 statistical package (SAS 
2004) and the sampling designs for modelling exercise are described in sections 5.3.1 
and 5.3.3. 
5.2 Self Organising Maps (SOMs) 
The SOM is a data visualisation and clustering technique developed by Teuvo 
Kohonen (Kohonen 1997).  As it is difficult to visualise high dimensional data, 
SOM’s strategy is to reduce data dimensions and to produce a map usually in 1 or 2 
dimensions to plot the similarities of the observations through the application of self-
organising neural networks.  The technique of SOMs has been applied in many 
different fields, such as its utilisation in revealing distinct gene expression patterns, 
the application in various microarray experiments, the classification of cancers and 
studies of social science (Roussinov and Chen 1998; Khan, Wei et al. 2001; Nguyen 
and Rocke 2002; Wang, Delabie et al. 2002). 
Figure 5.3 is an example of using SOM to cluster randomly coloured squares to 
illustrate the idea of a SOM.  The main purpose of SOM is to project high 
dimensional data on a lower dimensional map and reveal the similarity of the data.  
In order to easily explain its schema, all samples (i.e. the squares shown in Figure 5.3 
(a)) have been presented in colour.  Thus, the three dimensional data for each sample 
is represented by the variables of red, blue and green.  For instance, the green square 
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with a black border shown in Figure 5.3 (a) is composed of the three RGB values (R: 
0.01, G: 0.79 and B: 0.23).  After processing using the SOM algorithm, the 
multidimensional data can be projected onto a lower order surface to facilitate 
visualisation, for example, a two dimensional image map similar to the case of 
Figure 5.3 (c).  The generation of the SOM in the present study was carried out by an 
in-house perl script and the process to construct the examples shown in Figure 5.3 is 
described by the following steps. 
1. The data of each sample is normalised into one value range if the attributes of the 
data are diverse, such as the molecular weight and the number of atoms of a 
compound.  For demonstration, the 100 samples shown in Figure 5.3 (a) were 
randomly represented in colour and this normalisation step can be omitted as the 
RGB values are arranged equivalently between 0 and 1. 
2. An initialised map is constructed as shown in Figure 5.3 (b).  The squares of this 
map were generated randomly.  The dimensions and the value range of each square’s 
data must match these in each sample shown in Figure 5.3 (a).  Therefore, the data of 
squares is composed of three RGB values each of which is between 0 and 1.  The 
number of map’s squares should be greater than the number of samples but the 
greater the squares count is, the more the time-consuming it is to compute the map.  
Figure 5.3 (b) shows a 100×100 map, i.e. 10,000 squares on the map.  The location 
(i.e. the x and y positions of the square on the map) and the RGB values of a square 
can be called a weight vector, and each weight vector possesses a unique location on 
the map.  Sometimes, the weights are referred to as neurons because SOMs are a type 
of neural network. 










3. Following the completion of the normalisation of samples and the initialisation of 
the map, the main algorithm of SOMs can be applied.  A sample is chosen randomly 
from Figure 5.3 (a) and is examined to calculate which square throughout the map, 
i.e. Figure 5.3 (b), is most similar to the selected sample.  The weight of the square 
with the shortest distance to the weight of the sample is the winner.  The winner 
square is commonly called as the Best Matching Unit (BMU).  The distance (i.e. 
similarity) between the selected sample and squares on the map can be obtained 




where pi and qi are values at the ith member of the sample data.  n is the number of 
data dimensions of the sample.  In this case, the n represents 3, i.e. the RGB values. 
4. This step is to scale the neighbours of the winner square (i.e. the BMU).  This 
scaling process actually contains two parts including determining the neighbours and 
adjusting the neighbour’s weights.  In the field of neural networks, this step is also 
called a learning process. 
In order to determine the neighbours of BMU, the radius of the BMU’s 
neighbourhood is calculated.  The radius starts large and commonly equals the width 
or height of the map, e.g. 100 in this case, but it is reduced during each time-step.  
Any squares identified within the radius are considered as the BMU’s neighbours 
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and their weights are adjusted to be more like the selected sample.  The closer the 
distance between an identified square and the BMU, the more its weight is altered. 
The determination of the rate to diminish the radius and to adjust the square’s weight 
can be obtained using Gaussian function.  Figure 5.4 plots the Gaussian function to 
illustrate the case of diminishing radius.  As one moves out from the peak, the radius 





where the letter sigma, σ0, is the initial radius at the time-step, t0, and the letter 
lambda, λ, is a time constant that can be deduced from the number of iterations, n, 
divided by log (radius of the map).  As shown by the Gaussian function (illustrated in 
Figure 5.4), the number of neighbours diminishes over time.  The “square’s weight” 




where the L0 is the initial rate for the adjustment, and the letters t and n are the time-
step and number of iterations. 
Chapter 5: The application of Structure-Activity Relationship (SAR) in ligand-protein binding study 
  105
The relevant parameters used in the case of Figure 5.3 are that the initial radius, σ0, is 
100; the number of iterations, n, is 1000; and the initial rate for the adjustment, L0, is 
0.1. 
5. Repeat step 3 for n iterations. 
6. Once the iterations have been finished, a final SOM map can be constructed as 
illustrated in Figure 5.3 (c) and then the samples shown in Figure 5.3 (a) can be 
located on the map using the same approach for finding the BMU.  For example, the 
green sample in Figure 5.3 (a) can be placed on the square of the final map with 
black border, and so on for other samples.  Once all of the samples have been 
positioned on the final map, the similar samples can be grouped together and 
visualised easier. 
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Figure 5.3. Schema of a Self Organising Map.  For demonstration, the 100 
samples (i.e. each square) in (a) were randomly presented in colour which is 
composed of three variables, i.e. red, blue and green.  For example, the green 
square with a black border is composed of RGB values as R: 0.01; G: 0.79; B: 
0.23.  The RGB values are arranged equivalently between 0 and 1.  (b) is an 
initialised map composed of 10,000 squares.  The dimensions and the value 
ranges of each square’s data must match these in each sample, i.e. three 
dimensional data (RGB) and data values are between 0 and 1.  (c) is the final 
map developed from the initial map (b) after processing the SOM algorithm.  
The samples can be then located on the final map according to similarity, i.e. to 
find the most similar colour.  The green square in (a) can be placed on the 
position with black border, and so on for other samples.  The similar samples, 
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Figure 5.4. Plot of Gaussian function for the instance of the diminishing radius 
to determine the neighbours of BMU during each time-step (described in section 
5.2 step 4).  The X axis is the number of iterations and Y is the radius to scale 
the neighbours of the winner square (i.e. the BMU).  As the function shown, the 









5.3 Results and discussion 
Of the 3,768 compounds (out of 3,775) used in the present study, 44 were active 
(1.16 %) and the rest inactive.  The number of utilised descriptor items for each 
compound is 1,532.  Table 5.1 is the profile of some general descriptors of the test 
set.  A comparison between this table with the molecular property profiles of the 
EDULISS database (i.e. Table 2.2) shows that the compounds are on average smaller 
in size but higher in solubility. 
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Table 5.1. Descriptor ranges of the compounds for the FKBP12 bioassay. 
Descriptor Max Min Average 
Standard 
deviation 
Molecular weight 1701.27 88.18 250.02 86.52 
Number of atoms 177 12 31.52 13.34 
Number of bonds 187 12 32.82 14.02 
Number of rings 11 0 2.30 1.01 
Number of oxygen atoms 46 0 2.43 2.24 
Number of nitrogen atoms 7 0 2.11 1.43 
Number of HAcc 46 0 4.43 2.06 
Number of HDon 25 0 1.42 1.45 
MLogP 9.49 -9.79 1.59 1.26 
Wiener 3D index (Å) 185654.60 196.42 3237.22 8034.07 
 
5.3.1 Building the logistic model 
50 compounds, 1 active and 49 inactive, were removed from the available data set 
randomly to be the test set and then the remainder used as the training set to build the 
logistic model (illustrated as Figure 5.1).  The process of model building and 
selection of predictive descriptors are summarised in Figure 5.5.  An initial result is 
that 38 descriptors are found to be good predictors with statistical significance at a p-
value level of 0.05, and these are listed in Table 5.2.  These descriptors with p-values 
below 0.05 and the best correlations with biological activity measured by NMR were 
selected to provide the best model.  These predictive descriptors are mainly 
calculated from three-dimensional representation of a molecule (21 out of 38), and 
are the classes of geometrical descriptors, including RDF descriptors, 3D-MoRSE 
descriptors, WHIM descriptors and GETAWAY descriptors.  Only 5 items are 
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derived from two-dimensional, compared with the 12 one-dimensional descriptors 
(i.e. functional groups and atom-centred fragments shown in Table 5.2).  The result 
seems to indicate that the 3D-based descriptors have higher potential effectiveness in 
such an SAR modelling study. 
3D MoRSE, a geometrical-based descriptor group with the full name “3D Molecule 
Representation of Structures based on Electron diffraction”, is derived from infrared 
spectra simulation using a scattering function suggested by Soltzberg and Wilkins 
(Soltzberg and Wilkins 1977).  These descriptors are fundamentally composed of 32 
equidistant values between 0 and 31 Å-1.  Each value can consequently be weighted 
by a series of atomic properties for fitting in a biological study.  Previous work 
shows that the fundamental principle of 3D MoRSE descriptors has been 
successfully applied to a 2D to 3D conversion programme known as CORINA and 
neural networks, as well as to distinguish compounds binding to the target receptors 
(Gasteiger, Sadowski et al. 1996; Schuur, Selzer et al. 1996; Schuur and Gasteiger 
1997). 
GETAWAY, which stands for GEometry, Topology, and Atom-Weights AssemblY, 
is a set molecular descriptors deduced from a leverage matrix called molecular 
influence matrix (MIM).  It is a symmetric A×A matrix where A represents the 
number of atoms (Consonni, Todeschini et al. 2002).  The elements of the matrix are 
calculated from the spatial coordinates of the molecule atoms and then weighted by 
different atomic properties, such as atomic mass, polarisability, van der Waals 
volume and electronegativity.  As the GETAWAY descriptors contain the relevant 
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information of molecular geometry, they have good prediction capability in 
physicochemical property modelling (Consonni, Todeschini et al. 2002). 
The model fitting exercise also reveals the presence of some molecular functional 
groups and fragments that are remarkably associated with the prediction of 
compound activity.  The 2D chemical structures of the predictive functional groups 
are shown in the legend of Table 5.2.  Although the first appearance of this built 
model tends to be more related to the 3D-descriptors, these 1D-descriptors should not 
be neglected as these molecular sub-fragments can be considered as “structure 
making” factors (Fedorowicz, Zheng et al. 2004).  Furthermore, the number of 
nRCONR2, nRSR and nThiazoles shows a statistically significant difference 
between active and inactive compounds measured by the analysis of the ANOVA 
procedure.  The averages of these functional group counts in the active and inactive 
compounds are 0.42 vs. 0.05 (nRCONR2), 0.44 vs. 0.11 (nRSR) and 0.12 vs. 0.04 
(nThiazoles) respectively.  The result of the modelling and ANOVA analysis shows 
that the presence of these predictive functional groups tends to give a positive 
contribution to the binding interaction between the target and compounds. 
The logistic model gives a scaled value between 0 and 1 presenting the predicted 
probability to be active for each compound, i.e. higher values for active compounds 
and lower values for inactive ones.  The statistical profiles of the predicted values of 
bioassay outcomes are shown in Tables 5.3.  The result of the training set (Table 5.3 
(a)) shows that the model is indeed able to discriminate between the active and 
inactive compounds on average, as the mean of the predicted probabilities of the 
inactive group is particularly low.  However, the model has incorrect predictions for 
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some observations.  There are 7 active compounds whose predicted probabilities are 
below 0.3 while 15 inactive compounds have predicted values larger than 0.3.  
Applying the model to calculate the probabilities of test set (Table 5.3 (b)) shows a 
good but not yet totally reliable prediction.  Several stricter validation tests have been 
carried out and will be discussed in the subsequent section. 
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Figure 5.5. Summary of the Logistic Regression Model building process.  The 
model is built using a training set and is to predict the compound activity.  (a) is 
the procedure of stepwise selection to select predictive molecular descriptors.  
The effect-column lists the selected independent variables, i.e. descriptors.  The 
most significant predictive descriptor, i.e. X1334, first enters into the model and 
other descriptors are added sequentially to the model with a goal of obtaining 
the most appropriate combination of descriptors and the best model.  The model 
omits the descriptors whose p-value was greater than 0.05 (marked by red 
frames) during the selection.  (b) is the finally estimated intercept and 
regression coefficients of each selected descriptor for the probability calculation.  
The selected descriptors are detailed in Table 5.2. 
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Table 5.2. Potentially predictive descriptors selected by the logistic modelling 
exercise, i.e. the 38 best estimated descriptors shown in Figure 5.5 (b).  The 
descriptions for each descriptor are quoted from DRAGON web site 
(http://www.talete.mi.it/). (continued on next two pages) 
Items Descriptions Classes 
T(O..Br) sum of topological distances between O..Br topological descriptors
ATS7p Broto-Moreau autocorrelation of a topological 
structure - lag 7 / weighted by atomic 
polarizabilities 
2D autocorrelations 
ESpm01d Spectral moment 01 from edge adj. matrix 
weighted by dipole moments 
edge adjacency indices
BEHm3 highest eigenvalue n. 3 of Burden matrix / 
weighted by atomic masses 
Burden eigenvalues 
BELm3 lowest eigenvalue n. 3 of Burden matrix / 
weighted by atomic masses 
Burden eigenvalues 
G(N..N) sum of geometrical distances between N..N geometrical descriptors
G(O..Br) sum of geometrical distances between O..Br geometrical descriptors
RDF025u Radial Distribution Function - 2.5 / unweighted RDF descriptors 
RDF110e Radial Distribution Function - 11.0 / weighted 
by atomic Sanderson electronegativities 
RDF descriptors 
Mor05m 3D-MoRSE - signal 05 / weighted by atomic 
masses 
3D-MoRSE descriptors
Mor10m 3D-MoRSE - signal 10 / weighted by atomic 
masses 
3D-MoRSE descriptors
Mor11m 3D-MoRSE - signal 11 / weighted by atomic 
masses 
3D-MoRSE descriptors
Mor24m 3D-MoRSE - signal 24 / weighted by atomic 
masses 
3D-MoRSE descriptors
Mor30v 3D-MoRSE - signal 30 / weighted by atomic 
van der Waals volumes 
3D-MoRSE descriptors
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Mor26e 3D-MoRSE - signal 26 / weighted by atomic 
Sanderson electronegativities 
3D-MoRSE descriptors
Mor32e 3D-MoRSE - signal 32 / weighted by atomic 
Sanderson electronegativities 
3D-MoRSE descriptors
G2u 2st component symmetry directional WHIM 
index / unweighted 
WHIM descriptors 
E2u 2nd component accessibility directional WHIM 
index / unweighted 
WHIM descriptors 
G2e 2st component symmetry directional WHIM 
index / weighted by atomic Sanderson 
electronegativities 
WHIM descriptors 
Dm D total accessibility index / weighted by atomic 
masses 
WHIM descriptors 








HATS8m leverage-weighted autocorrelation of lag 8 / 
weighted by atomic masses 
GETAWAY 
descriptors 








R1v+ R maximal autocorrelation of lag 1 / weighted 
by atomic van der Waals volumes 
GETAWAY 
descriptors 
nRCONH2 number of primary amides (aliphatic) functional group counts
nRCONR2 number of tertiary amides (aliphatic) functional group counts
nArCO number of ketones (aromatic) functional group counts
nArNO2 number of nitro groups (aromatic) functional group counts
nN(CO)2 number of imides (-thio) functional group counts
Chapter 5: The application of Structure-Activity Relationship (SAR) in ligand-protein binding study 
  115
nRSR number of sulfides functional group counts
nPyrazoles number of Pyrazoles functional group counts
nIsoxazoles number of Isoxazoles functional group counts
nThiazoles number of Thiazoles functional group counts
C-018 =CHX* atom-centred fragments
H-053 H attached to C0(sp3) with 2X attached to next 
C 
atom-centred fragments
S-108 R=S atom-centred fragments
*: X represents any electronegative atom (O, N, S, P, Se, halogens). 












Al = H or aliphatic 
group linked through C 
nRCONR2: 
Al = H or aliphatic group 
linked through C 
Y = Ar or Al (not H, not 
C = O) 
nArCO: 
Ar = aromatic group 
linked through any atom 
Y = Al or Ar 
nArNO2: 
Ar = aromatic group linked 
through N 
nN(CO)2: 
Y = H or C 
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 Active compounds  Inactive compounds 
Mean 0.697 0.004 
STD 0.309 0.033 
Min 0 0 
Max 1 0.824 
Observations 43 3,675 
*: There are 50 compounds removed randomly from the PubChem available data set 
before model building.  The removed compounds include 1 active and 49 inactive 
observations respectively. 
 
 Active compounds  Inactive compounds 
Mean - 0 
STD - 0 
Min - 0 
Max 0.99 0 
Observations 1 49 
*: The 50 removed compounds. 
5.3.2 SOM analysis 
A fundamental theorem suggests that similar structures should exhibit similar 
properties (Ruecker and Ruecker 1993).  It follows that the active compounds should 
display some similar patterns which are able to discriminate themselves from the 
inactive compounds.  Yet, it remains problematic how to reveal or describe the 
similarity of compounds based on types of molecular features.  The logistic 
modelling exercise described in section 5.3.1 has selected 38 predictive descriptors 
a: training set* 
b: test set* 
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which are of greatest utility in discriminating active and inactive compounds.  As 
mentioned above, the SOM technique is able to project high dimensional data onto a 
low dimension map which can be used to visualise the sample similarity.  Figure 5.6 
illustrates an SOM analysis summarising the similarity of the PubChem FKBP12 
available data set based on the 38 predictive descriptors.  The analysis groups the 
compounds which have similar patterns into identical positions or clusters.  In order 
to present the clusters for easy observation, the map size has been enlarged to 
200×200, i.e. 40,000 lattices for 3,768 observations in total.  The blue and gray 
squares represent the locations of active and inactive compounds respectively.  In 
some cases, both classes located in the same position are then shown as red squares 
(Figure 5.6).  An initial inspection of the map shows it to be not as discriminative as 
expected.  The squares of active and inactive compounds are mostly located in the 
identical positions or clusters.  However, a crowded square, shown as black, is 
located in the amplified cluster of Figure 5.6.  The crowded square contains 48 
compounds of which 13 are active (30 % out of 44) whereas 35 (1 % out of 3,724) 
are inactive.  In the amplified cluster, there are 16 active and 172 inactive 
compounds in total. It indicates that the analysis of SOM based on the 38 predictive 
descriptors succeeds in aggregating the 36 % active compounds in this cluster and 
discriminate them from 95 % inactive compounds, and successfully visualises the 
result. 
It is important to note that most of the 16 active compounds show strong binding 
affinities: 10 out of the 16 active compounds are found in the top twenty binding 
results when ranked by the estimated Kd values (μM), including the two strongest 
binding observations, i.e. ID: 16725062 and 16725059.  The 2D chemical structures 
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of these 16 active compounds are shown in Figure 5.7.  Two common patterns 
occurring between these compounds include the amide (N–C=O) and sulfide (C–S–C) 
groups represented in blue and pink respectively.  The amide group is the 
fundamental fragment of keto amide carbonyl.  Previous studies indicate that the 
amide carbonyl of FK506’s keto amido group forms an important part of the binding 
to FKBPs.  Figure 5.8 shows the chemical structure of FK506 and its keto amido 
group is highlighted in red.  The amide carbonyl portion forms a hydrogen-bonding 
interaction with FKBP and the ketone carbonyl oxygen engages with three aromatic 
residue side chains of FKBP forming a carbonyl binding pocket (Holt, Konialian-
Beck et al. 1994).  For the compounds that mimic FK506, the presence of this 
binding portion is commonly reported and considered as an important synthesis 
objective (Dubowchik, Vrudhula et al. 2001).  Figure 5.9 demonstrates an instance of 
FKBP docking study in which the hit compound shows a strongest binding affinity 
(Kd: 0.2 μM) as it contains an amide group and the ketone carbonyl oxygen, 
coloured in red, forming an essential hydrogen-binding interaction with the side 
chain Tyr 26 (PDB ID: 1J4R).  In addition, the sulfur atom also fits into the 
hydrophobic pocket around the edge of the binding site (Stebbins, Zhang et al. 2007).  
On the other hand, the items of the predictive descriptors selected by the above 
modelling exercise are in line with the previous studies.  The functional groups listed 
in Table 5.2 partially fit the structural fundamentals of these two crucial binding 
portions and contribute to the higher binding interaction.  In order to estimate if the 
interaction exists between these two portions, Table 5.4 shows a survey using MCS 
(Maximum Common Subgraph, described in chapter 3) to find the compounds that 
contain the groups of two sub-structures a (N–C=O–C–X–C–Y) or b (N–C=O–C–S–
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C–Y) respectively.  The letter X stands for any atom of N, O or P, and the Y 
represents an aliphatic or aromatic ring.  47 (a) and 39 (b) compounds are found in 
the whole PubChem available data set containing these sub-structures.  The X in 
group a, i.e. N–C=O–C–X–C–Y, is actually only ever an oxygen atom.  Although the 
number of observed compounds in group b is fewer than those in group a, 38.5 % of 
the observed compounds in group b are shown as active whereas only 4.3 % in group 
a.  The compounds divide into two sets, i.e. the groups of amides (N–C=O) and 
sulfides (C–S–C), with both adjacent together showing a higher probability to bind 
with FKBP12.  
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Figure 5.6. Clustering of FKBP12 bioassay compounds, 3,768 (44 active and 
3,724 inactive) in total, by SOM analysis.  The map size is 200×200.  The 
number of data dimensions for each compound is 38 which are the predictive 















*: There are 48 compounds placed on the crowded (black) square. 13 of them are 
active and 35 of them are inactive. 
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Figure 5.7. The 16 active compounds placed in the amplified cluster shown in 
Figure 5.6.  The amide (N–C=O) and sulfide (C–S–C) groups are represented in 
blue and pink respectively.  The labels represent the compound’s ID, estimated 
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Figure 5.9. Molecular docking studies.  (a) A hit compound has its amide group 
coloured in red; (b) A docked structure of FKBP12 (PDB ID: 1J4R) and the 
ligand is the hit compound.  The hydrogen-bonding interaction between the side 
chain Tyr 26 and the ketone carbonyl oxygen of the amide group is highlighted 







(quoted from Stebbins, Zhang et al. 2007)
Chapter 5: The application of Structure-Activity Relationship (SAR) in ligand-protein binding study 
  123






Total of observed compounds 47 39 
Active compounds 2 15 






X: The atoms of N, O or P.  None of atom N and P has been found within the 47 
observed compounds. 
Y: Aliphatic or aromatic ring. 
 
5.3.3 Stricter model validation 
In order to verify that the fitted model can be generalised to the same type of new 
data, the above logistic analysis has been repeated while removing a set of 
compounds prior to the modelling exercise.  Although the built model (described in 
section 5.3.1) gives a good accuracy of prediction as shown in Table 5.3, the number 
of test set, i.e. 1 active and 49 inactive compounds, is not strict enough for model 
validation.  This section presents the results of twenty more restrictive test sets.  In 
each test, there are 4 active and 372 inactive compounds removed randomly from the 
PubChem available data set, i.e. removing about 10 % from each of the two classes.  
The remaining data, which is known as the training set, is then utilised for the 
modelling exercise.  The fitted model based on the training set is called the “new 
model” and the model built by the entire PubChem available data set without prior 
removal of any compound is called the “old model”.  Accordingly, the old model 
a b
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possesses a relative better fitting quality as it is built by the complete data set.  The 
twenty new models are compared individually with the old model.  As the results 
show, the tests of the new models show good predictions for the inactive compounds.  
7,440 observations (372×20) in total give predicted probabilities which are extremely 
low from 0 to 0.15 where only three of them are greater than 0.1.  However, unlike 
the results of the inactive compounds, the predictions for the active compounds are 
barely satisfactory, and are shown in Figure 5.10.  The predicted values obtained 
from the new models tend to underestimate the probabilities of the active compounds.  
Only 17.5 % cases (14 out of 80 observations) in red frames in Figure 5.10 exhibit 
the good predictions in the tests of No. 3, 4, 5, 6, 7, 8, 11, 13, 15, 16, 17 and 20.  The 
2D chemical structures of these well-predicted compounds are shown in Figure 5.11.  
Predictably, these compounds commonly contain the groups of amides and sulfides. 
5.4 Summary 
The application of the Logistic Regression Model succeeds in revealing the 
potentially important molecular descriptors and essential sub-structures involved in 
the binding interaction between compounds and target.  Although the built model 
only predicts the activity of compounds accurately for fewer cases in the stricter 
validation tests, it is still useful in exhibiting the features of these well-predicted 
compounds.  These compounds can be the query template in molecular similarity 
searches for further application.  Furthermore, the revealed descriptors can also 
represent the molecular similarity whilst being applied in the clustering applications 
such as SOMs in this study.  
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Figure 5.10. Predicted probabilities of 80 active compounds in the twenty 
stricter hold-out tests.  In each hold-out test, there are 4 active and 372 inactive 
compounds removed randomly from PubChem available data set (i.e. removing 
about 10 %), and the remaining data (the training set) is then utilised for the 
modelling exercise, so finally twenty individual fitting models are built.  The 
twenty fitting models using the training set are called the “new models” and the 
model built by the entire PubChem available data set is called the “old model”.  
Each new model is then competed individually with the old model.  The X axes 
list the 4 previously removed compounds (test set) and Y axes show their 
predicted probabilities using the new and old models, i.e. each active compound 
having two predicted probability values.  The cases in red frames exhibit good 
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Figure 5.11. Chemical structures of the well-predicted compounds in the twenty 
stricter hold-out tests.  The amide (N–C=O) and sulfide (C–S–C) groups are 
represented in blue and pink respectively.  The labels represent the compound’s 
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6. The application of Atomic Characteristic Distance (ACD) and 
EDULISS 2.0 for ligand discovery 
This chapter presents the results of ligand discovery on the known 3D structure of 
pyruvate kinase using the approach of small-molecule database mining.  The 
application of ACD (Atomic Characteristic Distance, described in chapter 2) and the 
facilities of EDULISS 2.0 have been used in the mining processes.  The steps in this 
ligand discovery range from a set of simple database queries via the interface of 
EDULISS to a series of complicated small-molecule screenings mainly using ACD.  
The entire data mining process can be divided into two stages which are described as 
stage 1 and stage 2 respectively in this chapter.  The candidate compounds are then 
tested for inhibition of enzyme activity, and some of the protein-ligand complex 
structures are also crystallised.  The crystallographic experiments and bioassays 
mentioned in this chapter were performed by my colleague Dr. Hugh Morgan. 
6.1 Materials and methods 
6.1.1 Overview of target protein 
The target protein used in this study is a pyruvate kinase, PK (EC 2.7.1.40), which is 
vital in the energy producing step of glycolysis.  PK catalyses the transfer of a 
phosphoryl group from phosphoenolpyruvate (PEP) to ADP to yield pyruvate and 
ATP (Mesecar and Nowak 1997) shown as below: 
 
Other than the presence of the reaction substrates, i.e. PEP and ADP, the catalysis 
also requires the monovalent and divalent cations, i.e. M(I) and M(II), prior to any 
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activity being detected (Yu, Lee et al. 2003).  Both monovalent and divalent cations, 
including K+, and Mg2+ or Mn2+, are involved in the reaction.  K+ is an essential 
activator of PKs, whose presence causes 2-6 fold higher affinities of the relevant 
substrates than in the absence of K+.  The presence of K+ induces the correct 
geometrical arrangement of the active site residues, allowing either PEP or ADP to 
bind in the pocket independently, whereas in the absence of K+ the two substrates 
have an ordered binding mechanism as ADP cannot bind to the pocket before PEP 
(Oria-Hernandez, Cabrera et al. 2005).  By contrast with K+, the divalent cations, 
mainly Mg2+ and in some cases Mn2+, cause global and local conformational changes 
in the pocket and directly interact with the transferred phosphoryl group to yield ATP 
(Matte, Tari et al. 1998). 
The architectures of PKs have been isolated and characterised from a number of 
species.  In vertebrates it has been found to exist as four isoforms, including the L-
form found in the liver, the R-form in erythrocytes, the M1 form in skeletal muscle 
and the M2 form in the foetus (Lovell, Mullick et al. 1998).  Most of PKs exist as a 
homotetramer and each subunit encompasses four domains.  Apart from the N-
terminal domain, the commonly discussed domains are labeled as A, B and C.  
Figure 6.1 (a) is the ribbon structure diagram of an E. coli PK subunit and Figure 6.1 
(b) schematically shows domains A, B and C in green, blue and red, respectively.  
The active site located between domains B and A is the docking pocket for the 
relevant substrates, including PEP and ADP, as well as the required monovalent and 
divalent cation.  The fructose-1,6-bisphosphate (FBP) binding site is located in 
domain C.  As FBP is the allosteric effector of several species PKs, this binding site 
is also commonly called the effector site (Mattevi, Valentini et al. 1995).  A proposed 
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hypothesis of the mechanism of PK’s allosteric regulation is that the movement of 
the three domains takes place within each subunit when it is activated by the docking 
of PEP and FBP (Mattevi, Bolognesi et al. 1996).  When the movement occurs, two 
types of conformational changes can be observed, including rotation of the A, B and 
C domains within each subunit and every subunit within the tetramer.  Figure 6.2 
illustrates the tetramer conformation change due to the domain movements.  When 
domain B shows an open conformation (Figure 6.2 (a)), the enzyme is in the inactive 
state, called the T-state, whereas it is in the active state when domain B is closed 
(Figure 6.2 (b)), called the R-state.  During the transition of T-state to R-state, the 
domain and subunit orientations cause a decrease in height and an increase in width 
of the tetramer. 
A major difference of enzyme control property between the PKs of mammalian host 
and trypanosomatid protozoans is that the allosteric regulation of mammalian PK is 
in response to F-1,6-BP, however protozoans’s PK is regulated by F-2,6-BP 
(Valentini, Chiarelli et al. 2000).  An early study indicated that F-1,6-BP shows a 
similar effect to F-2,6-BP on trypanosoma brucei but it needs approximately 4000-
fold higher concentrations (Schaftingen, Opperdoes et al. 1985).  Apart from directly 
blocking the active site to inhibit the function of protozoans’ PK, this unique 
diversity in the allosteric regulation provides a possible strategy for the effector site 
ligand design to interfere with PK’s allosteric regulation and thereby to produce 
activity against related diseases caused by protozoans such as Leishmania.  
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Figure 6.1. Illustration of the domains, catalytic site and FBP binding site of an 
E. coli PK subunit (monomer).  (a) Ribbon structure diagram.  (b) Schematic 
representation of the domain A, B and C shown in green, blue and red, 
respectively.  Both Figure 6.1 and 6.2 are schematically quoted from Mattevi, 








Figure 6.2. Illustration of the tetramer conformation change due to the 
movements of domains.  (a) The T-state / inactive: domain B is opened.  (b) The 
R-state / active: domain B is closed.  From T- to R-state, the domain and subunit 
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6.1.2 Applied structures of target protein 
For the purpose of ligand design and database mining, a known 3D protein-complex 
structure with a reliable resolution is needed.  There is a bioassay result published on 
the PubChem website (PubChem AID: 361) which utilises quantitative high-
throughput screening (Inglese, Auld et al. 2006) to investigate the influence of 
51,415 compounds on the effectiveness of the enzyme PK from Bacillus 
stearothermophilus.  According to the result, there are 602 of the tested compounds 
identified as either PK activators or inhibitors, but none of the 3D protein-ligand 
complex structures has been reported. 
An X-ray structure of sulphate-bound PK of Leishmania mexicana (LmPYK; PDB 
ID: 3E0V) has been published (Tulloch, Morgan et al. 2008), which is in an active-
like conformation.  In the crystalline state, there are three and two sulphate ions in 
the active and effector sites of each subunit, illustrated as Figure 6.3.  Comparing this 
to the ATP-bound PK structure 1A49 obtained from rabbit (49.4 % sequence identity 
with 3E0V examined by PDBSum of EMBL-EBI; http://www.ebi.ac.uk/pdbsum/), 
the two sulphate ions (out of three) in the active site, i.e. γS and βS, occupy the 
positions close to the γ-phosphate and β-phosphate of ATP, respectively (Figure 6.3 
(b)).  The βS sulphate ion forms three hydrogen bonds with H54, K335 (domain A) 
and R175 (domain B), and these interactions construct a bridge between domain A 
and B.  The two effector site sulphate ions, S(i) and S(ii), mimic the phosphates of F-
2,6-BP (Figure 6.3 (c)).  Sulphate S(i) is bound in the same position as the 6-
phosphate of F-1,6-BP in the PK structures of 1A3W (yeast; 49.5 % identity), 1LIU 
(human erythrocyte; 48.3 % identity) and 1T5A (tumour; 49.8 % identity).  The other 
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sulphate ion S(ii) is located in a position close to the 1-phosphate of F-1,6-BP found 
in similar structures. 
We chose the sulphate-bound PK structure, i.e. 3E0V, to be the target for the ligand 
design in stage 1.  Conversely, since we have successfully crystallised a protein-
ligand complex at a resolution of 2.3 Å, whose sequence is exactly the same as 
LmPYK 1PKL (Rigden, Phillips et al. 1999), we decide to use this structure in stage 
2 to be the target.  As the structure was crystallised at a neutral pH 7.2 in its active 
conformation, it is a more favourable target for ligand design. 
6.1.3 Applied data mining approaches 
The applied data mining approaches are mainly ACD (Atomic Characteristic 
Distance) detailed in chapter 2 and the facilities of EDULISS 2.0 which have also 
been developed for database mining.  In order to explain the methods used more 
clearly, the details of ligand design will be described in the following sections. 
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Figure 6.3. Subunit structure (monomer) of sulphate-bound LmPYK (PDB ID: 
3E0V) at a resolution of 3.3 Å.  (a) and (d) are orthogonal views.  The active site 
can be seen in (b) and the effector site is shown in (c).  All sulphate ions and the 
interacted residues are shown as sticks.  The potential hydrogen bonds are 
shown as yellow dashed lines.  The three active site sulphate ions, i.e. γS, βS and 
δS, are shown in (b), in which the γS and βS ions occupy the positions close to 
the γ-phosphate and β-phosphate of ATP comparing with the PK structure of 
1A49 (rabbit), respectively.  The two effector site sulphate ions, shown in (c), 
mimic the phosphates of F-2,6-BP.  S(i) is bound in the same position as the 6-
phosphate of F-1,6-BP in the PK structures of 1A3W (yeast), 1LIU (human) and 
1T5A (tumour).  S(ii) locates in a position close to the 1-phosphate of F-1,6-BP 
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6.2 Results and discussion 
This section also includes the descriptions of ligand designs and data mining 
processes used in stage 1 and 2. 
6.2.1 Stage 1: To hit compounds that contain two or more sulphate groups with 
sulphur atoms that have geometries consistent with the distances between 
the sulphate ions in the sulphate-bound PK structure 
The positions of the five sulphate ions found in the active and effector sites of the 
sulphate-bound PK structure, i.e. LmPYK 3E0V, provide a starting point for the 
ligand design.  Table 6.1 lists the geometrical distances between these ion pairs.  We 
aim to select the compounds possessing two or more sulphate groups and the sulphur 
atoms are at the distances fitting the distances between sulphate ions found in 
LmPYK 3E0V active or effector sites. 
6.2.1.1 Design of screening criteria 
As EDULISS has a series of molecular descriptors regarding the functional groups 
and geometrical distances between atoms, the first screening can be accomplished 
via the interface of EDULISS.  According to the geometrical distances between 
sulphate ion pairs listed in Table 6.1, we gave a tolerated range for the screening 
criterion as 6 to 9.5 Å.  Considering the flexibility of the compounds, the preferred 
selection is to further choose the candidates which do not possess backbone 
flexibility.  From the mining results, we selected 1,3,6,8-Pyrenetetrasulfonic acid for 
co-crystallising the ligand-protein complexes.  The chemical structure is shown as 
Figure 6.4 together with the geometrical distances between the sulphur atoms.  
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Table 6.1. Distances between the five sulphate ions in the active and effector 
sites*.  The five sulphate ions are shown in Figure 6.3 (b) and (c). 
 Active site  Effector site 
Subunit No. δS - γS γS - βS βS - δS  S(i) - S(ii) 
A 7.99 6.54 8.95 8.61 
B 8.53 6.92 8.80 8.74 
C 8.27 6.51 8.90 9.29 
D 8.51 7.25 8.31 9.67 
Range 7.99 – 8.53 6.51 – 7.25 8.31 – 8.95  8.61 – 9.67 
Average 8.3 6.8 8.7 9.1 
*: All of the distances are in angstrom (Å).  
 
Figure 6.4. Pyrene-like compounds whose sulphate groups are at the distances 
fitting the criterion, i.e. 6 to 9.5 Å, to mimic the positions of sulphate ions found 
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6.2.1.2 Screening and crystallisation result 
The 1,3,6,8-Pyrenetetrasulfonic acid bound PK complex has been crystallised 
successfully at the resolution 2.1 Å and its structure model is shown as Figure 6.5.  The 
orthogonal views of the tetramer conformation are shown as Figure 6.5 (a) and (d) 
where the subunit A, B, C and D are coloured by red, gray, blue and yellow, 
respectively.  Four pyrene-like compounds, i.e. 1,3,6,8-Pyrenetetrasulfonic acid, can 
be found in the active sites of each subunit (marked by blue frames) and another odd 
one is only bound the subunit B (marked by red frames).  Figure 6.5 (b) illustrates 
the active site of subunit B where the three pink ions, labelled as γS, βS and δS, are 
of the LmPYK 3E0V active site sulphate ions placed by overlapping the domain A 
and C of the subunit B (aligning the residues 1-88 and 183-497; RMSD fit: 0.362).  
The pyrene-like compounds have docked on the active sites but did not exactly fit the 
required position, i.e. the positions of the γS, βS and δS sulphate ions.  However, 
there is an odd pyrene-like compound bound on the edge of subunit B between 
LmPYK tetramers within the crystal lattice.  The compound interacts with R194 via 
π-π interaction illustrated as Figure 6.5 (c) and shown with its electron density where 
the red structure belongs to the neighbouring symmetry related molecule.  At this 
binding position, the compound potentially enhances the packing arrangement in the 
crystal unit cells thus it promotes crystallisation and provides a better structure 
resolution than LmPYK 3E0V (2.1 v.s. 3.3 Å).  The better resolution provides more 
precise observation for the residues, metals or waters found in the active and effector 
site for further ligand design and screening.  Furthermore, the pyrene-like 
compounds can only bind the edge of subunit B but not in the active sites at low 
concentration.  As this is a useful property in crystallisation, this compound has been 
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used in lower concentration for some consequent crystallographic experiments in 
order to improve the structure resolution. 
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Figure 6.5. Structure model of the pyrene-like compound bound LmPYK at the 
resolution 2.1 Å.  (a) and (d) illustrate the tetramer conformation in orthogonal 
views (subunit A: red, B: gray, C: blue and D: yellow).  Four pyrene-like 
compounds, i.e. 1,3,6,8-Pyrenetetrasulfonic acid, can be found in the active sites 
of each subunit (marked by blue frames) and the other one is only bound 
subunit B (marked by red frames).  (b) shows a pyrene-like compound binding 
the active site of subunit B with its electron density.  The three pink ions, 
labelled as γS, βS and δS, are the LmPYK 3E0V active site sulphate ions placed 
by overlapping the domain A and C (aligning the residues 1-88 and 183-497; 
RMSD: 0.362).  (c) shows the odd pyrene-like compound interacting with R194 
(subunit B) via π-π interaction.  The red structure belongs to the neighbouring 
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6.2.2 Stage 2: Application of Atomic Characteristic Distance (ACD) to more 
complex screening requirements 
In stage 1, the screening simply considered the distances between identical atoms and 
the crystal model shows that the selected candidates appeared to bind the active sites 
weakly.  In this stage, the screening takes both the interatomic distances between 
various atom types and the hydrogen bond interactions observed in the binding sites 
into account.  Also, we use an LmPYK/ATP/FBP complex structure as the target 
instead of the sulphate-bound PK structure used in stage 1. 
As described in 6.1.2 section, the sequence of the used target protein is entirely the 
same as LmPYK 1PKL but it is in the R-state / active conformation.  There are ATP 
and oxalate molecules in the active site and a F-2,6-BP molecule in the effector site 
respectively, illustrated as Figure 6.6 (a) and (c).  The potential interactions of the 
ATP and F-2,6-BP molecules in the two sites are schematically shown in Figure 6.6 
(b) and (d).  The interactions are shown as yellow dashed lines, which are defined as 
at a potential hydrogen bond length (≤ about 3.2 Å).  Several water molecules are 
involved in the interactions between these two molecules and residues. 
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Figure 6.6. Subunit structure of the target which is an ATP- and F-2,6-BP-
bound complex in R-state / active conformation, whose sequence is the same as 
LmPYK 1PKL (Rigden, Phillips et al. 1999).  (a) and (c) are reversed views.  The 
active site ATP and effector site F-2,6-BP molecules are marked by red frames.  
(b) and (d) schematically diagrams the potential H-bond interactions of ATP 
and F-2,6-BP.  The interactions are shown as yellow dashed lines, which are 
defined as at a potential hydrogen bond length (≤ about 3.2 Å).  The hydrogen 
bond donors (HDon) and acceptors (HAcc) are coloured by blue and red, and 
labelled by their residue names and IDs, respectively.  The potential ionic 
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6.2.2.1 Design of screening criteria 
We aim to find the compounds which are able to mimic the interactions of ATP and 
F-2,6-BP molecules in the two binding sites.  Figure 6.7 (a) and Figure 6.8 (a) 
schematically show the interesting interatomic distances found in ATP and F-2,6-BP 
molecules, respectively.  In the case of ATP (Figure 6.7), the interatomic contacts 
and distances between O2*/ATP, O2A/ATP, γP/ATP, HOH58 and HOH420 form 
the screening criteria to search for the preferred candidates, but we select a terminal 
sulphate (-SO3
-) to substitute for the position of γP/ATP in order to continue the 
study from stage 1.  The designs of the screening motifs have been topologically 
outlined in Figure 6.7 (b) and (c).  The first screening operation extracts compounds 
from the EDULISS 2.0 collection which possess one or more terminal -SO3
-, and 
then we further investigate their interatomic distances between specified atom types 
which have to geometrically match the motifs shown as the figures.  The two atoms 
in the compounds to mimic HOH58 and HOH420 could be either hydrogen bond 
donor or acceptor.  A series of tolerances have been given for each interatomic 
distance from 10 to 25 %. 
Although the interface of EDULISS 2.0 has provided the facility to perform ACD, it 
can only ensure that the hit compounds possess the specified interatomic distances 
but not the conjunctions.  An in-house java script was written using the CDK java 
tool kit and was used to accomplish these multiple requirements.  This screening 
approach has also been applied in the cases of F-2,6-BP molecules (Figure 6.8) 
which illustrates the relevant interaction of the bound F-2,6-BP molecules in the 
effector site and the motifs for screening, shown as Figure 6.8 (b) to (f).  
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Figure 6.7. Schematic diagrams of the interesting interactions of ATP in the 
active site.  (a) represents the selected interatomic conjunctions between three 
ATP atoms and two waters.  (b) and (c) topologically outline the interatomic 
conjunctions and distances between the selected atoms, and form the screening 
motifs.  The hydrogen bond donors (HDon) and acceptors (HAcc) are coloured 
by blue and red, and labelled by their residue names and IDs, respectively.  The 
position of γP/ATP has been replaced by a terminal sulphate (SO3).  The tables 
below (b) and (c) list the number of hit compounds based on the motifs and a 
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Figure 6.8. Schematic diagrams of the relevant interactions of F-2,6-BP (FBP) in 
the effector site.  (a) represents the selected interatomic conjunctions between 
five atoms in F-2,6-BP and three waters.  The description of (b) to (f) is the same 
as described in Figure 6.7 (b) and (c).  The position of P2/FBP has been replaced 





























Chapter 6: The application of Atomic Characteristic Distance (ACD) and EDULISS 2.0 for ligand discovery 
  147
6.2.2.2 Screening results 
The screening result shows that in the EDULISS 2.0 collection 5,365 compounds 
possess one or more terminal SO3.  The numbers of hit compounds in a range of 
tolerances are tabulated below the figures of each case in Figure 6.7 and 6.8, 
respectively.  Since the screening has effectively excluded the unfit compounds, the 
numbers of hits are acceptable for further detailed inspection to select the preferred 
candidates one by one.  Also there is a set of compounds which appears to be hit 
throughout the various cases consistently.  Considering the reasons mentioned above 
and the compound solubility, we selected 8 compounds to be test candidates for 
further experimental assay.  The chemical structures of the 8 compounds are shown 
as Figure 6.9 in 2D together with their common properties.  As the application of 
ACD aims to screen compounds which possess the specified interatomic 
conjunctions and distances regardless of the conventional rule-based screenings, only 
one compound (Comp. 4) fits the Lipinski’s rule of five. 
6.2.2.3 Bioassay and crystallisation results 
Table 6.2 summarises the examined inhibition of the LmPYK enzyme activity caused 
by the 8 compounds.  The examination is based on the pH change monitored over 
time as a direct result of LmPYK enzyme activity.  In the uninhibited state, the pH 
value increases from 6.3 to 7.3 as LmPYK converts ADP and PEP into ATP and 
pyruvate.  The pH value change is caused by the loss or gain of a hydroxyl group.  
All of the assays were done in duplicate and the values are listed in Rate (1) and (2) 
columns.  As a result, Comp. 3 and Comp. 5 show 33.34 and 100 % inhibition in 
LmPYK enzyme activity, respectively. 
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Figure 6.9. Chemical structures of the 8 selected compounds whose ACDs fitted 
the screening motifs shown in Figure 6.7 (b) to (c) and Figure 6.8 (b) to (f).  The 
common chemical properties are tabulated for each compound.  The orientated 
3D structures are the representative if the compound fits two or more screening 
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a: Number of rings; b: Number of rotatable bonds; c: Topological polar surface area 
using N,O,S,P polar contributions. 
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Table 6.2. Summary of all LmPYK inhibition data caused by the 8 compounds 

















 21.21 22.27 21.74 100.00 - - 
Comp. 1 31.51 27.96 29.74 136.80 - 1.4 
Comp. 2 65.25 61.36 63.31 291.19 - 2.9 
Comp. 3 16.18 12.76 14.47 66.66 33.34 - 
Comp. 4 46.24 48.60 47.42 218.12 - 2.2 
Comp. 5 0 0 0 0 100 - 
Comp. 6 - 49.25 49.25 226.54 - 2.3 
Comp. 7 79.00 84.88 81.94 376.91 - 3.8 
Comp. 8 NA NA NA NA - - 
a: All assays were done in duplicate and the values are listed in Rate (1) and (2) 
columns. 
b: No ligand added. 
 
Comp. 3 / Ponceau S is predicted to bind the effector site as it has been found in the 
hit of each screening motif for the effector site.  The schematic diagrams of the fitted 
ACDs, i.e. interatomic conjunctions and distances between the selected atoms, are 
shown as Figure 6.10. The most well fitted part is in its disulfonic naphthol fragment.  
The Comp. 3 bound complex structure has been crystallised successfully at a 
resolution of 2.7 Å and its structure model is shown as Figure 6.11 (a) where the four 
subunits of the tetramer conformation are coloured by yellow, gray, green and red 
respectively.  The blue subunit belongs to the neighbouring symmetry unit.  Comp. 3, 
marked by the red frame, binds the effector site of the red subunit and is partially 
placed in the active site of the blue subunit, illustrated as Figure 6.11 (b).  There are 
four residues involved in the binding interactions in the effector site, including H483, 
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K486 and T402 at a potential hydrogen bond length (≤ about 3.2 Å) and V485 
forming hydrophobic contact. 
As F-2,6-BP (FBP) and three waters, including HOH3158, HOH3160 and HOH1866, 
form a part of the screening motifs, these four molecules have been placed by 
overlapping the domain A and C of the LmPYK/ATP/FBP complex structure 
(aligning the residues 1-86 and 206-498; RMSD fit: 0.334) in order to be contrasted 
with the binding position of Comp. 3, shown as Figure 6.11 (c).  Although the 
binding position of Comp. 3 does not appear to exactly overlap the four motif 
molecules, the disulfonic naphthol fragment of Comp. 3 is very close to a phosphate 
group of the FBP and one of the waters at the distance ≤ 3.2 Å.  It occupies a part of 
FBP binding site.  As the result, the protein loop from residue A481 to G487 forming 
the allosteric binding pocket is accordingly rotated to accommodate the binding of 
Comp. 3.  The binding of the allosteric effector molecule FBP is therefore no longer 
possible as the site has been blocked and cannot accommodate FBP binding. 
As the effector site residues mostly interact with the disulfonic naphthol fragment of 
Comp. 3, we further tested 2-naphthol-3,6 disulfonic acid, i.e. the core of the 
fragment.  The crystal of LmPYK in the complex with 2-naphthol-3,6 disulfonic acid 
has been obtained but the extremely long cell edge (about 500 Å) is problematic for 
the collection of processable data.  The modelling and refinement process is still 
underway at this time. 
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Figure 6.10. Schematic diagrams of Comp. 3 / Ponceau S in different 
orientations to show whose ACDs, i.e. interatomic conjunctions and distances 
between the selected atoms, are fitted to the five screening motifs shown in 
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Comp. 5 / Reactive Blue 4 is expected to bind the active site as it fits the motif for 
the active site shown as Figure 6.7 (b) at a tolerance 15 %.  The schematic diagrams 
of the fitted ACDs are shown as Figure 6.12.  Although Comp. 5 shows a good 
inhibition in LmPYK enzyme activity according to the bioassay result, a crystal of its 
LmPYK complex bound at the active site could not be obtained successfully. 
Previous studies indicate that a series of anthraquinone dyes, including Comp. 5, are 
able to mimic the adenine nucleotides acting as ligands to interact with nucleotide-
binding sites of some relevant enzymes and receptors such as hexokinase (Puri 1994; 
De Moliner, Moro et al. 2003; Breier, Bohacova et al. 2006).  We therefore modified 
the screening technique and used MCS (Maximum Common Subgraph, described in 
chapter 3) to select other analogues of Comp. 5 containing the core structure 
anthraquinone.  The additionally selected candidates are Reactive Blue 2, Acid Blue 
25 and Acid Blue 80, and their chemical structures with the common properties are 
shown as Figure 6.13.  The core structure, i.e. anthraquinone, is coloured red. 
Only Acid Blue 80 bound complex crystal has been obtained at a resolution of 2.3 Å.  
The model of the tetramer structure is shown as Figure 6.14 (a) where the bound 
Acid Blue 80, marked by the red frames, can be found in the active sites of the two 
gray subunits.  The Acid Blue 80 molecule binds in the active site via potential 
hydrogen bond interactions with five residues including the side chains of R49, N51, 
Y304 ( ~3.5 Å) and K335 (~3.7 Å) and the backbone nitrogen of G331, illustrated as 
Figure 6.14 (b). 
In order to contrast the geometrical binding position of Acid Blue 80 with the 
position of ATP, Figure 6.14 (c) shows the binding positions of the two molecules by 
Chapter 6: The application of Atomic Characteristic Distance (ACD) and EDULISS 2.0 for ligand discovery 
  154
overlapping the domain A and C of the LmPYK/ATP/FBP complex structure 
(aligning the residues 1-86 and 206-498; RMSD fit: 0.413).  One of the sulphate 
groups in Acid Blue 80 almost overlaps the α-phosphate of ATP.  As Acid Blue 80 
occupies the active site, it consequently prevents the ADP molecule from binding. 
6.3 Summary 
The facilities of EDULISS 2.0 provide a convenient interface allowing users to 
perform a series of queries.  It is most useful in the early stages of experimental 
ligand binding projects for initial screening and to indicate which initial compounds 
should be purchased.  Its large collection of small-molecule structure files also offers 
a higher probability to hit candidates, particularly when using complex screening 
criteria.  The application of ACD gives a good scope for the ligand design as well as 
helping to reduce the number of candidates so that researchers can directly inspect 
and further select the preferred compounds based on empirical bio- or 
physicochemical knowledge.  The screening approaches used in this study have 
shown success in selecting ligands that have been shown by X-ray crystallography to 
bind to the template protein.  The crystal structures of these complexes provide 
insight into the interactions occurring in ligand binding site and into the 
conformation changes that can be induced in the complex. 
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Figure 6.11. Structure model of Comp. 3 / Ponceau S bound LmPYK at 
resolution 2.7 Å.  (a) illustrates the tetramer conformation where the four 
subunits are coloured by yellow, gray, green and red respectively.  The blue 
subunit belongs to the neighbouring symmetry unit.  Comp. 3 / Ponceau S binds 
the effector site of the red subunit and is partially placed in the active site of the 
blue subunit marked by the red frame.  (b) enlarges the Comp. 3 binding site 
and shows the interactions between Comp. 3 and four residues in the effector 
site via hydrogen bond and hydrophobic interactions.  (c) contrasts the 
geometrical binding position of Comp. 3 with the location of F-2,6-BP (FBP) 
and three water molecules located by overlapping the domain A and C of the 
LmPYK/ATP/FBP complex structure (aligning the residues 1-86 and 206-498; 
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Figure 6.12. Schematic diagrams of Comp. 5 / Reactive Blue 4 in different 
orientations to show whose ACDs, i.e. interatomic conjunctions and distances 
between the selected atoms, are fitted the screening motifs shown in Figure 6.7 











Figure 6.13. Chemical structures of the 3 additionally selected compounds 
which possess the same core, i.e. Anthraquinone marked by red, as Comp. 5 / 
Reactive Blue 4.  The common chemical properties are tabulated for each 
compound.  The labels represent the compound’s name, SPH number and the 
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Figure 6.14. Structure model of Acid Blue 80 bound LmPYK at the resolution 
2.3 Å.  (a) illustrates the tetramer conformation where the bound Acid Blue 80 
molecules, marked by the red frames, can be found in the active sites of the two 
gray subunits.  (b) enlarges the Acid Blue 80 binding site and shows the 
potential hydrogen bond interactions between Acid Blue 80 and five residues in 
the active site.  (c) contrasts the geometrical binding position of Acid Blue 80 
with the location of ATP located by overlapping the domain A and C of the 
LmPYK/ATP/FBP complex structure (aligning the residues 1-86 and 206-498; 
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7. Development of a database and web-based interface for novel 
metalloprotein descriptors and their application 
7.1 Introduction 
Previous chapters have discussed the physicochemical descriptors, including the 
atomic characteristic distance (ACD) between specified atom types for small 
molecules. This chapter discusses a different set of descriptors that describe the 
geometry of various metal sites in metalloproteins, provisionally named unorthodox 
metalloprotein descriptors.  The work in this study mainly develops a relational 
database system and web-based interface to store and apply these descriptors, called 
MESPEUS (MEtal Sites in Proteins at Edinburgh UniverSity). 
The investigation of metal sites in metalloproteins has for some time been a major 
interest and research area of Dr. Marjorie M Harding of the School of Biological 
Sciences (http://tanna.bch.ed.ac.uk/ for more details).  Since her research was first 
published in 1999 (Harding 1999), she has constantly investigated the newly added 
crystallographic structures and updates her results, while also discussing them in a 
series of publications (Harding 2000; Harding 2001; Harding 2002; Harding 2004; 
Harding 2006).  The subjects of the study mainly involve the validation of the 
coordination number of the specified metal sites, the coordination shapes, the donor 
types, the metal-donor distances and the architecture of metal coordination groups 
etc.  The study manages to provide a useful reference and potential recommendations 
for building or validating a protein structure model during refinement, particularly 
for structures where resolution is limited.  The compilation of structural data is also 
useful for interpretation of electron-density maps of new protein structures.   
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As the volume of data has increased considerably, a database system and web-based 
interface become appropriate in order to manage the relevant information efficiently 
and share it with the crystallography community.  My colleague Yi-gong Sheng has 
also contributed to write a set of perl scripts for the work of establishing the database.  
The following sections present the procedures for creation and manipulation of 
MESPEUS with some demonstrations and applications.  These were published in 
2008 (Hsin, Sheng et al. 2008). 
7.2 Materials and methods 
7.2.1 Details of information stored 
The geometry information of metal in the MESPEUS database is derived from 
metalloprotein structures which were deposited in the Protein Data Bank (PDB) not 
later than 1 January 2007 (Berman, Henrick et al. 2007).  We choose the PDB files, 
including protein and nucleic acid crystal structures, which contain one or more 
metal atoms and are determined by diffraction methods at a resolution of 2.5 Å or 
better.  When more than one copy of the protein molecule with metal site(s) is 
present in the crystal asymmetric unit, all of the metal sites are stored in the database.  
The metal atoms selected are biologically common, including Fe, Ni, Mn, Ca, Cu, Na, 
Mg, K, Co and Zn.   
Some of the information is directly extracted from the content of PDB files, 
including 1) the name of protein, 2) the class and title of protein given in the 
HEADER of the PDB file, 3) the structure resolution in Å, 4) the crystal space group 
and cell dimensions, 5) the refinement programme used, 6) the R factor and Rfree, 7) 
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the B values of atoms involved in metal sites, 8) the occupancy values of donor 
atoms.   
The other stored information regarding the geometry of metal sites is extracted and 
then evaluated for each PDB file by a programme called MP (Harding 2001).  The 
programme performs the identification of metal sites in PDB files, the confirmation 
of donor atoms in residues or ligands, the measurement of metal-donor distances in 
metal sites, and the difference between the actual distance and the target distance 
(Harding 2006) is then obtained.  The names of all metal and donor atoms are stored 
as they appear in the PDB files.  In order to describe the distortion of the shape of a 
coordination group, the MP programme estimates the r.m.s deviation between the 
actual interbond angles around the metal atom and the values for ideal geometry 
(Harding 2000).  The following subsections give the essential descriptions for the 
evaluation mentioned above. 
7.2.1.1 Target distance 
The target distance in the present study is a set of predicted distances between donor 
groups and specified metals, which are obtained from a series of analyses of metal 
sites in protein structures using the PDB deposited coordinates combined with the 
information from analogous metal-coordination compounds in the Cambridge 
Structural Database, CSD (Allen 2002; Allen and Taylor 2004).  The CSD was used 
through the UK Chemical Database Service at Daresbury Laboratory (Fletcher, 
McMeeking et al. 1996), and stores the results of over 400,000 determinations at 
present, including small organic and metal-organic molecules.  The structures 
deposited in the CSD have been determined by X-ray or neutron diffraction and are, 
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by marcromolecular standards, very well resolved and the resulting structures have 
been applied in various fields (Allen and Motherwell 2002; Orpen 2002; Taylor 
2002). 
Initially, the study of target distances only used the metal complexes in the CSD as it 
provided a better accuracy than that of most protein structure determinations.  All of 
the small molecules used in the study were required to have R factor ≤ 0.065 and 
contain specified metals interacting with ligands which are analogues to the amino 
acid side chains commonly found in proteins.  The analogues mimic the carboxylate 
groups, alcohols, phenolates, thiolates, imidazole groups of amino acid side chains 
and water molecules.  The motifs of metals interacting with these analogues are 
shown in Figure 7.1, schematically quoted from Harding 1999.  Programmes QUEST 
and VISTA (Allen, Davies et al. 1991; Bruno, Cole et al. 2002) were used for the 
motif search and analysis.  The observed distances in different metal-donor 
combinations were then subjected to a series of statistical analyses giving a set of 
objectively reliable values called target distance.  Since the PDB is continually 
adding new structures, similar analysis to that mentioned above was then applied to 
the PDB data (determined at structure resolution ≤ 1.25 Å), so that target distances 
have been refined by evaluating the agreement between the values obtained from 
PDB and CSD.  The revised target distances have been tabulated in Harding 2006.  
Atoms, excluding carbon and phosphorus, are identified as part of the metal site, i.e. 
donors, if they are within the target distance plus a tolerance 0.75 Å to the metal atom.   
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Figure 7.1. Motifs of M-analogues in CSD for the search queries where the letter 
M represents a metal coordinated with an analogue which mimics the amino 
acid side chain.  Both (a) and (b) illustrate coordinations between metals and 
carboxylate groups; the bonds of M-O2, C-O1 and C-O2 can be any type; in (b) 
a hydrogen bond is involved in the coordination occurred in many carboxylates 
where the OW is a water molecule.  (c), (d) and (e) represent the alcohol groups 
coordinated to metals.  (f) shows a phenolate groups coordinated to a metal; the 
bonds of M-O shown in (c), (d), (e) and (f) can be any type.  (g) and (h) illustrate 
imidazole groups coordinated to metals in where all bounds could be any type 
but the Cγ atoms should be sp2 carbon.  (i) shows a thiolate group coordinated 
to metal where the bond of M-S could be type.  The full descriptions of these 


































7.2.1.2 Deviation of the shape of a coordination group 
The distortion of the shape of a coordination group can be described as the r.m.s 
deviation, δ, when the actual interbond angles are compared with the values of a 
regular (or ideal) geometry.  The present study mainly considers the cases of metal 
coordination number 4, 5, and 6.  The ideal geometries of coordination groups are 
shown in Figure 7.2, schematically quoted from Harding 2000.  The geometries are 
regardless of the bond type.  The r.m.s deviation of the coordination number 4, 5, and 
6 can be obtained by following equation: 
eq. 7.1 
where the αi is the actual value of an angle measured from the interbonds in the  
coordination group and the αideal stands for the ideal bond angle in a regular geometry.  
The n is the number of angles which are needed to provide a full description for each 
coordination shape and it could be deduced from CN(CN-1)/2 where CN is the 
coordination number  (Howard, Copley et al. 1998).  For instance, there are 10 
angles needed to describe a trigonal bipyramid or tetragonal pyramid sphere as their 
coordination number is 5, that is n = 5(5-1)/2 = 10.  The smaller the value of δ the 
closer is the actual shape to the ideal geometry. 
Other than determining the distortion of a coordination geometry, the r.m.s deviation 
can also be an indicator describing the nearest shape when the coordination group 
tends to form multi-geometries alternatively.  As shown in Figure 7.2, the shape may 
be either trigonal bipyramid or tetragonal pyramid when the coordination number is 
5.  In order to determine a nearest shape for this case, the r.m.s deviations of the two 
coordination geometries can be calculated respectively and then the nearest 
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description of shape can be assigned by comparing their deviations.  For example, 
the nearest shape is recommended as trigonal bipyramid when δtrigonal bipyramid < 
δtetragonal pyramid, otherwise it is assigned as tetragonal pyramid.  Similarly, this 
judgement can be applied to the case of coordination number 4 determining the shape 
if tetrahedral or square planar.   
Figure 7.2. Regular geometries (shapes) of coordination groups where the letter 
M represents a metal coordinated with donor atoms D.  (a) illustrates a metal 
coordinates with 6 donor atoms and the ideal shape of the coordination group is 
a octahedral.  Octahedral bond angles are 90° so that for example, the ideal 
angles of D1-M-D4 and D1-M-D2 are 90° and 180°, respectively.  (b) and (c) 
show the geometries when the coordination number is 5 and the shape could be 
either trigonal bipyramid or tetragonal pyramid.  The largest bond angles are 
D1-M-D2 in both two shapes.  (d) and (e) are the regular geometries for the 
coordination number 4.  In (d), all of the ideal bond angles in a tetrahedral are 
equivalent, e.g. D1-M-D2: 109.5°, whereas the ideal bond angles in a square 
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7.2.2 Construction of the database 
As described in section 2.2.4, a relational database is the most reasonable choice for 
the data storage as it is fast, efficient and compatible with various scripts.  Similarly 
to EDULISS 2.0, we chose a MySQL database for the present study and designed a 
set of proper tables to relationally organise data.  The major schema of MESPEUS 
database design is shown in Figure 7.3, in which a number of keys, i.e. primary key 
(PK), unique key (UK) and index (I), have been assigned to the specified columns in 
order to manage the data integrally and enhance the query performance. 










PK: Primary key; UK: Unique key; I: Index 
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The root of the tables is the “PROT_INFO” table which contains the fundamental 
geometry information of collected protein structures, including the information 
extracted from the content of PDB files directly and the number of metal sites found 
in a structure.  The columns of CELL1 to CELL6 are for the cell dimensions, i.e. a, b, 
c, α, β, γ (Å and degrees), and the LINK column provide the link of the particular 
protein page shown on the PDB website. 
The table “METAL_INFO” stores the properties of metal atoms found in PDB 
structures.  The metal name, residue number and chain letter are saved as they appear 
in the atom list in PDB files.  The RMSD column is for the r.m.s difference between 
each actual metal-donor distances found in the metal site and the target values.  It is a 
useful quality indicator for the reported distances and geometry of a metal site.  A 
large r.m.s difference may simply be due to large coordinate errors in a low 
resolution structure, or to an error in identification of donor atoms or interpretation of 
the site.  The columns of DEL_1 to DEL_4 are for the four indicators of metal 
stereochemistry.  As mentioned in section 7.2.1.2, the distortions of the coordination 
shapes have been measured and described as the deviation (δ) for the cases of 
coordination number 4 to 6.  For coordination number 4, the DEL_1 and DEL_2 
column store the r.m.s deviations from an ideal tetrahedral and square planar 
respectively.  The deviation from bar 4 (a ‘‒’ symbol upon 4) symmetry is stored in 
the column DEL_3.  The bar 4 symmetry in a regular tetrahedron is illustrated in 
Figure 7.4.  Consider it is a regular tetrahedron composed of four donors A, B, C and 
D around metal M and all of the interbond angles, i.e. AMB etc, are equal.  The 
dashed line is one of the bar 4 axes and a regular tetrahedron has three bar 4 axes, 
which bisects the angles AMD and BMC.  If the tetrahedron is squashed along the 
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dashed line, i.e. the bar 4 axis, eventually it becomes square planar with ABCD all in 
the same plane as M.  At all stages of this squashing, the symmetry is still bar 4, and 
the angles should be AMD=BMC and AMB=AMC=DMC=DMB.  The calculation 
of the r.m.s deviation of bar 4 symmetry in this study is defined by Marjorie Harding 
and the steps are shown as following: 
bm1: the mean of AMD and BMC 
bm2: the mean of AMB, AMC, DMC, DMB 
dbar4: one sixth of the sum of the squares of AMD-bm1, BMC-bm1, AMB-bm2, 
AMC-bm2, DMB-bm2, DMC-bm2 
Figure 7.4. Illustration of bar 4 symmetry in a regular tetrahedron for the r.m.s. 
deviation calculation, which is composed of four donors A, B, C and D, and a 
metal M.  (a) A, M and D are in the plane of the paper, B is in front and C is 
behind.  The dashed line is a bar 4 axis which bisects the angles AMD, BMC 
(the other two bar 4 axes should be able to be observed between AMB and 
CMD).  (b) when the tetrahedral is squashed from the bar 4 axis, it becomes a 









This is then calculated for each of the three possible positions of the bar 4 axis 
(bisecting AMD, AMB and CMD) and the minimum value is taken.  The value of 
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column DEL_4 is recorded as 0 when the nearest shape is tetrahedral, whereas it is 1 
for square planar.  For coordination number 5, the column DEL_1 and DEL_2 are for 
the deviations from trigonal bipyramid and tetragonal pyramidal, respectively.  When 
the nearest shape is trigonal bipyramid, the DEL_4 is 0, whereas > 0 for tetragonal 
pyramidal.  The deviations are stored in the DEL_1 column for the case of 
coordination number 6. 
In some cases, two alternative positions for a donor molecule or metal itself have 
been detected during refinement.  The atoms of the distorted molecule are labelled by 
A and B according to their occupancy values as higher occupancy is labelled as A 
and B for the lower.  The labels are recorded as the last character of the atom names 
in the PDB file.  Disorder like this is sometimes reported in poorly determined 
structures, but it is certainly seen in some structures determined at high resolution.  
Figure 7.5 illustrates four instances in which the disorders occur in either the 
coordination group or the metal atom.  Figure 7.5 (a) demonstrates the two 
alternative positions for a carbonate ion which is coordinated to an iron atom found 
in the 1A8E protein at a structure resolution of 1.6 Å.  In this type disorder, the 
atoms with lower occupancy, i.e. labelled as B, have been recognised and excluded 
from storage.  The second case (Figure 7.5 (b)) shows that the zinc atom is too close 
to the sulphur atom at a distance of 2.36 Å and the nearest oxygen atom is at a 
distance of 1.75 Å (PDB ID: 1C1N; resolution: 1.4 Å), so that the atoms of zinc and 
SO4 molecule have been labelled as A and B in its PDB file.  The case shown in 
Figure 7.5 (c) reveals that a disorder due to the alternative positions for the Ca 
(colored by yellow) and Mg (colored by green) atoms found in the 1S83 protein 
structure at a resolution of 1.25 Å.  The occupancy values of the Ca and Mg atoms 
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are both 0.5 since they share the occupancy in the refinement.  In Figure 7.5 (d) is the 
case found in 2GBA (resolution: 0.92 Å) where two identical copper atoms are 
disordered and labelled as A and B, respectively.  The two atoms are very close to 
each other as the distance between them is only 0.67 Å.  All of the disorders 
illustrated in Figure 7.5 have been given an error flag for the associated metal atom 
and recorded in column ERR_ID of table “METAL_INFO”. 
The “DONOR_R_INFO” table mainly stores the identifiers of donor residues as 
shown in PDB files.  When the metal site involves the oxygen atoms of carboxylate 
from GLU and ASP and the oxygen atoms are both within the target distances plus 
the tolerance or if carboxylate groups bridge two metal atoms, the interaction will be 
defined as bidentate and labelled as “b” in the R_BID column, otherwise blank.  The 
identifiers of donor atoms with the values of atomic occupancy and B-factors as 
shown in PDB files can be found in table “DONOR_A_INFO”.  The actual metal-
donor distance and the difference from target distance are stored in the DIST and 
DIF column, respectively.  In the same way, the donor atoms from carboxylate 
groups forming bidentate interaction with metals are labelled as “b” in the A_BID 
column.  The interbond angles in metal sites and the distances between donor atoms 
are stored in the “DD_ANGLE” table.  The “MM_DIST” table contains the distances 
between metals found in each protein structure if the protein possesses two or more 
metal sites. 
All of the tables have been relationally organised by a set of specified columns. For 
example every P_ID column refers to the ID column of root table “PROT_INFO” 
and the M_ID columns all refer to the ID column of “METAL_INFO”.  The 
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description of the columns in each table is also available at the MESPEUS website, 
http://eduliss.bch.ed.ac.uk/MESPEUS/images/MESPEUS_table.pdf.   
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Figure 7.5. Disorders in coordination group and in metal atom.  (a) illustrates 
the two alternative positions for a carbonate ion coordinated with an iron atom 
(PDB ID: 1A8E).  The CO3 at the position with higher occupancy (0.65) is 
labelled as A, the other with lower occupancy (0.35) labelled as B and excluded 
from storage.  (b) shows the distortion of zinc and SO4 molecules with 
occupancy 0.38 and 0.48, respectively (PDB ID: 1C1N).  The zinc atom is very 
close to the sulphur and nearest oxygen atom at the distance of 2.36 and 1.75 Å, 
respectively.  (c) reveals a disorder due to the alternative positions for the Ca 
(yellow) and Mg (green) atom  (PDB ID: 1S83).  (d)  shows two identical 
disordered ions, i.e. copper A and B, found in 2GBA.  The two copper atoms are 
very close at the distance 0.67 Å.  An error flag has been given for these 
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7.2.3 Construction of the web-based interface 
In the same way as EDULISS 2.0, the web-based interface of MESPEUS is built by 
using the Java Servlet technology and JavaServer Pages and is hosted at an Apache 
Tomcat web server.  The software architecture is constructed as Model-View-
Controller (MVC) model in order to enable extensibility in functionality and for ease 
of maintenance (described in section 2.4.1).  For representing the molecular 
structures in 3D on web pages, this web site uses Jmol as the viewer (described in 
section 2.4.2.1).  An open source application for displaying statistical charts, called 
JFreeChart (http://www.jfree.org/), has also been applied, which provides the charts 
with drilldown enabled function allowing users to examine charts to the desired level 
of detail.  The web-based interface allows users to set series of query criteria to 
access the MESPEUS database without requiring any knowledge of SQL.  It displays 
the accessible information of metal coordination groups and renders the individual 
metal site with distances, angles and coordination geometry etc.  The home page of 
MESPEUS web site is shown as Figure 7.6 and is available at 
http://eduliss.bch.ed.ac.uk/MESPEUS/.  A detailed demonstration for its 
manipulation is given in section 7.4.1. 
7.3 The statistical profile of metal sites in MESPEUS 
At present, the database contains 10,919 metalloprotein structures extracted from the 
PDB.  A significant number of metal atoms are listed in whole PDB files which do 
not appear to be within chemical bonding distance, i.e. target distance plus 0.75 Å, of 
any appropriate atoms.  In many cases, there are not even any appropriate atoms 
within 3.6 Å.  These cases do not make chemical sense, and can only be regarded as 
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incomplete structure determinations and these metal atoms are not included in the 
MESPEUS database.  The numbers of metal sites are listed in Table 7.1 grouped by 
metal types.  The listed numbers include the cases in which the metal sites are 
present in the asymmetric unit, so that the number of distinct metal sites should be 
fewer than the number listed.  Further, the PDB contains many groups of very similar 
proteins within which the metal sites are similar or identical.  Some metal or donor 
atoms are listed with low occupancy and for the disordered pairs like those shown in 
Figure 7.5 (a), only the one with higher occupancy has been retained.  Coordinate 
errors can be large when atom positions have low occupancy and so metal donor 
distances derived from them may have large errors; the presence of disordered sites 
gives meaningless results for coordination number.  Sites with low occupancy can be 
identified in the database as described in section 7.2.2 and excluded from searches, 
leaving the observations with occupancy 1.0 separated into column (2) of Table 7.1.  
Column (3) and (4) are further subdivided from column (2) as not all of the metal 
atoms interact with protein directly.  For example, there is a large number of cases 
for Mg which are simply hydrated ions, such as Mg(OH2)6
2+.  Alternatively, some 
metal atoms are only interacting with ligand molecules, or with DNA or RNA.  A 
survey shows that there are 312 of the PDB files used for MESPEUS database 
described as DNA or RNA in their PDB HEADER and 308 of them are simply DNA 
or RNA structures as none of the amino acid residues can be found in the PDB files.  
Figure 7.7 gives a good instance (PDB ID: 1DPL; resolution: 0.83 Å) to show a 
structure deposited in PDB which is a DNA structure without the presence of protein.  
The coordination group of the Mg site in the structure is composed of six water 
molecules forming a typical octahedral geometry, i.e. Mg(OH2)6
2+.  As the structure 
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has been well determined, the occupancy values of the donor atoms are 1.0.  Given 
the result shown in column (3), the most common metals in metalloprotein are Fe, Ca, 
Zn and Mg, whereas there are relatively fewer Co and Ni containing proteins. 
























Sites with metal 
and donor 
occupancy = 1.0 
(3) 




Sites from column 
(2) without metal-
protein interactions
Na 2,372 2,069 1,768 301 
Mg 5,561 4,953 3,676 1,277 
K 1,424 1,259 1,108 151 
Ca 7,120 6,425 6,018 407 
Mn 2,118 1,810 1,688 122 
Fe 7,763 7,226 7,003 223 
Co 637 506 356 150 
Ni 534 398 366 32 
Cu 1,327 1,105 1,088 17 
Zn 6,031 5,073 4,979 94 
Total 34,896 30,824 28,050 2,774 
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Figure 7.7. DNA structure with no protein present (PDB ID: 1DPL; resolution: 
0.83 Å) where the Mg site is composed of six water molecules (marked by blue 
frame).  The values of donor occupancy are 1.0 and the site is formed as a 












7.4 Applications of MESPEUS database and web interface 
7.4.1 Fundamental manipulation of web interface 
The MESPEUS web interface has been designed to allow straightforward searching 
for particular kinds of interactions, with the possibility of selecting only higher 
resolution structures.  Alternatively, users can simply give a PDB ID to yield all of 
the metal sites in that protein.  The query criteria can be set up via the main query 
page as shown in Figure 7.8.  The page provides a list of convenient options, as 
tabulated below the figure, which are the particular types of donor residue groups 
and atoms found in database.  As the selection shown in Figure 7.8, the page has 
been filled for a query about Mg links to ATP with the maximum structure resolution 
set at 2.5 Å, then the first result is a list of all the metal-donor atom distances 
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satisfying the search query, together with information on coordination number of the 
metal, shape, atom numbers and so on, as shown in Figure 7.9.  The distributions of 
the reported Mg-OATP distances and structure resolutions of hit proteins can be 
displayed by histograms together with the general statistical profiles, such as the 
numbers of observations, the means of reported distances and structure resolutions 
and their value ranges.  The histograms are drilldown enabled allowing users access 
to the desired level of detail.  For example, if the bar marked by * is clicked upon, 
the page will only list the data of the samples whose Mg-OATP distances are within 
the range of ≥ 1.8 and < 1.9 Å.  The page also allows downloading the query result as 
a tab-separated file and entries can be removed from the list by clicking the “Delete” 
button before calculating distributions. 
Users can click the link of metal name printed in the list as marked by ** in Figure 
7.9 to open a page like Figure 7.10 showing the detail of the specified metal site.  
Alternatively, a page like Figure 7.11 shows the whole metal-containing protein 
when users click the link of PDB ID as marked by ***.  Both pages use Jmol to 
present the molecular structures in 3D with a set of buttons below the pictures 
allowing users to conveniently manipulate the structures, such as dynamically to 
centre the specified metal, rotate the views, measure the angles or distances, reveal 
the location(s) of metal site(s) in protein, or add other information.  Users can obtain 
the desired geometry information of metal sites and inspect them via these two pages 
directly.  
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In order to serve the researchers who are familiar with SQL, a page allowing input of 
SQL statements and direct access of the MESPEUS database has been set up and is 
available at http://eduliss.bch.ed.ac.uk/MESPEUS/query_SQL.jsp.   
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Figure 7.8. Main query page for the MESPEUS web interface.  From the top, 
users can simply give a PDB ID to yield all of the metal sites in that protein.  
Alternatively, users can set a variety of query criteria, including to select metal 
of interest (multiple choices allowed); to specify the metal coordination number 
as any or 1 to 12 with 6 different logical operators; to choose the type of donor 
residue group (the list on the left) and atom (on the right), or input a name of 
non-protein donor, such as ATP, which should be identical with the residue 
code recorded in the PDB file; to determine the maximum structure resolution 













Donor Residue Group Sub Options 
1 ASP O of side chain carboxylate in aspartic acid (OD) Any 
   Monodentate 
   Bidentate 
2 GLU O of side chain carboxylate in glutamic acid (OE) Any 
   Monodentate 
   Bidentate 
3 SER O of hydroxyl group in serine (OG) - 
4 THR O of hydroxyl group in threonine (OG) - 
5 HIS N of imidazole in histidine ND and NE 
   N of imidazole in histidine (ND) 
   N of imidazole in histidine (NE) 
6 CYS S of thiol group in cysteine - 
7 Main chain carbonyl O of any amino-acid residue - 
8 Other donor atom in the protein molecule O of amide group of asparagine (OD) 
   O of amide group of glutamine (OE) 
   O of phenolate group of tyrosine (OH) 
   S of methionine side chain (SD) 
   Main Chain N, Any AA (Rare) 
   N in LYS side chain (Very Rare) 
   N in ARG side chain (Very Rare) 
   Any other atom 
9 Donor atom from a non-protein molecule O of water molecule 
   O in any other non-protein molecule 
   N in any non-protein molecule 
   S in any non-protein molecule 
   Any other atom 
   Search by name of non-protein donor 
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Figure 7.9. Result page of the search for Mg linked to ATP with the maximum 
structure resolution at 2.5 Å.  The search yielded 412 examples in 84 proteins or 
DNA/RNA structures.  The distributions of observed Mg-OATP distances and the 
structure resolutions of hit proteins can be displayed as histograms together 
with their general statistical profiles, such as the numbers of observations, the 
means of reported distances and structure resolutions and their value ranges.  
The list from the left side gives the actual Mg-OATP distance measured, 
coordination number, shape with the r.m.s deviation from the ideal geometry, 
metal name, donor group, PDB ID with resolution, the r.m.s. difference between 
metal-donor atom distances and the target distances, and the difference between 
the two distances.  The list can be downloaded as a tab-separated file and the 
entries can be removed by clicking the “Delete” button.  *: Clicking here selects 
this distance range only.  **: Links to a page like Figure 7.10.  ***: Links to a 
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Figure 7.10. Page for specified metal site found in PDB ID: 1F2U.  When 
selecting the metal name in the results listed in Figure 7.9, the metal site can be 
displayed by Jmol, as well as its relation to the whole protein molecule together 
with the information of the site geometry and a list of donor resides.  Here, the 
metal, Mg (cyan coloured), is coordinated by the O atoms from SER and GLN, 
two phosphate O atoms (one β, one γ) of ATP, and two water molecules.  The 
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Figure 7.11. Page for specified metal containing protein (PDB ID: 1F2U).  When 
the PDB ID is selected in the results listed in Figure 7.9, the metalloprotein can 
be displayed by Jmol, as well as its crystallographic information and the details 
of each metal site found in the structure.  This page also allows directly linking 
to the PDB web site for more details of this protein.  Here, the protein has two 
chains, A and B, with one Mg-ATP site on each.  *: A dynamic link to centre 
this metal site in the view on left.  **: Links to a page like Figure 7.10 showing 
















7.4.2 Importance of near atomic resolution in deriving mean bond distances 
We have been concerned to derive the best average values for distances from metal 
atoms to different kinds of donor atoms in structures deposited in the PDB, for use in 
validation, electron density map interpretation, model fitting or for restrained 
refinement.  The average interaction distance can be evaluated from all the data in 
the database, or from the higher resolution structure determinations only.  The 
average found for a particular distance is often slightly smaller when only higher 
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resolution observations are used than when all results are used.  Table 7.2 gives an 
example of Zn-N of histidine with coordination number 4, in which the observations 
listed include the interaction from Nδ and Nε of imidazole side chain (coordination 
groups with the donor atom occupancy ≤ 0.9 and geometrical disorder as described in 
section 7.2.2 have been excluded).  It shows that the mean distance can be fairly 
different when the observations are various in the level of resolution determinations 
and the standard deviation, representing the scatter of results, is smaller at higher 
resolution.  The most precise averages, i.e. those with smallest standard deviation, 
are from X-ray structures with resolution better than 1.3 Å (i.e. near atomic 
resolution). 
This result agrees with a previous study which applied CSD data where the average 
for the equivalent interactions there is 2.00 (0.02) Å for 25 observations (Harding, 
2006).  Figure 7.12 illustrates the wide scatter of reported distances from poor to 
good resolution structures.  It shows that good consistency of observations only 
occurs at a fairly high resolution.  The standard deviations in the level of high 
resolution determination suggest that very little variation in the particular distance is 
expected, e.g. < 0.02 Å, but the wide variation above must be due to coordinate 
errors remaining after structure refinement.  According to these results, it is strongly 
recommended that for such averages only the highest resolution results practicable be 
used, consistent with a reasonable number of observations for statistical requirements.   
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Table 7.2. Effect of resolution on mean distance found for Zn-N of histidine, 
with Zn coordination number 4.  It excludes the coordination groups with the 
occupancy of donor atoms ≤ 0.9 and geometry disorder.  The Nδ and Nε of 
histidine imidazole side chain are both included as there is no significant 
difference in their means if the two Nδ and Nε are kept separate.   
Max. resolution (Å) No. observations Mean (s.d.) (Å) 
2.5 3,583 2.10 (0.13) 
1.8 1,007 2.07 (0.09) 
1.5 261 2.06 (0.06) 
1.3 88 2.03 (0.04) 




Figure 7.12. Reported values of Zn-NHis distances for zinc coordination number.  
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7.4.3 Application: a survey of interactions between Mg and adenosine 
triphosphate (ATP) 
Phosphate-magnesium interactions are crucial in many enzyme mechanisms, such as 
in the kinases mentioned in chapter 6.  The interactions are essential in most ATP 
catalysis (Williams, Oren et al. 1993; Hansson and Kannangara 1997; Mesecar and 
Nowak 1997; Zhang, Yang et al. 2009).  There is a particularly rich source of 
structural information available in the PDB for metal-ATP interactions and this 
survey provides an overview of the interaction geometries found from the database 
for protein-Mg-ATP complexes.  The MESPEUS web interface can find all links 
from Mg to O of ATP as the case shown in Figure 7.9 and present the Mg site as in 
Figure 7.10 and 7.11.  For the detailed analysis, it was more convenient to use SQL 
statements to access the database to find all Mg with ATP links and then to apply 
perl scripts for further investigation.  There are 197 Mg-OATP-phosphate sites in 84 
proteins found in the database, in which the occupancy values of donor atoms are > 
0.9 without geometrical disorders.  Table 7.3 shows the mean distance of Mg-OATP-
phosphate using structures solved at different resolutions.  The observations exclude the 
distances > 2.6 Å as they have been considered as outliers.  Seven observations in 
structures at resolution < 1.5 Å give a mean Mg-OATP-phosphate distance of 2.05 (0.07) 
Å, but for a reliable average more observations are desirable. 
Table 7.4 shows the distribution of coordination number for Mg-ATP sites in 
different level of structure resolution.  The most common is coordination number 6, 
which is consistent with the result of searching the coordination number found of all 
Mg sites in structures regardless of the donor types (in the research only structures 
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determined at resolution 1.8 Å or better were used, and 63.9 % of Mg sites have a 
coordination number of 6).  Some observations from lower resolution structures 
appear to have coordination number < 4 which suggests that the reliability of these 
data is questionable and some of the analyses may be incomplete or the atoms 
identified as Mg may actually be water molecules as these molecular sizes are quite 
similar. 
Table 7.3. Mean distance of Mg-OATP-phosphate in different level of structure 
resolutions.  The observations listed here have excluded the samples with 
distance > 2.6 Å. 
Max. resolution (Å) No. observations Mean (s.d.) (Å) No. proteins 
2.5 385 2.18 (0.18) 82 
2.3 253 2.17 (0.18) 61 
2.0 126 2.17 (0.18) 34 
1.8 74 2.13 (0.15) 21 
1.5 7 2.05 (0.07) 3 
 
 
Table 7.4. Coordination numbers found for Mg-ATP sites in different level of 
structure resolutions. 
Coordination numbers Max. 
resolution 
(Å) 1 2 3 4 5 6 7 
2.5 3 10 20 26 21 114 3 
2.3 - 4 8 10 11 92 1 
2.0 - 1 4 4 4 48 1 
1.8 - - 2 2 4 26 1 
1.5 - - - 1 - 2 - 
 
After removal of identical sites within crystal asymmetric units (e.g. the examples 
shown in Figure 7.13), 66 Mg-OATP-phosphate remained and are listed in Appendix 2 
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together with the information of donors and some statistics.  It shows that the most 
common protein types are transferases.  Mg is normally linked to protein through one 
or two amino acid side chains, mainly ASP, GLU, ASN, GLN or SER, THR, but 
there are two examples with three links to protein, and three with links to main chain 
carbonyl oxygen (marked by a superscript a). 
Previous experimental studies have tried to address the coordination pattern, i.e. the 
preferred interaction, between Mg and the oxygen atoms of ATP phosphates, but the 
results are equivocal.  Some of them propose that the Mg2+ ion may be preferably 
coordinated with the oxygen atoms from each of the three ATP phosphates (Kuntz 
1973; Mildvan 1987), but some suggest that the usual coordination pattern should 
involve two oxygen atoms only, i.e. the oxygen from γ- and β-phosphate groups 
respectively (Auerbach, Huber et al. 1997; Liao, Sun et al. 2004).  The present 
survey tends to agree with the latter.  ATP may be linked to Mg through one, two or 
all three phosphate groups.  The most common pattern (23 examples) is linkage 
through the β- and γ-phosphate groups, but all other possibilities also occurred.  
There are only two cases where linkage is through two O atoms of the same 
phosphate group (marked by a superscript b).  The Mg coordination group may also 
include one to four water molecules and occasionally another small molecule like 
oxalate as a bidentate ion. 
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Figure 7.13. Removal of identical sites within crystal asymmetric units for 
Appendix 2.  All Mg atoms and water molecules are shown as green and red 
spheres, respectively.  The interacting amino acids and ATP are shown as stick 
style.  (a) illustrates that there are four identical Mg-ATP sites found in each 
chain of 2BEK, all composed of one OTHR, two OATP-phosphate (Oβ- and Oγ-phosphate) 
and three water molecules.  Only the Mg site located in chain A, colored by red, 
has been retained and listed in Appendix 2.  (b) shows that two Mg sites in 1TID 
have been listed in the table, because the site found in chain A (colored by red) 
is composed of one OASN, three OATP-phosphate (Oα-, Oβ- and Oγ-phosphate) and two 
water molecules, whereas the site located in chain B (colored by green) only 
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7.5 Discussion and summary 
Unlike the descriptors for small molecules, the study of the unorthodox 
metalloprotein descriptors, i.e. the geometry information of metal sites, mainly 
concerns the inter-molecular interactions as well as factors in the determination of 
the protein structure.  The storage for these descriptors should not only include 
complete crystallographic information of global protein structures but also record the 
evaluated deviation from ideal geometries of metal sites in order to provide a precise 
observation and application. 
The MESPEUS database with its user-friendly web interface allows immediate 
identification and display of the metal sites in any specified protein whose structure 
is in the PDB, determined at resolution 2.5 Å or better.  Alternatively, the web 
interface can identify all metal sties with a particular kind of contact, giving distance, 
coordination number, and atoms names for each as well as average distances and 
structural resolutions and their distributions.  Further, as shown in the cases of 
applications, SQL queries to the database can extract additional information about 
the interactions of different metals with proteins.  
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8. Summary, conclusions and future work 
In drug discovery projects, research importantly focuses on ligand-protein 
interactions.  To discover a new drug, the general intent is to find a drugable small 
molecule from tested compounds (or drug candidates), which should be able to 
specifically interact with the binding site of the preselected target protein resulting in 
the disruption of the native ligand-protein interactions and inhibiting the protein’s 
activity.  In modern drug discovery, several approaches have been used to aid the 
small-molecule screening, such as high-throughput screening (HTS), database 
mining or virtual high-throughput screening (VHTS) as mentioned in Chapter 1.  In 
order to carry out the process efficiently, those approaches iteratively utilise 
databases (or libraries) which are seen as a powerful and convenient tool in storing 
and retrieving relevant information. 
This project applies structure-based and database mining approaches to study ligand-
protein interactions.  The major aims of this project include: the development of a 
small-molecule database which stores a vast number of commercially purchasable 
compound structures and their molecular properties (i.e. the descriptors) with a web-
based interface for the database; the discovery of correlations between compound 
activity and molecular descriptors using the known bio-assay outcomes; the 
application of designed structure-based mining to discover ligands (inhibitors) for 
targeted protein structures.  Finally, another area of ligand-protein interactions 
considered in this project is the metal-binding sites in metalloproteins.  The present 
work undertook some surveys of various metal sites found in metalloprotein 
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structures as well as the development of a database system and web-based interface 
to store and apply the geometry information of those metal sites. 
8.1 Development of small-molecule database, EDULISS 2.0 
In order to support the studies of structure-activity relationship (SAR) and structure-
based mining, we have developed a relational database system called EDinburgh 
University Ligand Selection System (EDULISS 2.0) which primarily stores the 
structure-data files (SDfiles) of +5.5 million commercial purchasable small 
molecules collected from 28 prominent supplier chemical catalogues and over 1,500 
various calculated molecular properties (descriptors) for each compound.  The tables 
of this database have been designed to allow good accessibility for other applications 
or scripts and a well planed approach to implement future updates.  A user-friendly 
web-based interface of EDULISS 2.0 has been established and is available at 
http://eduliss.bch.ed.ac.uk/ providing a series of straightforward facilities to satisfy 
the need of data-mining for drug discovery. 
The present work develops a very efficient procedure to identify unique compounds 
from the vast collection using three high discrimination descriptors (W3D: Wiener 
3D index; Whete: Wiener-type index from electronegativity weighted distance 
matrix; Vu: V total size index, unweighted WHIM descriptors) to distinguish the 
compounds prior to performing the structure comparisons.  This strategy 
considerably reduces the number of required pair-wise structure comparisons from 
3×1013 down to 6×106, thus the recognition of unique compound in EDULISS 2.0 
can be done very efficiently.  Using this approach we could show that the total 
number of unique compounds present is 4,011,697. 
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8.2 Applications of Structure-Activity Relationship (SAR) in ligand-protein 
binding study 
PubChem bioassay data, an NMR based screening assay for a human FKBP12 
protein (PubChem AID: 608) was utilised together with a series of molecular 
descriptors to construct a prediction model using a Logistic Regression approach.  
This model reveals the molecular descriptors which are correlated with ligand 
activity, and predicts the probability of ligand-protein binding.  The result is that 38 
descriptors are found to be good predictors (listed in Table 5.2): they are mainly 
calculated from three-dimensional representation of a molecule (21 out of 38), and 
are the classes of geometrical descriptors, including RDF descriptors, 3D-MoRSE 
descriptors, WHIM descriptors and GETAWAY descriptors.  This result seems to 
indicate that the 3D-based descriptors have higher potential effectiveness in such an 
SAR modelling study.  The model fitting exercise also reveals the presence of some 
molecular functional groups and fragments that are clearly associated with the 
prediction of compound activity.  The numbers of functional groups nRCONR2, 
nRSR and nThiazoles show a statistically significant difference between active and 
inactive compounds measured by the analysis of the ANOVA procedure.  In the 
prediction of ligand-protein binding probability, however, the built models are barely 
satisfactory to predict the activity of compounds accurately in the 20 stricter 
validation tests. 
The present work applies a neural network technique called SOMs to visualise the 
PubChem compound similarity based on the 38 predictive descriptors.  The analysis 
of SOM succeeds in aggregating the 36 % active compounds (16 out of 44) in a 
cluster and discriminate them from the 95 % inactive compounds as only 172 (out of 
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3,724) inactive compounds were found in the cluster, and successfully visualises the 
result as shown in Figure 5.6.  Most of the active compounds aggregated in the 
cluster show strong binding affinities and possess two common structural patterns 
including the amide (N–C=O) and sulfide (C–S–C) groups with both groups adjacent 
showing a higher probability to bind with FKBP12. 
This SAR study succeeds in revealing the potentially important molecular descriptors 
and essential sub-structures involved in the binding interaction but the built model 
only predicts the activity of compounds accurately for fewer cases in the stricter 
validation tests.  The failure of prediction may be caused by the fact that the 
descriptors we used for the modelling exercise represent the properties of a whole 
molecular structure, but the active compounds may only partially interact with the 
binding site, e.g. only a fragment of the molecule involved in the interaction.  
Moreover, some descriptors are highly correlated to others and in some cases the 
descriptors belonging to the same group present high correlations between 
themselves as demonstrated in Figure 4.1 and 4.3.  The large number of redundant or 
similar variables in representing the molecular characteristics may distort the 
modelling evaluation and cause a situation that the selected descriptors in the 
repeated validation tests are often different but they are actually very similar.  Too 
many descriptors also cause over-fitting in the modelling process as the more the 
descriptors used, the greater the likelihood to obtain a correlation.  The large number 
of descriptors also increases the requirements of computing and storage.  The 
selection of proper descriptors prior to modelling exercise should be considered in 
the future work, such as only selecting the representation of the descriptors which are 
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similar or show high correlations between themselves.  Similarly, to provide a full 
the representation of the descriptors, it is also necessary to consider the presence of 
bioisosteres which are molecular functional groups or atomic types that have 
physicochemical similarities, including the size, shape, hydrophobicity, electronic 
distribution and so on, and show similar biological properties  (Kraus 1983).  For 
example, the groups of CO2, N2O, N3
-, and CNO- are found to be similar in physical 
properties and are considered as a group of isosteres, as well as the Cl, Br, I, SH and 
PH2 because these atomic types have the same number (in this case 7) of peripheral 
electrons (Patani and LaVoie 1996).  A full description is given by Silverman 2004. 
8.3 Application of Atomic Characteristic Distance (ACD) and EDULISS 2.0 
for ligand discovery 
We have developed a molecular descriptor called ACD (Atomic Characteristic 
Distance) to profile the distribution of specified atom types in a compound, including 
halogens, sulphur, phosphorus, and hydrogen bond donors and acceptors.  This 
molecular descriptor is encoded into a set of bit strings using the bit-wise algorithm 
(illustrated in Figure 2.8) which are ideal for storage, manipulative facility and high-
speed screening.  The present work applies the ACD and the facility of EDULISS 2.0 
including its small-molecule collection and web-based interface to find possible 
inhibitors for pyruvate kinase.  The selected candidate compounds were tested for the 
inhibition of protein catalysis activity, and some of the protein-ligand complex 
structures have also been crystallised. 
In stage 1, we designed a mining question based on the positions of the five sulphate 
ions found in the active and effector sites of the sulphate-bound PK structure (i.e. 
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LmPYK 3E0V) to find the compounds possessing two or more sulphate groups.  The 
sulphur atoms are at the distances fitting the distances between the five sulphate ions.  
We selected 1,3,6,8-pyrenetetrasulfonic acid via the interface of EDULISS for co-
crystallising the ligand-protein complexes.  The result is that the complex has been 
crystallised successfully at the resolution 2.1 Å and its structure model is shown as 
Figure 6.5.  Four pyrene-like compounds, i.e. 1,3,6,8-pyrenetetrasulfonic acid, were 
found in the active sites of each subunit; one additional compound was bound 
between subunit B of adjacent model in the lattice.  The four pyrene-like compounds 
found in the active sites appear to bind the active sites weakly.  At the binding 
position of the odd one, the compound potentially enhances the packing arrangement 
in the crystal unit cells thus it promotes crystallisation and provides a better structure 
resolution.  We also observed that this compound can only bind the edge of subunit 
B but not in the active sites at low concentration, hence this compound has been used 
in lower concentration for some consequent crystallographic experiments in order to 
improve the structure resolution. 
In stage 2, we used an LmPYK/ATP/FBP complex structure as the target and the 
screening took both the interatomic distances between various atom types and the 
hydrogen bond interactions observed in the binding sites into account.  We applied 
the idea of ACD and wrote a java script to accomplish these multiple requirements.  
The design of screening criteria and the result of each screening are illustrated and 
tabulated in Figure 6.7 and 6.8.  The screens are seen to be able to effectively 
exclude the unfit compounds allowing further detailed inspection to select the 
preferred candidates one by one.  We selected 8 compounds (shown as Figure 6.9) 
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and two of them (Comp. 3 / Ponceau S and Comp. 5 / Reactive Blue 4) show 33.34 
and 100 % inhibition in LmPYK enzyme activity, respectively (summarised in Table 
6.2).  The Comp. 3 bound complex structure has been crystallised successfully at a 
resolution of 2.7 Å and its structure model is shown as Figure 6.11.  Comp. 3 occupies a 
part of FBP (the allosteric effector) binding site resulting in the inhibition of the 
kinase activity.  Although Comp. 5 shows a good inhibition in LmPYK enzyme 
activity, a crystal of its LmPYK complex bound at the active site could not be 
obtained successfully.  We therefore modified the screening technique to select three 
analogues of Comp. 5 (Reactive Blue 2, Acid Blue 25 and Acid Blue 80) containing 
the core structure anthraquinone shown as Figure 6.13.  The Acid Blue 80 bound 
complex crystal has been obtained at a resolution of 2.3 Å (shown as Figure 6.14), 
which occupies the active site and consequently prevents the ADP molecule from 
binding and disturbs the kinase’s allosteric function. 
The web-based interface of EDULISS 2.0 is most useful in the early stages of 
experimental ligand binding projects for initial screening.  As EDULISS contains a 
large collection of commercially purchasable small molecules, it offers a higher 
probability to hit candidates, particularly when using complex screening criteria, and 
allows researchers to purchase the preferred compounds directly without chemical 
synthesis.  The application of ACD gives a good scope for the ligand design and has 
shown success in selecting ligands.  In future work, ACD could be developed to 
include information about rings in a compound.  Rings affect molecular 
hydrophobicity which is seen to be important in the binding interaction.  For example, 
we could flag the geometrical centre of an interesting ring and then determine the 
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distances between the centre and the specified atom types, so that the characteristic 
of the compound can be structurally profiled in more detail and the ligand design can 
take the interaction involving the hydrophobic pocket found in the binding site into 
account.  At present, bit strings of ACD can only ensure that the compounds possess 
the specified interatomic distances but not the conjunctions of the specified atoms.  
This remaining requirement should be accomplished in the future work.  Finally, the 
EDULSS database and interface should be continually updated, stabilised and 
enhanced with new elements to extend its utility for other applications.  For example, 
the collected small molecules can be further decomposed into fragments using e.g. 
Murcko method (Bemis and Murcko 1996) for the requirement of fragment-based 
drug design (Rees, Congreve et al. 2004; Hajduk 2006).  This approach is 
increasingly used for drug discovery in this decade and has been successful in 
finding potent inhibitors for various targets (Hajduk and Greer 2007).  Alternatively, 
the fragments could be applied to virtual high-throughput screening to simplify the 
computational analysis for binding interaction.   
8.4 Development of a database and web-based interface for novel 
metalloprotein descriptors and their application 
Other than the use of physicochemical descriptors, including the atomic 
characteristic distance (ACD), we also discuss a different set of descriptors that 
describe the geometry of various metal sites to look into the metal-binding sites in 
metalloproteins for the study of ligand-protein interaction.  The geometric 
information of metals is derived from metalloprotein structures which were deposited 
in the Protein Data Bank (PDB) not later than 1 January 2007, including protein and 
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nucleic acid crystal structures.  The structures should contain one or more metal 
atoms and are determined by diffraction methods at a resolution of 2.5 Å or better.  
The metal atoms selected are biologically common, including Fe, Ni, Mn, Ca, Cu, Na, 
Mg, K, Co and Zn.  The present work has developed a relational database system and 
web-based interface to store and apply these descriptors, called MESPEUS (MEtal 
Sites in Proteins at Edinburgh UniverSity) and it is available at 
http://eduliss.bch.ed.ac.uk/MESPEUS/. 
This study discusses the importance of near atomic resolution in deriving mean bond 
distances between observed metal and the donor atoms.  As an example, the observed 
mean distance for Zn-N of histidine with coordination number 4 is given in Table 7.2.  
The mean distance can be fairly different depending on the resolution of the structure 
determination.  The standard deviation, representing the scatter of results, is smaller 
at higher resolution; good consistency of observations only occurs at a fairly high 
resolution as illustrated in Figure 7.12.  A survey of interactions between Mg and 
adenosine triphosphate (ATP) indicates that the most common protein types which 
contain Mg-OATP-phosphate sites are transferases and Mg is normally linked to protein 
through one or two amino acid side chains, mainly ASP, GLU, ASN, GLN, SER or 
THR.  As the preferred interaction of Mg-OATP-phosphate, the most common pattern is 
linkage through the β- and γ-phosphate groups, but all other possibilities also 
occurred (detailed in Appendix 2).  Mg is commonly coordinated with 6 donors and 
other than amino acids and ATP the coordination group may also include one to four 
water molecules and occasionally another small molecule like oxalate as a bidentate 
ion. 
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The MESPEUS database with its user-friendly web interface provides a good 
capability to immediately identify and display the metal sites.  The stored geometry 
information of metal sites manages to provide a useful reference and potential 
recommendations for building or validating a protein structure model during 
refinement as well as useful for interpretation of electron-density maps in new 
protein structures.  In some metal site studies, researchers are widely interested in the 
donors which indirectly interact with the metal atom through hydrogen bonds to one 
of the direct donors, i.e. the so-called second shell (Christianson and Fierke 1996; 
Karlin, Zhu et al. 1997).  Second shell donors are defined as any non-amino acid 
molecule or residue whose distance to the non hydrogen atoms of the direct donor 
groups is within 3.5 Å (Karlin and Zhu 1997).  The second shell donor groups have 
shown a contribution to the energetic stabilisation of the metal complex (Dudev, Lin 
et al. 2003).  The future work of MESPEUS can extend its scope to involve the 
geometry information of these second shell donor groups allowing researchers to 
understand their characteristic or the preference of donor group types, and the 
information can also be applied in the structure refinement.   
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Appendix 1.  Chemical structures of the 44 active compounds in the PubChem 
bioassay (PubChem AID: 608).  The labels represent the compound’s ID, 
estimated Kd value (μM) and the rank in the overall bioassay.  (continued on 

























































































*: Data didn’t be provided by PubChem. 
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Appendix 2. Mg sites with links to ATP and to protein.  Column cngp lists the one letter code of amino acid side chain donor groups and O 
represents main chain carbonyl oxygen; sd1 and sd2 are sequence separations of first and second donors, second and third donors (-1 for nil); 
CN is coordination number; rms is r.m.s. deviation of metal-donor atoms distance from target distance (described in section 7.2.1.1) to be a 
quality indicator; resln is structure resolution; npd_1 to npd_5 are full names from PDB files of all non-protein donor groups; class is from 
PDB header.  Only three sites link to main chain carbonyl oxygen (marked by a superscript ‘a’), and two cases where the linkage is through 
two O atoms of the same phosphate group (marked by a superscript ‘b’). (continued on next three pages) 
cngp sd1 sd2 CN rms resln PDB npd_1 npd_2 npd_3 npd_4 npd_5 Class 
D -1 -1 3 0.39 2.50 2AQX ATP_O3G_2462_ ATP_O2A_2462_ _ _ _ TRANSFERASE 
D -1 -1 6 0.09 1.60 1KJ9 ATP_O1G_1_ HOH_O_123_ HOH_O_129_ HOH_O_133_ HOH_O_252_ TRANSFERASE 
D -1 -1 4 0.14 2.50 2AQX ATP_O3G_1462_ ATP_O2A_1462_ HOH_O_105_ _ _ TRANSFERASE 
D -1 -1 4 0.19 2.50 2AQX ATP_O1G_2462_ ATP_O1B_2462_ _ _ _ TRANSFERASE 
D -1 -1 6 0.23 2.25 1Y8Q ATP_O2G_801_ ATP_O2B_801_ HOH_O_220_ HOH_O_414_ HOH_O_727_ LIGASE 
D -1 -1 3 0.26 2.40 1DER ATP_O1B_1_J ATP_O2A_1_J _ _ _ CHAPERONIN 
D -1 -1 6 0.36 2.10 1U5R ATP_O2B_411_ HOH_O_18_ HOH_O_46_ HOH_O_316_ _ TRANSFERASE 
D -1 -1 2 0.37 2.30 1Q97 ATP_O3B_485_ _ _   _ _ TRANSFERASE 
D -1 -1 4 0.49 2.30 1Q97
b
 ATP_O1G_485_ ATP_O2G_485_ ATP_O1A_485_ _ _ TRANSFERASE 
DD 2 -1 6 0.35 2.00 1DY3 ATP_O2B_200_A ATP_O1A_200_A  HOH_O_78_Z HOH_O_140_Z _ PYROPHOSPHORYLASE 
DD 2 -1 6 0.47 2.00 1DY3 ATP_O1G_200_A ATP_O2B_200_A  87Y_O16_201_A HOH_O_141_Z _ PYROPHOSPHORYLASE 
DD 98 -1 6 0.12 2.11 1MB9
b
 ATP_O2G_702_ ATP_O2A_702_ ATP_O3A_702_ HOH_O_655_ _ HYDROLASE 
DE 16 -1 3 0.54 2.20 2CJA ATP_O2A_1507_B _ _ _ _ LIGASE 
DE 99 -1 5 0.37 2.40 1N56 ATP_O1A_1803_ HOH_O_648_ HOH_O_1023_ _ _ TRANSFERASE/DNA 
DOD
a
 1 97 7 0.35 2.40 1N56 ATP_O1G_1803_ ATP_O1A_1803_ HOH_O_666_ _ _ TRANSFERASE/DNA 
 
  209
cngp sd1 sd2 CN rms resln PDB npd_1 npd_2 npd_3 npd_4 npd_5 Class 
E -1 -1 6 0.10 1.60 1KJ9 ATP_O3G_1_ ATP_O2B_1_ EDO_O1_15_ HOH_O_35_ _ TRANSFERASE 
E -1 -1 3 0.39 2.15 1YFR ATP_O1B_1500_ ATP_O1A_1500_ _ _ _ LIGASE 
E -1 -1 3 0.61 2.40 2I4O ATP_O3G_402_ ATP_O2B_402_ _ _ _ LIGASE 
ED 2 -1 5 0.28 2.20 1TFW ATP_O3G_1501_ ATP_O2B_1501_ ATP_O1A_1501_ _ _ TRANSFERASE/RNA 
ED 24 -1 6 0.11 2.10 1A49 OXL_O1_2333_D OXL_O4_2333_D ATP_O2G_2335_D HOH_O_6439_ _ TRANSFERASE 
ED 24 -1 5 0.17 2.10 1A49 OXL_O1_1733_C OXL_O4_1733_C ATP_O2G_1735_C _ _ TRANSFERASE 
EE 12 -1 6 0.11 1.60 1KJ9 ATP_O2G_5_ ATP_O2A_5_ HOH_O_420_ _ _ TRANSFERASE 
EQ 3 -1 4 0.41 2.40 2I4O ATP_O2B_402_  ATP_O2A_402_ _ _ _ LIGASE 
EQ 3 -1 5 0.39 2.40 2I4O MG_MG_302_ ATP_O2B_401_ ATP_O2A_401_ _ _ LIGASE 
HN 163 -1 3 0.39 2.00 1YUN ATP_O1B_1220_ _ _ _ _ TRANSFERASE 
N -1 -1 6 0.15 2.40 2BU2 ATP_O2G_1386_A ATP_O2B_1386_A ATP_O1A_1386_A HOH_O_40_Z HOH_O_87_Z TRANSFERASE 
N -1 -1 6 0.31 2.20 1TC0 ATP_O1B_601_ ATP_O2A_601_ HOH_O_75_ HOH_O_109_ HOH_O_110_ CHAPERONE 
N -1 -1 3 0.32 2.50 1TID ATP_O1G_201_ ATP_O1B_201_ _ _ _   TRANSCRIPTION 
N -1 -1 6 0.43 2.50 1TID ATP_O1G_200_ ATP_O1B_200_ ATP_O1A_200_ HOH_O_2_ HOH_O_49_ TRANSCRIPTION 
N -1 -1 3 0.45 2.00 1CSN ATP_O1G_299_ ATP_O2A_299_ _ _ _ PHOSPHOTRANSFERASE 
ND 13 -1 6 0.08 2.40 1S9J ATP_O1B_535_ ATP_O2A_535_ HOH_O_97_ HOH_O_98_ _ TRANSFERASE 
ND 13 -1 6 0.11 2.20 1QMZ ATP_O2G_381_A ATP_O3B_381_A ATP_O2A_381_A HOH_O_111_Z _ COMPLEX(PROTEINKINASE/CYCLIN) 
ND 13 -1 6 0.37 2.10 1U5R ATP_O2G_412_ ATP_O2A_412_ HOH_O_31_ HOH_O_225_ _ TRANSFERASE 
O
a
 -1 -1 3 0.49 1.70 1XNG ATP_O1G_304_ ATP_O2B_304_ _ _ _ LIGASE 
O
a
 -1 -1 6 0.34 1.70 1XNG ATP_O1G_303_ ATP_O2B_303_ ATP_O2A_303_ HOH_O_55_ HOH_O_161_ LIGASE 
R -1 -1 3 0.46 2.50 1XDP ATP_O2A_704_ HOH_O_94_ _ _  TRANSFERASE 
 
  210
cngp sd1 sd2 CN rms resln PDB npd_1 npd_2 npd_3 npd_4 npd_5 Class 
RR 30 -1 4 0.40 2.50 1XDP ATP_O1G_701_ _ _ _ _ TRANSFERASE 
S -1 -1 6 0.03 1.85 2IYW ATP_O1G_201_A ATP_O1B_201_A HOH_O_10_Z HOH_O_200_Z HOH_O_204_Z TRANSFERASE 
S -1 -1 6 0.06 1.70 1E2Q ATP_O3G_302_A ATP_O1B_302_A HOH_O_21_Z HOH_O_22_Z HOH_O_23_Z THYMIDYLATEKINASE 
S -1 -1 6 0.10 2.27 1W7A ATP_O2G_1801_A ATP_O2B_1801_A HOH_O_2101 _A  HOH_O_2110 _A HOH_O_2132 _A DNABINDING 
S -1 -1 6 0.14 2.50 1XEF ATP_O3G_800_ ATP_O2B_800_ HOH_O_160_ HOH_O_165_ HOH_O_171_ TRANSPORTPROTEIN 
S -1 -1 6 0.28 2.50 2C8V ATP_O3G_5292_A ATP_O1B_5292_A HOH_O_4_Z HOH_O_13_Z HOH_O_97_Z XIDOREDUCTASE 
S -1 -1 2 0.69 2.40 1KVK ATP_O3G_535_ _ _ _ _ TRANSFERASE 
SQ 28 -1 6 0.06 1.50 2CBZ ATP_O1G_1873_A ATP_O2B_1873_A HOH_O_187_Z HOH_O_278_Z _ TRANSPORT 
SQ 103 -1 6 0.04 1.60 1F2U ATP_O1G_901_A ATP_O1B_901_A HOH_O_48_ HOH_O_51_ _ REPLICATION 
SQ 105 -1 6 0.10 2.50 1XEX ATP_O1G_1001_ ATP_O1B_1001_ HOH_O_30_ HOH_O_109_ _ CELLCYCLE 
T -1 -1 5 0.08 2.40 1E79 ATP_O2G_600_A ATP_O2B_600_A HOH_O_72_Z HOH_O_73_Z _ ATPPHOSPHORYLASE 
T -1 -1 6 0.16 1.80 2BEK ATP_O3G_500_A ATP_O2B_500_A HOH_O_62_Z HOH_O_183_Z HOH_O_321_Z CHROMOSOMESEGREGATION 
T -1 -1 6 0.16 1.94 1SVM ATP_O1G_800_A ATP_O2B_800_A HOH_O_5_ HOH_O_803_ HOH_O_804_ VIRUS/VIRALPROTEIN 
T -1 -1 6 0.19 2.40 1II0 ATP_O2G_1591_ ATP_O1B_1591_ HOH_O_2073_ HOH_O_2102_ HOH_O_2209_ HYDROLASE 
T -1 -1 6 0.22 2.20 1YTM ATP_O3G_1541_ ATP_O2B_1541_ HOH_O_9_ HOH_O_229_ HOH_O_351_ LYASE 
T -1 -1 6 0.30 1.80 1OS1 ATP_O3G_541_ ATP_O2B_541_ HOH_O_674_ HOH_O_716_ HOH_O_738_ LYASE 
TDE 38 61 6 0.16 1.80 1A82 ATP_O3G_802_ ATP_O1B_802_ HOH_O_444_ _ _ BIOTINBIOSYNTHESIS 
TE 86 -1 6 0.13 2.10 1G64 ATP_O2B_1000_ ATP_O2A_1000_ HOH_O_1380_ HOH_O_1381_ _ TRANSFERASE 
TE 86 -1 6 0.14 2.10 1G64 ATP_O2B_999_ ATP_O2A_999_ HOH_O_1331_ HOH_O_1332_ _ TRANSFERASE 
TQ 28 -1 6 0.07 2.05 2BBS ATP_O2G_1_ ATP_O2B_1_ HOH_O_7_ HOH_O_202_ _ TRANSPORTPROTEIN 
N -1 -1 6 0.18 2.20 1TC0 ATP_O1B_301_ ATP_O2A_301_ HOH_O_38_ HOH_O_50_ HOH_O_125_ CHAPERONE 
 
  211
cngp sd1 sd2 CN rms resln PDB npd_1 npd_2 npd_3 npd_4 npd_5 Class 
             
The following proteins have ≥ 75 % sequence identity to proteins in the list above, as established with PISCES (Wang and Dunbrack 2003) and the sites appear very similar. 
E -1 -1 6 0.16 1.60 1KJ8 ATP_O3G_1_ ATP_O2B_1_ HOH_O_29_ HOH_O_231_ _ TRANSFERASE 
E -1 -1 3 0.51 1.60 1KJ8 ATP_O3G_5_ HOH_O_726_ _ _ _ TRANSFERASE 
EE 12 -1 6 0.08 1.60 1KJ8 ATP_O2G_1_ ATP_O2A_1_ HOH_O_22_ _ _ TRANSFERASE 
EE 12 -1 7 0.41 1.60 1KJ8 ATP_O2G_5_ ATP_O3B_5_ ATP_O2A_5_ HOH_O_539_ _ TRANSFERASE 
ND 13 -1 6 0.32 2.10 1U5R ATP_O3G_411_ ATP_O2A_411_ HOH_O_218_ HOH_O_261_ _ TRANSFERASE 
T -1 -1 4 0.26 2.30 1XMJ ATP_O2G_1_ ATP_O2B_1_ HOH_O_105_ _ _ MEMBRANEPROTEIN,HYDROLASE 
TQ 28 -1 6 0.13 2.25 1XMI ATP_O2G_4_ ATP_O2B_4_ HOH_O_687_ HOH_O_709_ _ MEMBRANEPROTEIN,HYDROLASE 
TQ 28 -1 4 0.15 2.35 1R0Z ATP_O2G_404_ ATP_O2B_404_ _ _ _ TRANSPORTPROTEIN 
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A database with details of the geometry of metal sites in proteins has been set
up. The data are derived from metalloprotein structures that are in the Protein
Data Bank [PDB; Berman, Henrick, Nakamura & Markley (2006). Nucleic
Acids Res. 35, D301–D303] and have been determined at 2.5 Å resolution or
better. The database contains all contacts within the crystal asymmetric unit
considered to be chemical bonds to any of the metals Na, Mg, K, Ca, Mn, Fe, Co,
Ni, Cu or Zn. The stored information includes PDB code, crystal data, resolution
of structure determination, refinement program and R factor, protein class
(from PDB header), contact distances, atom names of metal and interacting
atoms as they appear in the PDB, site occupancies, B values, coordination
numbers, information on coordination shapes, and metal–metal distances. This
may be accessed by SQL queries, or by a user-friendly web interface which
searches for contacts between specified types of atoms [for example Ca and
carboxylate O of aspartate, Co and imidazole N of histidine] or which delivers
details of all the metal sites in a specified protein. The web interface allows
graphical display of the metal site, on its own or within the whole protein
molecule, and may be accessed at http://eduliss.bch.ed.ac.uk/MESPEUS/. Some
applications are briefly described, including a study of the characteristics of Mg
sites that bind adenosine triphosphate, the derivation of an average Mg—
Ophosphate distance and some problems that arise when average bond distances
with high precision are required.
1. Introduction
Metal atoms occur in many proteins and may be essential for catalytic
function, or for the maintenance of structure, or for as yet uniden-
tified reasons. Metal sites can be well characterized by X-ray crystal
structure determination. In the relational database MESPEUS (metal
sites in proteins at Edinburgh University), we have assembled
geometric information for ten biologically common metals from files
in the Protein Data Bank (PDB; Berman et al., 2006). The database
now includes sites in crystal structures determined at resolution 2.5 Å
or better, by diffraction methods, for the metals Na, Mg, K, Ca, Mn,
Fe, Co, Ni, Cu and Zn, and in the PDB at 1 January 2007. There are
34 896 metal sites in 10 919 structures; nucleic acid structures are
included, as well as proteins. Geometric information can be useful (i)
in the interpretation and fitting of models to electron-density maps,
(ii) in the validation of structures or in restrained structure refine-
ment when only low-resolution diffraction data are available, and (iii)
for defining a ‘docking pocket’ for virtual screening in structure-
based drug design (see Taylor et al., 2008). Furthermore, when a metal
site has been identified in a new structure, related sites in known
structures can be compared quickly. Na and K sites are included
because, although their interactions with protein are better described
as electrostatic interactions than as bonds, knowledge of the
geometry of the sites can be useful. When they occur in metallo-
proteins, the metals V, Mo and W are normally present in anionic
forms, such as MoO4
3, and often in association with cofactors; their
interaction with the protein structure and its amino-acid side chains is
quite different from that of the metals that are present as cations, and
so they are not included in the database.
Previous work has extracted characteristic bond distances and
metal-site geometry from the PDB (Harding, 2000, 2001, 2006) and
made comparisons with small molecule structures in the Cambridge
Structural Database (CSD; Allen, 2002). These publications did not
give access to the individual observations. MESPEUS now contains
these observations from structures in the PDB at 1 January 2007.
Castagnetto et al. (2002) described a different database, Metallo-
Scripps MDB, also available on the Web and concerned with metals in
protein structures, but new material does not appear to have been
added to this since 2004.
For each metal atom, interactions with surrounding atoms which
are within chemically bonding distances were extracted using the
program MP described by Harding (2000); this distance is the ‘target’
distance, already characterized (Harding, 2006), plus a tolerance,
0.75 Å, to allow for coordinate errors in structure determination.
These ‘donor’ atoms in the metal coordination group are often O, N
or S from functional groups in the amino-acid side chains of the
protein, or of the main chain carbonyl group, but they may also be
from water molecules, substrate analogues or other non-protein
molecules present in the crystal. Thus, for each metal site, a coordi-
nation number and a description of the geometry could be derived
and stored (see the next section for details of the information
stored).
The web interface for this MESPEUS database provides the
possibility of searching for different combinations of metal and donor
atom and retrieving the distances. The mean distance (and standard
deviation) can be evaluated; the maximum crystal structure resolu-
tion used can be restricted; individual metal sites can be examined by
graphical display, with or without the surrounding protein structure.
2. Methodology
2.1. Details of information stored
Some information has been extracted directly from PDB files and
some with the program MP (Harding, 2000, where a fuller description
of some of the terms can be found). For each protein or nucleic acid
structure in the PDB, determined by diffraction methods at a reso-
lution of 2.5 Å or better, and containing one or more metal atoms, the
PDB code is stored, together with the name of the protein, the class
of protein (HEADER in PDB file), the data resolution (Å), the space
group and cell dimensions, the refinement program used, the R factor,
and Rfree. Within each structure, the names of all metal and donor
atoms are stored as they appear in the PDB file; for metal atoms the
coordination number, B value and information on the shape of the
site (e.g. the average deviation from tetrahedral or square planar for
sites with coordination number 4) are stored, and for donor atoms
their distances from the metal atom, their occupancies and B values.
The r.m.s. difference between the actual metal donor atom distances
and the target values is stored, as an indicator of the quality of the
geometry at each metal site. Metal coordination numbers are stored,
as evaluated by the program MP from the PDB file. Symmetry-
related atoms are not stored in the PDB and no attempt has been
made in this version of the MESPEUS database to generate them;
occasionally the metal coordination group should include atoms in
neighbouring symmetry-related units, e.g. when the metal atom lies
on a two-, three- or fourfold symmetry axis in the crystal, and in these
cases the value found for the coordination number will be too low.
Also stored are the E.C. numbers for enzymes (where given in the
PDB), metal–metal distances, indicators for bidentate carboxylate
groups, angles between bonds at the metal sites, and error informa-
tion, e.g. the presence of disorder at the site. All the information can
be accessed by SQL queries [Structured Query Language, see http://
dev.mysql.com/doc/refman/5.0/en/ or Chamberlin et al. (1976)].
Further details of the tables are available at http://eduliss.bch.ed.
ac.uk/MESPEUS/query_SQL.jsp.
2.2. The construction of the database
The Fortran program MP (Harding, 2001) examined each PDB file
in turn and gave a log file summarizing the geometric data for each
metal site found. Using Perl scripts these data were written to the
database tables. Information not given in the log files (e.g. structure
refinement program used, R factors) was extracted directly from the
PDB files. In cases where two alternative positions for a side chain
have been detected in the refinement and indicated by A and B as the
last character of the atom names, the B atoms (with lower occupancy)
have been removed and an error flag set for the associated metal
atom. About one-tenth of the metal sites are affected in this way. (At
other metal sites where a number of low-occupancy donor atoms are
reported there may also be disorder.)
2.3. Construction of the web interface
The web interface of MESPEUS was established utilizing a Java
web-based approach. In order to enable changes in functionality and
for ease of maintenance, the web site was constructed using Model-
View-Controller (MVC) software architecture. MVC separates the
data model, user phase and control logic into three individual
components so that modifications to one component can be made
with minimal impact to the others. The web interface allows the client
to set series of query criteria to access the MESPEUS database
without requiring any knowledge of SQL. It displays the accessible
information of metal coordination groups and displays the individual
metal site with distances, angles and coordination geometry.
computer programs
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Figure 1
The search screen of the web interface, filled in for query about Mg links to adenosine triphosphate (ATP).
3. Contents of database
At present, the database contains material from 10 919 structures in
the PDB, with numbers of metal sites as shown in Table 1. Some metal
or donor atoms are listed with low occupancy, and in some cases there
were pairs of disordered sites only one of which has been retained.
Coordinate errors can be large when atom positions have low occu-
pancy, and the presence of disordered sites gives meaningless results
for coordination numbers. These sites can be identified in the data-
base and excluded from searches, leaving the numbers shown in
column (2) of Table 1 (and except where stated otherwise all the
applications below use fully occupied atom positions). Not all the
metal sites interact directly with protein. The number of these is
particularly large for Mg [see Table 1, column (4)]. Some are simply
hydrated ions such as Mg(OH2)6
2+; others interact only with ligand
molecules, or with RNA or DNA (about 300 of the PDB files used for
our database describe RNA or DNA structures without protein).
When more than one copy of the protein molecule with metal
site(s) is present in the crystal asymmetric unit, all are listed in the
database – for metal to donor atom distances they should represent
separate observations. For this reason the number of distinct metal
sites is only circa 60% of the total number of sites listed. Furthermore,
the PDB contains many groups of very similar proteins within which
the metal sites are similar or identical.
3.1. The web interface
The MESPEUS web interface has been designed to allow
straightforward searching for particular kinds of interactions, with the
possibility of selecting only higher-resolution structures, as shown in
Fig. 1. Alternatively, a PDB code can be given to yield all the metal
sites in that protein. The first result is a list of all the metal–donor
computer programs
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Figure 2
Results of the search for Mg linked to ATP; this yielded 412 examples in 84 proteins or DNA/RNA structures. Average Mg—O distances and their distributions can be
displayed. *: Clicking here selects this distance range only. **: Links to a page like Fig. 3 showing details of the specified metal site. ***: Links to a page like Fig. 4 showing the
whole metal-containing protein.
Table 1
Numbers of metal sites in the MESPEUS database.
Note that a significant number of metal atoms are listed in PDB files which do not appear
to be within chemical bonding distance (target distance plus 0.75 Å) of any appropriate
atoms; in many cases there are not even any appropriate atoms within 3.6 Å. This does
not make chemical sense and can only be regarded as incomplete structure















Na 2372 2069 1768 301
Mg 5561 4953 3676 1277
K 1424 1259 1108 151
Ca 7120 6425 6018 407
Mn 2118 1810 1688 122
Fe 7763 7226 7003 223
Co 637 506 356 150
Ni 534 398 366 32
Cu 1327 1105 1088 17
Zn 6031 5073 4979 94
Total 34 896 30 824 28 050 2774
atom distances satisfying the search query, together with information
on coordination number of the metal, shape, atom names etc. as
shown in Fig. 2. Mean distances and distributions can be obtained, or
the list may be downloaded for other use. Any metal site selected can
be displayed graphically and its position in the whole protein struc-
ture shown (Figs. 3 and 4).
4. Applications of database and web interface
4.1. The importance of near atomic resolution in deriving mean
bond distances
We have been concerned to derive the best average values for
distances from metal atoms to different kinds of donor atoms in
structures deposited in the PDB, for use in validation, electron-
density map interpretation, model fitting or restrained refinement.
The average bond distance can be evaluated from all the data in the
database, or from the higher-resolution structure determinations
only. We and others (e.g. Meyer Klaucke, 2007) have noticed that
often the average found for a particular distance, for example Zn—N
of histidine with coordination number 4, shown in Table 2, is slightly
smaller when only high-resolution structure determination results are
used than when all results are used. The standard deviation (s.d.),
representing the scatter of results, is, as expected, smaller too.
The most precise averages, i.e. those with smallest standard
deviation, are those for the highest-resolution results, better than
1.3 Å at least, i.e. near atomic resolution; these agree best with the
CSD average for equivalent interactions, 2.00 (2) Å for 25 observa-
tions (Harding, 2006). Fig. 5 shows the wide scatter of reported
distances from poor-resolution structures; it is only at fairly high
resolution that there is good consistency of observations. On chemical
grounds very little variation in this particular distance is expected
(say < 0.02 Å); nearly all the variation above must be due to coor-
dinate errors remaining after structure refinement. (Other kinds of
distance, e.g. M—Ocarboxylate, can show more chemical variation.) It is
strongly recommended that for such averages only the highest-
resolution results practicable be used, consistent with a reasonable
number of observations.
4.2. Application: a survey of interactions between Mg and adenosine
triphosphate (ATP)
Phosphate–magnesium interactions are crucial in many enzyme
mechanisms. There is a particularly rich source of structural infor-
computer programs
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Figure 3
By clicking on the metal name in the results shown in Fig. 2, the metal site can be displayed by Jmol (http://jmol.sourceforge.net/), as well as its relation to the whole protein
molecule. Here, the metal, Mg (cyan coloured), is coordinated by the O atoms from Ser and Gln, two phosphate O atoms (one , one ) of ATP, and two water molecules. The
buttons below the pictures allow users to centre and rotate the view and add other information.
Table 2
Effect of resolution on mean distance found for Zn—N of histidine, with Zn
coordination number 4 (N and N" of histidine are both included; if they are kept
separate, no significant difference in their means is found).
Maximum resolution (Å) No. of observations Mean (s.d.) (Å)
2.5 3583 2.10 (13)
1.8 1007 2.07 (9)
1.5 261 2.06 (6)
1.3 88 2.03 (4)
1.1 21 2.02 (4)
mation available in the PDB for metal–ATP interactions and this
survey provides an overview of the interaction geometries found
from the database for protein–Mg–ATP complexes. The web inter-
face can find all links from Mg to O of ATP. For the detailed analysis,
it was more convenient to use one SQL query to find all Mg with ATP
links, and a second to pick up all the other atoms, protein or other-
wise, linked to each Mg; Perl scripts were then used to present the
results more conveniently. This yielded 136 Mg sites from 46 proteins;
transferases were the commonest protein types. After removal of
identical sites within crystal asymmetric units, 66 sites remained and
are listed, together with some statistics, in Table D (deposited1). In
these, Mg is normally linked to protein through one or two amino-
acid side chains, most commonly Asp, Glu, Asn, Gln, Ser and Thr, but
there are two examples with three links to protein, and three with
links to main chain carbonyl oxygen. ATP may be linked to Mg
through one, two or all three phosphate groups; the commonest
pattern (23 examples) is linkage through the - and -phosphate
groups, but all other possibilities occur, although there are only two
cases where linkage is through two O atoms of the same phosphate
group. The Mg coordination group may also include one to four water
molecules, and occasionally another small molecule like oxalate (as a
bidentate ion). More than half have total coordination number 6, the
expected coordination number for Mg. A surprisingly large number,
20, appear to have coordination number  4; this suggests that the
reliability of some of the data is questionable – some of the analyses
may be incomplete, or some of the atoms identified as Mg may in fact
be water molecules. Figs. 3 and 4 show an example of an Mg site with
ATP. Seven observations in structures at resolution  1.5 Å give a
mean Mg—Ophosphate distance of 2.05 (7) Å, but for a reliable average
more observations are desirable.
4.3. Application: Mg interactions with other phosphates
To establish an Mg—Ophosphate distance from a larger number of
higher-resolution observations, it was necessary to include other
phosphate ligands. Identifying phosphates from the atom names in
the PDB is not straightforward, but by selecting with SQL queries O
atoms whose residue names (het group names, see ‘het groups’
section of PDBSUM, http://www.ebi.ac.uk/thornton-srv/databases/
pdbsum/) include the letter P and whose atom names include one of
the letters A, B or G, or O atoms whose atom names include the letter
P, over 2000 Mg—Ophosphate links were found, 75 of which are from
computer programs
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Figure 4
By clicking on the protein name in the results shown in Fig. 2, information about the protein is tabulated, as well as details of each metal site; the whole protein molecule is
displayed by Jmol. Here the protein has two chains, A and C, with one Mg–ATP site on each. *: A dynamic link to centre this metal site in the view on the left. **: Links to a
page like Fig. 3 showing the specified metal site.
Figure 5
Reported values of Zn —Nhis distances for Zn coordination number 4, as a function
of resolution.
1 Supplementary data for this paper are available from the IUCr electronic
archives (Reference: KK5027). Services for accessing these data are described
at the back of the journal.
structures with resolution 1.3 Å or better. These have an average
Mg—O distance of 2.06 (8) Å, in good agreement with the value
above [and also close to the target distance given for Mg—Ocarboxylate
(Harding, 2006)]. The commonest links found are to adenosine
diphosphate (ADP; 453 links to Mg), ATP (410), atrial natriuretic
peptide (ANP; 299), and guanosine disphosphate (GDP; 219),
imidotriphosphate (GNP; 195) and triphosphate (GTP; 113). It is
again clear that linkage through two O atoms of one –PO4– group is
very rare, and that for the triphosphates ATP, GTP and CTP (cyti-
dine) the linkage is often bidentate, through the - and -phosphate
groups, not the  group.
4.4. Application: Mg compared with Mn and Co
DNA polymerases, RNAses, transposases and integrases all
require one or two Mg ions as an integral part of their enzymatic
mechanism (Steitz & Steitz, 1993). The effect of substituting Mn or
Co for Mg frequently results in modified activities, either partial or
complete inhibition of activity or in some cases enhancement of
activity and broadening of substrate specificity (Frank & Woodgate,
2007). It may be possible to relate at least some of these differences in
enzyme activity to differences in coordination geometry of the bound
metal in the active site. Mg and Co divalent ions are very similar in
size, while Mn2+ is significantly larger, e.g. Mg—O and Co—O are
2.07 Å while Mn—O is 2.17 Å. They have somewhat different
preferences for amino-acid donors; Co and Mn are much less likely
than Mg to interact with serine, threonine or main chain carbonyl
oxygen, and more likely to interact with histidine [see http://
tanna.bch.ed.ac.uk/, item 4, ‘..frequency of occurrence..’, or
Dokmanić et al. (2008)]. Here, coordination numbers (Table 3) and
shapes have been compared in structures with resolution 1.8 Å or
better. For each metal, more than half of the metal sites have coor-
dination number 6, and the next most important coordination
number is 5. Coordination numbers higher than 6 are almost always
associated with multidentate ligands, and coordination numbers less
than 4 or 5 may represent incomplete structure determinations, or
cases where additional donor atoms are present but are in neigh-
bouring asymmetric units not listed in the PDB files, or, particularly
in the case of Mg, unreliable data in the PDB, because of the difficulty
of locating Mg or distinguishing it from O of water. When the coor-
dination number is 6 the shape is octahedral, but the average
distortion from ideal octahedral is considerably less for Mg, 7 (5),
and Co, 8 (8), than for Mn, 11 (6) [see Harding (2000) for a
discussion of distortions]. When the coordination number is 5 the
ideal shapes may be described as trigonal bipyramidal or tetragonal
pyramidal; real metal sites are often between these two, and the
description is based on which ideal version it is least distorted from.
For Mg the tetragonal pyramid is strongly favoured (more than 95%
of observations) with average distortion 8 (6); for Mn and Co there
are near equal numbers of each shape with greater distortions. (All
this information can be gathered from repeated queries of the web
interface and some manual averaging, or it can be found very effi-
ciently with SQL queries of the database.)
4.5. Application: listing of metal coordination groups
These lists were described by Harding (2004). Metal coordination
groups (metal sites) were categorized by the sequence of amino-acid
donors and the relative positions of these amino acids in the poly-
peptide chain, using one-letter codes for the amino acids, and the
differences between the successive residue numbers. For example,
CHCC Zn 2 18 3 describes a coordination group in which Zn is
coordinated to the thiolate S of Cys(n), where n is the amino-acid
residue number, an imidazole N of His(n + 2), and the thiolate S
atoms of Cys(n + 2 + 18) and Cys(n + 2 + 18 + 3). Coordination
number and information on other non-protein donors present are
also given. The new database has allowed the preparation of new lists
including all metal sites in the PDB at January 2007. For each metal
atom in the database, the full names of all its donor atoms were
extracted with an SQL query; Perl scripts were used to convert these
to one-letter amino-acid codes, check that all donor atoms have site
occupancy > 0.7, work out sequence separations etc., as well as
remove duplicate coordination groups within the asymmetric unit of
any one crystal. The lists are available at http://tanna.bch.ed.ac.uk
(item 3, ‘New lists..’). They allow quick identification of other proteins
with coordination groups identical or similar to a specified one, and
could provide a resource for the study of patterns of metal coordi-
nation and protein evolution. A direct link to this database is
planned.
5. Conclusions, summary
The database, with its user-friendly web interface, allows immediate
identification and display of the metal sites in any specified protein
whose structure is in the PDB, determined at resolution 2.5 Å or
better. Alternatively, the web interface can identify all metal sites
with a particular kind of contact, giving distance, coordination
number and atom names for each, as well as average distances and
distribution of distances. Furthermore, as shown in several applica-
tions, SQL queries to the database can extract additional information
about the interactions of different metals with proteins.
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Table 3
Coordination numbers found for Mg, Mn and Co in structures determined at
resolution 1.8 Å or better.
1 2 3 4 5 6 7 8 9
Mg 42 84 91 101 195 956 25 2 1
Mn 3 6 8 26 78 246 19 3
Co 2 5 3 11 52 131
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Virtual screening overview: tools and
approaches
Ligand discovery can be regarded as a simple matching
problem: we would like to find a small molecule (ligand)
with the appropriate shape and charge properties to bind
effectively to a target protein of interest. High-throughput
screening (HTS) provides one possible experimental route to
a solution and libraries consisting of over 1 million
compounds can be tested in days. Computational screening
provides a complementary approach and with massively
parallel processing, millions of compounds per week can be
tested. Estimates of the number of potential small molecule
drug-like compounds vary between 1018 and beyond 1063
(Lipinski and Hopkins, 2004). Consequently, for any specific
target protein, even if the results from each assay and
each docking run were totally reliable (which is not the
case), it would still be impossible to test binding for every
potential ligand. The commonly accepted Lipinski criteria
(Lipinski et al., 1997) for orally active drug-like molecules
set physicochemical property limits to increase the prob-
ability of good drug bioavailability. Drug-like molecules are
expected to have a molecular weight (MW) p500 Da, p5
hydrogen bond donors (HBDs), p10 hydrogen bond accep-
tors (HBAs) and a CLog P p5 (the octanol-water partition
coefficient calculated as described by Moriguchi et al. (1992)
(MLogP) p4.15). More stringent criteria have been proposed
for initial searches. For example, Lead likeness restricts MW
to o350 Da and CLogP (the octanol-water partition coeffi-
cient, calculated using the Biobyte program (http://biobyte.
com.index.html) developed by Hansch and Leo) to o3
(Teague et al., 1999). Even these more stringent cutoffs do
little to reduce the astronomical numbers of potential
ligands and exploring such a large-scale-matching problem
will require imaginative computational and experimental
approaches.
Protein targets
Recent reviews have attempted to estimate the number of
druggable proteins in the Protein Data Bank (PDB) (Berman
et al., 2000). Druggable proteins have structural features that
facilitate binding to drug-like molecules. For proteins to
progress from intrinsic druggability to becoming a target
requires drug binding to modulate the biological role of the
protein and to bring about therapeutic benefit (Fishman and
Porter, 2005). Currently available literature identifies 1300
studied protein drug targets from humans and infective
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organisms (Hopkins and Groom, 2002; Russ and Lampel,
2005; Zheng et al., 2006). Estimates of the total number of
druggable targets in the human genome have been made
based on the number of disease genes; these give a total of up
to 1500 targets out of 25 000 in the human genome (Hopkins
and Groom, 2002). Bacterial and viral proteins also provide
targets; published estimates of the number of targets from
infective organisms are well over 1000. This suggests that
there should be a pool of about 3000 drug targets in total
(Zheng et al., 2006).
Of the 1300 currently studied targets, 44% are classified as
enzymes, the most populated biochemical class. A total of
557 enzymes are current research targets and 134 have
proved to be successful targets. Enzymes represent 50% of all
successful targets (Zheng et al., 2006). A total of 280 research
targets have experimentally determined structures with a
specific drug-binding domain (represented by 107-folds),
mainly by X-ray crystallography.
Within the PDB, there are about 250 uniquely different
(that is o10% amino acid identity) well-determined struc-
tures in complex with ‘peptide-ligands’. These represent a
subset of protein–protein interactions where the interaction
is controlled by a linear peptide on one side of the interface.
Table 1 shows some examples of protein–peptide inter-
actions. This group possibly represents the most druggable
subset of protein–protein interactions. Short linear peptides
are more amenable to replacement by small molecule
mimetics. Modulating protein–protein interactions is parti-
cularly attractive due to the pivotal role of such interactions
in cell signal transduction pathways and cell cycle progres-
sion (Fry and Vassilev, 2005; Chene, 2006).
There are a number of publicly accessible sources of
protein–ligand binding affinities and web-based tools de-
signed to aid the extraction of information from databases
containing structural information on protein targets. For
example, the BindingDB is a public, web-accessible database
of measured binding affinities for biomolecules and contains
data generated by isothermal titration calorimetry and
enzyme inhibition (http://www.bindingdb.org/). The Reli-
base database (http://relibase.ebi.ac.uk/) is a web-based tool
for the study of protein–ligand interaction. MSDmotif
(http://www.ebi.ac.uk/msd-srv/msdmotif/) provides a tool
for summarizing structural information on a database of
over 6000 protein–ligand complexes found in the PDB.
Small molecule databases
A number of publicly available small molecule databases
have been established over the last few years. The ligand.Info
database (http://ligand.info) (Grotthuss et al., 2004) is a
compilation of a number of publicly available databases
providing a Meta-Database of over 1 million entries with
calculated three-dimensional (3D) structures and some
information about biological activity. The ZINC database
(http://blaster.docking.org/zinc/) contains over 4.6 million
commercially available compounds in various 2D and 3D
formats (Irwin and Shoichet, 2005). Only compounds with
MW p700 Da, and calculated LogP values between –4 and 6
are stored. Simple Lipinski filters or other discreet subsets of
compounds can be selected.
An ambitious project financed by the National Institutes
of Health has the goal of discovering sets of molecules that
will specifically modulate the activities of the majority of
gene product in the human and other organisms. Fast
expanding databases are now being developed that
contain results from a number of high-throughput screens,
many of which use a set of over 100 000 chemically diverse
molecules. These data are available at NCBI’s database of
small organic molecules at http://www.ncbi.nlm.nih.gov/
sites/entrez?db¼pcassay.
EDULISS, the EDinburgh University Ligand Selection
System, is our in-house relational database that stores over
5 million available compounds, containing data from over
25 chemical catalogues. Of the 5.3 million compounds, 3.8
million are unique. 3D coordinates for each molecule are
stored with over 1500 topological, geometric, physicochem-
ical and toxicological descriptors per compound (Todeschini
and Consonni, 2005). The descriptors can be used inter-
actively to select subgroups of the database and also to
provide profiling information. One approach to identify
unique compounds is to compare the chemical graph of each
compound with the graph of every other. This approach is
extremely computationally expensive. An alternative meth-
od for identifying unique compounds in EDULISS’s large
collection has been developed. A small number of descrip-
tors including a 3D-Wiener index, an electronegativity
descriptor and a polarizability descriptor are used to group
compounds. The resulting small groups of molecules
with identical descriptors can then be compared using a
Table 1 Examples of protein-peptide interactions in the Protein Data Bank
PDB Protein Peptide Peptide sequence Function Reference
1YCR MDM2 p53 SQETFSDLWKLLPEN Antitumour (Vassilev et al., 2004)
1BXL (NMR) Bcl-XL Bak-BH3 GQVQRQLAIIGDDINR Apoptosis (Degterev et al., 2001)
1EBA EPO EPOR GGTXSCHFGPLTWVCKPQGG Anaemia (Qureshi et al., 1999)
1EJ4, 1WKW EiF4e EiF4e-BP RIIYDRKFLMECRN Malignant transformation (de and Graff, 2004)
1AXC PCNA p21 GRKRRQTSMTDFYHSKRRLIFS Antitumour (Gulbis et al., 1996)
1CKA c-CRK C3G PPPALPPKKR Oncogene (Wu et al., 1995)
1GUX Rb tumour suppressor E7 peptide DLYCYEQLN Antitumour (Lee et al., 1998)
1H9O SH2 Penta -peptide XVPML Signal transduction, cancer (Pauptit et al., 2001)
1QZ2 FKBP52 Hsp90 MEEVD Steroid signalling pathways (Wu et al., 2004)
1ELR HOP Hsp90 XMEEVD Signalling pathways (Scheufler et al., 2000)
1YVH c-CBL APS GRARAVENQXSFY Oncogene (Hu and Hubbard, 2005)
1G3F (NMR) XIAP-Bir3 Smac AVPIAQKSE Apoptosis (Liu et al., 2000)
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graph-matching program. A web-based interface for EDULISS
has been developed; this provides a convenient way of
extracting families of compounds with a user-defined set of
properties.
Database profiling and compound selection
The EDULISS database comprises 25 different commercial
and other smaller specialist compound collections. Of these,
some 4.3 million fit the Lipinski ‘rule of 5s’ (Lipinski et al.,
1997). A total of 3.2 million fit the Oprea lead-like criteria
(Hann and Oprea, 2004). The more stringent Astex Rule of 3
is met by 230 000 compounds (Carr et al., 2005) (statistical
profiles of some general descriptors are shown in Figure 1,
descriptor ranges are shown in Table 2). A study by Oprea
et al. (2007) investigated recent trends in the property space
of leads, drugs and chemical probes. Leads are generally
smaller, less complex and have lower LogP than drugs, due to
the inevitable modifications involved in the medicinal
chemistry optimization process.
It is desirable for a set of compounds for docking or assay
to be selected considering both protein target and screening
methodology. Solubility is of key importance for both
bioavailability and ‘screenability’. Experimentally derived
aqueous solubility data are not available for the majority
of compounds in the EDULISS database. Algorithms for
predicting aqueous solubility from structure almost univer-
sally rely on a directly proportional relationship between
LogP and solubility (Jorgensen and Duffy, 2002; Delaney,
2005). It might be appropriate to have a relaxed solubility
requirement (MLogP p4.21) and to include relatively large
compounds (p450 Da) with the aim of finding leads of high
affinity and high specificity for the target. A greater range of
molecular complexity may be explored with a higher MW
cutoff (Schuffenhauer et al., 2006). However, the application
of X-ray crystallography in lead discovery has different
property requirements. The technique identifies fragments
binding to significant regions of the target protein and then
employs fragment growing or linking strategies to improve
potency. Fragments are small molecules, 100–250 Da, with
few functional groups (Rees et al., 2004; Carr et al., 2005;
Hartshorn et al., 2005). In these techniques, virtual hit
ligands are soaked into crystals. Relative protein concentra-
tions are high, necessitating high ligand concentrations.
Solubility problems can be compounded by the practice of
soaking with a fragment cocktail to increase assay through-
put. Virtual screening subsets designed for fragment screens
Figure 1 Molecular property profiles of 5.3 million compounds in the EDULISS database. (a) MW. (b) MLogP. (c) Number of HBDs. (d)
Number of HBAs. Bin sizes for MWs are 5 Da and for MLogP, the number of HBDs and HBAs 1 U. EDULISS, EDinburgh University LIgand
Selection System; HBA, hydrogen bond acceptor; HBD, hydrogen bond donor; MLogP, the octanol-water partition coefficient calculated as
described by Moriguchi et al. (1992); MW, molecular weight
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need to have stringent solubility requirements, MLogP p3.0,
while containing diverse scaffolds decorated with a broad
range of functional groups (Moriguchi et al., 1992).
High-throughput virtual screening
High-throughput virtual screening achieves a high through-
put of test ligands by using simplified non-quantum
mechanical methods without the inclusion of complex
molecular dynamics (Woo and Roux, 2005). Typically, the
virtual screening process follows the steps outlined in
Figure 2. A ligand is selected and positioned into the target
protein-binding pocket in a given ‘pose’ (Muegge and
Martin, 1999). The resultant complex is scored on the basis
of intermolecular contacts to give a predicted strength of
binding interactions (Woo and Roux, 2005). Flexible docking
typically allows sampling of ligand and sometimes protein
conformations during the docking procedure. Rigid body
docking is however much less computationally expensive.
Exploring the conformers of relatively simple molecules
containing only three or four rotatable bonds (using a broad
step size) requires the generation of over 200 starting
conformations to be sampled in order to fully consider the
majority conformational space (Guner et al., 2004). The most
widely used flexible docking tools are GOLD (Genetic
Optimization for Ligand Docking) (Jones et al., 1997), FlexX
(Rarey et al., 1996; Kramer et al., 1999), DOCK (Ewing et al.,
2001), AutoDock (Goodsell et al., 1996), Glide (Friesner et al.,
2004; Halgren et al., 2004) and ICM (Internal Coordinate
Mechanics) (Abagyan et al., 1994). A variety of different
methods are used by the above tools to deal with ligand
flexibility such as genetic algorithms, incremental construc-
tion, simulated annealing and Monte Carlo methods
(Rosenfeld et al., 1995; Vieth et al., 1998). The diversity
exhibited by scoring functions has been used in consensus
scoring is implemented in, for example, X-SCORE (Wang
et al., 2003). Using different but well-performing scoring
functions, the accuracy of consensus methods can be greater
than any individual scheme (Bissantz et al., 2000; Stahl and
Rarey, 2001; Jacobsson et al., 2003; Raymond et al., 2004;
Xing et al., 2004; Feher, 2006). However, ‘artificial enrich-
ment’ is a potential pitfall, with scoring functions selected to
perform well on a specific protein–ligand complex (Verdonk
et al., 2004).
Perola et al. (2004) have reported that energy minimiza-
tion can significantly improve the accuracy of docking poses
found by GOLD (Jones et al., 1997) and ICM (Abagyan et al.,
1994) programs. Our results also showed that there is better
agreement between the docked pose and the crystallographic
pose using rigid body refinement. A ‘good fit’ is defined as an
root mean square distance (RMSD) p2 Å between corre-
sponding heavy atoms of the X-ray structure and the docked
ligand pose.
Virtual screening has proved successful in a number of
projects (Alvarez, 2004; Kitchen et al., 2004; Oprea and
Matter, 2004; Ghosh et al., 2006) (Table 3). One of the major
future challenges is to develop virtual screening methods
capable of identifying ligands that will interrupt protein–
protein interactions.
LIDAEUS as a tool for high-throughput virtual
screening
LIDAEUS, LIgand Discovery at Edinburgh UniverSity, our
in-house high-throughput virtual screening program (Wu
et al., 2003) generates a grid of site points in the binding
pocket of the target protein. Each site point is coloured: HBA,
HBD or hydrophobic, depending on the preferred protein
interaction (Figure 3).
Each molecule selected from the small molecule database
is placed in the binding pocket and atoms of the docked
molecule are matched to site points. An exhaustive fit of a
given number of atoms from the docked molecule onto the
site points is undertaken to identify reasonable poses. These
are stored for subsequent rigid body energy minimization.
Table 2 Descriptor ranges for the EDULISS database of 5.3 million
compounds
Descriptor Max Average Standard deviation
Molecule weight 2180.59 374.28 95.77
Number of bonds 306 47.05 13.05
Number of aromatic bonds 69 13.42 5.97
Number of rings 18 3.14 1.18
Sum of atomic van der Waals
volumesa (Å3)
172.82 29.29 7.71
Number of rotatable bonds 77 5.31 2.73
MLogP 134.05 3.29 3.35
Topological polar surface areab (Å2) 932.34 73.66 42.23
Abbreviations: EDULISS; LIgand Discovery at Edinburgh UniverSity; MLogP,
the octanol-water partition coefficient calculated as described by Moriguchi
(Moriguchi et al., 1992).
aScaled on Carbon atom.
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Figure 2 Steps involved in virtual screening using LIDAEUS.
LIDAEUS, LIgand Discovery at Edinburgh UniverSity.
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Table 3 Examples of hits from virtual screening experiments
Target Virtual screening Example structure* Reference Assay
Carbonic
anhydrase II







(Gruneberg et al., 2002) IC50 Sub
nanomolar








(Wang et al., 2000; Enyedy et al.,
2001)
IC50 9 mM






(Vangrevelinghe et al., 2003) IC50 80 nM








(McInnes et al., 2006) IC50 20 nM
GPCR Five targets 5-HT1A, 5-HT4,
Dopamine
D2, NK1, and CCR3
Compound PRX-93009 scored best for
5-HT1A, no structure shown
(Becker et al., 2004) Ki 1.0 nM













(Singh et al., 2002) IC50 1.3 nM
ERb GOLD 2.0 (Jones et al., 1997)
OH O
OH
(Zhao and Brinton, 2005) IC50 0.68 mM







(Brenk et al., 2003) IC50 0.25 mM
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There are various tunable parameters that influence how
thoroughly the binding pocket is explored and hence the
time required to dock a series of compounds. The precision
with which an atom matches the site point, called ‘resolu-
tion’ in this program, is usually set between 0.02 and 0.06 Å
and plays an important role in determining the number of
allowed starting poses. Resolution values greater than 0.06 Å
lead to an exponential growth in the number of starting
poses. Increasing the number and density of the site points
has a similar effect of dramatically increasing the number of
allowed starting poses.
In LIDAEUS, there are two built-in scoring functions, a
force field-based energy function and pose interaction profile
(PIP) a knowledge-based function (Kan, 2007). The energy
function is essentially a linear combination of van der Waals
and hydrogen bonding energies. The geometry-dependent
hydrogen bonding term incorporates salt bridges and
obviates the need for calculating hydrogen atom positions.
The program assigns fixed formal charges to identify
ionizable groups.
The PIP score uses a protein interaction profile that can be
assigned for specific regions of the binding pocket where
explicit types of ligand interactions, for example, a particular
hydrogen bond, are required. The PIP string is a hexadecimal
code containing information about the interactions made
between a given set of protein residues and the docked
ligand. The target PIP string is usually based on a known
X-ray crystal structure in which key features of the protein–
ligand binding interaction have been identified. It is a very
efficient process to match and score the bit strings of the
target interactions against those calculated for the docked
ligand pose. Thus, the PIP score can be used as a component
of the final score to ensure that docked ligands have both
favourable energies of interaction and satisfy specific inter-
actions in their pose.
While LIDAEUS is broadly similar in function to many
docking programs, it differs in two major areas: the extent to
which the fitting protocol can be modified by the user and
the modularity of the system. All definitions within the
program in the way of atom and site point types are soft, that
is, can be customized by the user. This happens at two levels:
one can initially type individual atoms according to
connectivity criteria and then group many or one of these
types into colours used in the pose generation or scoring
process. While using the default definitions allows for
standard searches using atoms grouped into broad classes
such as hydrophobic, HBA and HBD, it is possible to add
specific restrictions.
LIDAEUS exists as a series of modules that run as a UNIX
pipeline, so that initial typing of molecules, posing, scoring
and sorting are all separate programs. It allows us to easily
develop experimental modules and test different scoring
methods. The program is being developed in two areas. The
current flexible docking module is too slow to be used in a
high-throughput mode and this is being addressed. Sec-
ondly, a front end is being written that allows intermediate
users the ability to easily configure customizable features.
Table 3 Continued
Target Virtual screening Example structure* Reference Assay








(Wu et al., 2003) IC50 2.2 mM
Structures marked with an asterisk do not represent those initially identified by in silico screening. Minor chemical modifications have been made and from these
compounds the experimental data determined.
Figure 3 LIDAEUS site points in the binding pocket of CypA in
complex with cyclosporine-A (PDB code 1cwa). Each site point is
coloured depending on the preferred protein interaction (HBA, red;
HBD, blue; hydrophobic, grey). The magenta sphere represents a
key water molecule. Key residues are shown in bold. CypA, human
cyclophilin-A; HBA, hydrogen bond acceptor; HBD, hydrogen bond
donor; LIDAEUS, LIgand Discovery at Edinburgh UniverSity; PDB,
Protein Data Bank.
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The examples discussed in the paper were run on a modest
seven-node cluster. Run times are dependent on the target
protein, the ligand complexity and the site point resolution
set for LIDAEUS. However, representative times for a
database of 50 000 ligands would be 6 h. Using an IBM Blue
Gene/L supercomputer, run times have been reduced from 8
days on a seven-node cluster to 62 min on 1024 processors
using a standard data set of 1.67 million small molecules.
Validation of LIDAEUS docking and scoring
performance
The immunophilin proteins FKBP (FK506 Binding Protein)
and human cyclophilin-A (CypA) have been used as test
systems to develop and test the results from the database
mining program LIDAEUS. Despite having similar biological
profiles, the structure and active site of the two proteins are
very different. Both proteins have peptidyl-prolyl isomerase
activity and speed up the cis–trans equilibration of proline
residues by lowering the barrier to rotation about the imide
bond (Fischer et al., 1993). Inhibition of the enzymatic
turnover of an immunophilin substrate provides a functional
assay for screening potential inhibitors (Fischer et al., 1984).
X-ray crystallographic, surface plasmon resonance, iso-
thermal titration calorimetry and mass spectrometry results
provide complementary techniques for characterizing ligand
binding.
A set of nine chemically related ligands of human CypA
with IC50 values between 2 and 100 mM were used to test
LIDAEUS docking performance (referred to as the test set).
For each ligand, the X-ray structure is known and the RMSD
between corresponding atoms of the X-ray structure and the
ligand structure is used as a measure of fit. Correct docking
poses (RMSD p2 Å) of ligand 1 in the test set (Figure 4 shows
the correlation of PIP score and energy score were E, with
RMSD from X-ray structure for a ligand in the test set) were
all scored 40.93 by the PIP function and their energy scores,
E o11 kcal mol1. PIP scores are normalized between 0 and
1: a high PIP score indicates conserved interactions between
those in the X-ray structure and the docked pose. The other
ligands in the CypA test set have similar results, showing
that a combined total score of energy function and PIP
(matching a defined pose iinteraction profile) ranks the
correct docking binding mode higher than alternative poses
(Equation 1).




S, total score; E, force field-based energy score; PIP, knowl-
edge-based PIP score; W1, weighting factor specific to protein
system; W2, weighting factor specific to protein system.
For a set of nine related cyclophilin inhibitors, the effect of
changing the weights W1 and W2 was examined by system-
atically trialling different values. For this series of com-
pounds, the values that gave the best RMSD fit of the docked
pose compared to the crystallographic pose were weights of 1
and 40 for W1 and W2, respectively. These values proved
useful in identifying a new series of cyclophilin ligands (Kan,
2007).
The role of water in accurate docking
It has been reported in several studies that water-mediated
protein–ligand interactions are an important factor in the
docking process. Ligands can displace water in the active site
or incorporate them as an extension of the protein surface.
The presence of key water molecules can significantly
improve docking performance (Pospisil et al., 2002; Yang
and Chen, 2004). Our results show that eight out of nine
ligands in the test set were correctly docked into near-native
positions by LIDAEUS, while re-docking of six of them was
significantly improved when key water molecules were
included in the protein–ligand binding system. The presence
of the key waters enables the LIDAEUS program to identify
several important interactions involved in the complex and
construct the significant HBA or HBD site points at the
binding atom locations. (Key waters are those that form
bridging H bonds to both protein and ligand molecules).
Ligand 7 (Figure 5) is an example where including water
improved docking performance. The presence of the key
waters enables the LIDAEUS program to construct the
significant HBA or HBD site points at the binding atom
Figure 4 Correlation of PIP score and energy score, E, with RMSD from X-ray structure for ligand 1 of the CypA test set. (a) Plot of PIP score
against RMSD of docking poses with respect to X-ray structure. (b) Plot of energy score, E, against RMSD with respect to X-ray structure. Red
boxes highlight ‘good poses’ that meet scoring cutoffs: PIP score 40.93, energy score o11 kcal mol1. CypA, human cyclophilin-A; PIP, pose
interaction profile; RMSD, root mean square distance.
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locations. Furthermore, energy maps contoured with the
presence of key waters better represent the energy distribu-
tion in the local area. Thus, those maps would give the
correct fits lower energy scores than maps generated without
key waters.
Discovery of ligands for immunophilins
In a test to find CypA ligands, the ZINC database (Irwin and
Shoichet, 2005) of 2 million compounds was used as an
input for a LIDAEUS screen looking for compounds that
would match site points in the active site of CypA (two
parallel runs using 60 site points with a resolution of 0.06 Å
and 170 site points with a resolution of 0.04 Å). The top 2000
poses were re-ranked, specifying that hydrophobic inter-
actions with Phe113 and a hydrogen bond to Arg55 were
satisfied, using PIP scoring (Figure 6).
The combined energy and PIP scores ranged from 164 to
80 (arbitrary units). The top 360 unique compounds were
grouped according to chemical similarity (using molecular
fingerprinting and Tanimoto coefficients) and binding mode
(visually using Pymol). From this analysis, 14 compounds
(all chemically distinct from known cyclophilin inhibitors)
were purchased and tested for inhibition and binding by
peptidyl-prolyl isomerase assay (Kofron et al., 1991). Eleven
compounds showed a statistically significant reduction in
peptidyl-prolyl isomerase activity. Six of the 14 compounds
were ‘hits’ in the peptidyl-prolyl isomerase enzymatic assay;
they inhibited CypA with IC50 values ranging from 27 to
135 mM. Subsequent isothermal titration calorimetry studies
for the best three compounds gave Kd values of 2 to 8mM.
Virtual screening for CDK inhibitors using LIDAEUS
Cyclin-dependent kinases (CDKs) are key regulators in all
steps of the cell cycle and as such are interesting targets for
anticancer therapies. There are already a number of clinical
trials underway with CDK2 and CDK4 inhibitors for a range
of cancers (Collins and Garrett, 2005). The small molecule
inhibitors, roscovotine (Seliciclib) and flavopiridol, are
CDK2 inhibitors and show promising activity in lung cancer.
These drugs target the ATP binding site of the CDKs. This is a
problem in the design of CDK selective drugs, as all nine
CDKs show some homology and most of the active site
residues are well conserved. Another complicating factor in
the design of specific inhibitors is that the active form of the
kinase is induced by complex formation with a partner
cyclin and phosphorylation of a specific threonine residue
located on the T-loop of the kinase. These events cause subtle
changes in active site geometry, which may be important for
inhibitor design.
We used LIDAEUS to carry out a virtual screen of 50 000
commercially available compounds from the Maybridge
catalogue (www.maybridge.com) docked into the active site
of CDK2 (taken from the X-ray structure of the CDK2–
staurosporine complex; PDB code 1AQ1). The predicted top
120 poses based on the docking score were screened at a







Figure 5 Including water in site point generation. Poses were improved when an essential water molecule was used in the calculation of
energy maps and in site point construction. X-ray structure of the ligand is shown in white and docked poses in pink. (a) Illustrates how one
oxygen atom (O1) from the ligand was put into the experimental position (position A), but the other oxygen atom (O2) was put into position B
instead of position C, as revealed from the X-ray structure. (b) When the important water molecule (in magenta) is included in site point




Figure 6 PIP used in the CypA virtual screening experiment. The
top 2000 poses (rank ordered using the energy score, E,) were re-
ranked, specifying that there were predicted hydrophobic interac-
tions with Phe113 (grey lines) and a predicted hydrogen bond to
Arg55 (black dotted lines) using PIP scoring. The diagram shows a
molecule making interactions specified in the PIP. The green dashed
lines are non-covalent interactions not specified in the PIP. CypA,
human cyclophilin-A; PIP, pose interaction profile;
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inhibition of phosphorylation by CDK2/cyclinE. Twenty-
nine percent of the compounds were classed as active by
showing more than 30% inhibition. The most active four
compounds all had a heteroaryl-2-amino-pyrimidine core
and measured IC50 values between 0.9 and 17 mM (Table 4).
X-ray crystal structures of the four hits were obtained and
each was clearly identified in the ATP binding site. A
comparison was made of the calculated docked pose (with-
out any PIP influence) against the experimentally deter-
mined ligand structures. The four ligands were all found to
dock in twisted conformations with a twist of 35o around the
bond between the two aromatic rings. The RMSD atom
against atom fit of the three top scoring docked ligands
versus the experimental structure were 1.6, 1.58 and 3.42 Å
with scores of 24, 23 and 20 kcal mol1, respectively.
Despite the chemical similarity of these four ligands, they
adopt different binding modes (Table 4) CYC1 and CYC2
form identical hydrogen-bond interactions to ATP: NHy.O
(Glu81), Ny.HN(Leu83) and CHy.O(Leu83). When the
amine group is substituted as in CYC3 and CYC4, the ATP
binding mode is precluded and the ligand flips over to allow
the bulky substituent to point out of the pocket. An
alternative hydrogen bonding pattern is made CHyO
(Glu81), Ny.HN(Leu83) and NHy.O(Leu83). These four
structures provided an excellent starting point for the design
of chemical modifications. Over 40 related structures have
been synthesized to optimize in vivo potency. The tightest
binding ligand of this series, an amino derivative (CYC5),
has a Ki¼2 nM and was shown to induce cell death in
cultured HeLa cells (Wang et al., 2004a, b)
The importance of fine tuning a template structure
in virtual screening
The shape and surface of the target pocket is clearly one of
the most important factors in successful virtual screening
runs. The search for CDK2-specific inhibitors highlighted the
importance of understanding the biological role of the target
protein. A crystallographic study was used to analyse the
structures of six inhibitor ligands belonging to the thiazole-
pyrimidine class, identified by LIDAEUS; both in complex
with monomeric CDK2 and also with the binary CDK2/
cyclinA active complex (Wu et al., 2003; Kontopidis et al.,
2006). The activation of CDK2 by phosphorylation and
cyclin binding causes significant loop and helix movements
but leaves the shape of the ATP binding site relatively
unchanged with a maximum side-chain movement between
1 and 2 Å for residues comprising this pocket. However, these
small differences in pocket shape play a major role in the
relative binding strengths of inhibitors. In some cases, the
same ligands can adopt significantly different poses in
the monomeric and active complexes. Binding enthalpies
of the ligands have been estimated based on calculated van
der Waals and hydrogen bond contacts measured in the
crystal. The measured IC50 values correlate well with the
calculated interaction energy (energy score) for the binary
complex, but show poor correlation with the inactive
complex. This fits with the way the assay has been carried
out—using the active complex. It also suggests that the
enthalpic energy-scoring scheme, using van der Waals and
hydrogen bonding terms, provides a self-consistent measure
of binding strength (Kontopidis et al., 2006).
The discovery of cyclapolin, a potent Polo-like
kinase inhibitor
Polo-like kinase 1 (Plk1) controls the G2/M transition of the
cell cycle by phosphorylating a number of substrates that
function in mitotic progression. Overexpression of Plk1 is
frequently observed in tumours and in downregulation,
using small interfering RNA, has been shown to inhibit
cancer cell proliferation (McInnes et al., 2005). Small
molecule Plk-specific inhibitors are valuable biological tools
and can be used as leads for antitumour agents. A number of
general kinase inhibitors, such as staurosporine and purva-
lanol, are known to inhibit Plk1 (McInnes et al., 2005). After
years of intensive effort by academic and pharmaceutical
research groups, the X-ray structure of the kinase domain has
recently been published (Kothe et al., 2007) in complex with
a pyrazole inhibitor (PHA-680626), which has an IC50 value
of 0.5mM (PDB code 2owb). Before this structure became
available, we had developed a homology model of the kinase
domain of Plk based on the staurosporine-bound conforma-
tion of protein kinase A, which has a 31% sequence identity
(PDB code 1stc). The model was shown to be consistent with
the known structure-activity properties of a series of ligands
which were docked into the binding pocket in a similar
manner to that found in CDK2. LIDAEUS was used to dock a
library of 200 000 commercially available compounds into
the modelled active site of Plk1. A total of 350 of the top-
ranked compounds were then assayed by measuring inhibi-
tion of Plk1 phosphorylation of Cdc25C. A number of Plk1
inhibitors were identified with potencies ranging between
0.5 and 20 mM. A series of compounds (named the cyclapo-
lins) based on the benziathole N-oxide core of the most
active hit were synthesized and provide a consistent
structure-activity relationships for the inhibition of Plk1
(Figure 7). The most active compound in this series showed
significant improvement in potency and has an IC50 value of
2 nM. For this series, there is a good correlation between the
docking score and potency. Treatment of HeLa cells with
cyclapolin1 leads to mitotic cells that show severe spindle
abnormalities (McInnes et al., 2006).
Outlook
The evolution of structure-based lead discovery has been
guided by fashion and by some interesting technological
advances. Twenty-five years ago, we had the first useful
molecular graphics systems that could help medicinal
chemists visualize molecular properties. This technology
along with fast data collection and structure determination
of protein X-ray structures opened the path to structure-
based methods. Ironically, in the mid 1990s, just as this
approach was beginning to bear fruit, the fashion swung to
robotics and high-throughput screening, possibly spurred by
the newly founded discipline of Combinatorial Chemistry,
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which made it possible to generate very large libraries of
compounds. Now in larger organizations high-throughput
screening, in silico and structure-based approaches are quite
well integrated.
The main challenges in docking are still the old problems
of how to efficiently model effects including dielectrics,
entropy, water and flexibility. Advances in computer archi-
tectures may help tackle such problems. However, we also
need to design methods that allow efficient simulation of
these effects. Possibilities include using cliques of side
chain conformations around the active site, and hybrid
molecular modelling/quantum mechanical calculations.
High-throughput virtual screening, using simplified meth-
ods (non-quantum mechanical or complex molecular
dynamics), can already achieve docking rates of over 1 M
compounds an hour (Shave et al., 2008).
Table 4 CDK2 inhibitors discovered using LIDAEUS
Compound Kinase inhibition (CDK2/











17 ATP hydrogen-bonding pattern:
NHy.O(Glu81), 2.96 Å, Ny.HN(Leu83),
3.64 Å, CHy.O(Leu83), 3.36 Å









13 ATP hydrogen-bonding pattern:
NHy.O(Glu81), 2.86 Å, Ny.HN(Leu83),
3.30 Å, CHy.O(Leu83), 3.25 Å













Ligand flips over to allow the bulky
substituent to point out of the pocket









0.9 Alternative hydrogen bonding pattern:
CHy.O(Glu81), 3.31 Å, Ny.HN(Leu83),
2.92 Å, NHy.O(Leu83), 2.58 Å
Ligand flips over to allow the bulky
substituent to point out of the pocket
(Wu et al., 2003)
Colour coding denotes atoms involved in key hydrogen-bonding interactions.
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Technical advances in miniaturization (396-well plates)
and sensitive ligand-binding assays are already generating
very large amounts of binding data, which contribute to
structure-activity relationships. Accurate protein–ligand
binding data can add to our understanding of how proteins
recognize ligands. Identifying the key features of successful
virtual screening calculations can only enhance the chances
of discovering new ligands.
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